id	sid	tid	token	lemma	pos
cord-328352-l1q4uvxl	1	1	key	key	NN
cord-328352-l1q4uvxl	1	2	:	:	:
cord-328352-l1q4uvxl	1	3	cord-328352-l1q4uvxl	cord-328352-l1q4uvxl	NFP
cord-328352-l1q4uvxl	1	4	authors	author	NNS
cord-328352-l1q4uvxl	1	5	:	:	:
cord-328352-l1q4uvxl	1	6	Borlongan	Borlongan	NNP
cord-328352-l1q4uvxl	1	7	,	,	,
cord-328352-l1q4uvxl	1	8	Mia	Mia	NNP
cord-328352-l1q4uvxl	1	9	C.	C.	NNP
cord-328352-l1q4uvxl	1	10	;	;	:
cord-328352-l1q4uvxl	1	11	Borlongan	Borlongan	NNP
cord-328352-l1q4uvxl	1	12	,	,	,
cord-328352-l1q4uvxl	1	13	Maximillian	Maximillian	NNP
cord-328352-l1q4uvxl	1	14	C.	C.	NNP
cord-328352-l1q4uvxl	1	15	;	;	:
cord-328352-l1q4uvxl	1	16	Sanberg	Sanberg	NNP
cord-328352-l1q4uvxl	1	17	,	,	,
cord-328352-l1q4uvxl	1	18	Paul	Paul	NNP
cord-328352-l1q4uvxl	1	19	R.	R.	NNP
cord-328352-l1q4uvxl	1	20	title	title	NN
cord-328352-l1q4uvxl	1	21	:	:	:
cord-328352-l1q4uvxl	1	22	The	the	DT
cord-328352-l1q4uvxl	1	23	Disillusioned	Disillusioned	NNP
cord-328352-l1q4uvxl	1	24	Comfort	Comfort	NNP
cord-328352-l1q4uvxl	1	25	with	with	IN
cord-328352-l1q4uvxl	1	26	COVID-19	COVID-19	NNP
cord-328352-l1q4uvxl	1	27	and	and	CC
cord-328352-l1q4uvxl	1	28	the	the	DT
cord-328352-l1q4uvxl	1	29	Potential	potential	NN
cord-328352-l1q4uvxl	1	30	of	of	IN
cord-328352-l1q4uvxl	1	31	Convalescent	Convalescent	NNP
cord-328352-l1q4uvxl	1	32	Plasma	Plasma	NNP
cord-328352-l1q4uvxl	1	33	and	and	CC
cord-328352-l1q4uvxl	1	34	Cell	Cell	NNP
cord-328352-l1q4uvxl	1	35	Therapy	Therapy	NNP
cord-328352-l1q4uvxl	1	36	date	date	NN
cord-328352-l1q4uvxl	1	37	:	:	:
cord-328352-l1q4uvxl	1	38	2020	2020	CD
cord-328352-l1q4uvxl	1	39	-	-	HYPH
cord-328352-l1q4uvxl	1	40	08	08	CD
cord-328352-l1q4uvxl	1	41	-	-	SYM
cord-328352-l1q4uvxl	1	42	25	25	CD
cord-328352-l1q4uvxl	1	43	journal	journal	NN
cord-328352-l1q4uvxl	1	44	:	:	:
cord-328352-l1q4uvxl	2	1	Cell	cell	NN
cord-328352-l1q4uvxl	2	2	Transplant	transplant	NN
cord-328352-l1q4uvxl	2	3	DOI	doi	NN
cord-328352-l1q4uvxl	2	4	:	:	:
cord-328352-l1q4uvxl	2	5	10.1177/0963689720940719	10.1177/0963689720940719	CD
cord-328352-l1q4uvxl	2	6	sha	sha	NN
cord-328352-l1q4uvxl	2	7	:	:	:
cord-328352-l1q4uvxl	3	1	5c2cede17c25750ef19ccefb6c2f91bf4efb1501	5c2cede17c25750ef19ccefb6c2f91bf4efb1501	CD
cord-328352-l1q4uvxl	3	2	doc_id	doc_id	CD
cord-328352-l1q4uvxl	3	3	:	:	:
cord-328352-l1q4uvxl	3	4	328352	328352	CD
cord-328352-l1q4uvxl	3	5	cord_uid	cord_uid	NNS
cord-328352-l1q4uvxl	3	6	:	:	:
cord-328352-l1q4uvxl	4	1	l1q4uvxl	l1q4uvxl	.
cord-328352-l1q4uvxl	5	1	Coronavirus	Coronavirus	NNP
cord-328352-l1q4uvxl	5	2	disease	disease	NN
cord-328352-l1q4uvxl	5	3	2019	2019	CD
cord-328352-l1q4uvxl	5	4	or	or	CC
cord-328352-l1q4uvxl	5	5	COVID-19	covid-19	NN
cord-328352-l1q4uvxl	5	6	is	be	VBZ
cord-328352-l1q4uvxl	5	7	highly	highly	RB
cord-328352-l1q4uvxl	5	8	infectious	infectious	JJ
cord-328352-l1q4uvxl	5	9	,	,	,
cord-328352-l1q4uvxl	5	10	which	which	WDT
cord-328352-l1q4uvxl	5	11	can	can	MD
cord-328352-l1q4uvxl	5	12	lead	lead	VB
cord-328352-l1q4uvxl	5	13	to	to	IN
cord-328352-l1q4uvxl	5	14	acute	acute	JJ
cord-328352-l1q4uvxl	5	15	and	and	CC
cord-328352-l1q4uvxl	5	16	chronic	chronic	JJ
cord-328352-l1q4uvxl	5	17	debilitating	debilitating	JJ
cord-328352-l1q4uvxl	5	18	symptoms	symptom	NNS
cord-328352-l1q4uvxl	5	19	,	,	,
cord-328352-l1q4uvxl	5	20	as	as	RB
cord-328352-l1q4uvxl	5	21	well	well	RB
cord-328352-l1q4uvxl	5	22	as	as	IN
cord-328352-l1q4uvxl	5	23	mortality	mortality	NN
cord-328352-l1q4uvxl	5	24	.	.	.
cord-328352-l1q4uvxl	6	1	The	the	DT
cord-328352-l1q4uvxl	6	2	advent	advent	NN
cord-328352-l1q4uvxl	6	3	of	of	IN
cord-328352-l1q4uvxl	6	4	safe	safe	JJ
cord-328352-l1q4uvxl	6	5	and	and	CC
cord-328352-l1q4uvxl	6	6	effective	effective	JJ
cord-328352-l1q4uvxl	6	7	vaccines	vaccine	NNS
cord-328352-l1q4uvxl	6	8	or	or	CC
cord-328352-l1q4uvxl	6	9	antiviral	antiviral	JJ
cord-328352-l1q4uvxl	6	10	drugs	drug	NNS
cord-328352-l1q4uvxl	6	11	remains	remain	VBZ
cord-328352-l1q4uvxl	6	12	distant	distant	JJ
cord-328352-l1q4uvxl	6	13	in	in	IN
cord-328352-l1q4uvxl	6	14	the	the	DT
cord-328352-l1q4uvxl	6	15	future	future	NN
cord-328352-l1q4uvxl	6	16	.	.	.
cord-328352-l1q4uvxl	7	1	Practical	practical	JJ
cord-328352-l1q4uvxl	7	2	public	public	JJ
cord-328352-l1q4uvxl	7	3	health	health	NN
cord-328352-l1q4uvxl	7	4	measures	measure	NNS
cord-328352-l1q4uvxl	7	5	,	,	,
cord-328352-l1q4uvxl	7	6	such	such	JJ
cord-328352-l1q4uvxl	7	7	as	as	IN
cord-328352-l1q4uvxl	7	8	social	social	JJ
cord-328352-l1q4uvxl	7	9	distancing	distancing	NN
cord-328352-l1q4uvxl	7	10	,	,	,
cord-328352-l1q4uvxl	7	11	hand	hand	NN
cord-328352-l1q4uvxl	7	12	washing	washing	NN
cord-328352-l1q4uvxl	7	13	,	,	,
cord-328352-l1q4uvxl	7	14	and	and	CC
cord-328352-l1q4uvxl	7	15	wearing	wear	VBG
cord-328352-l1q4uvxl	7	16	a	a	DT
cord-328352-l1q4uvxl	7	17	face	face	NN
cord-328352-l1q4uvxl	7	18	mask	mask	NN
cord-328352-l1q4uvxl	7	19	,	,	,
cord-328352-l1q4uvxl	7	20	are	be	VBP
cord-328352-l1q4uvxl	7	21	the	the	DT
cord-328352-l1q4uvxl	7	22	current	current	JJ
cord-328352-l1q4uvxl	7	23	recommended	recommend	VBN
cord-328352-l1q4uvxl	7	24	guidelines	guideline	NNS
cord-328352-l1q4uvxl	7	25	by	by	IN
cord-328352-l1q4uvxl	7	26	the	the	DT
cord-328352-l1q4uvxl	7	27	Centers	Centers	NNPS
cord-328352-l1q4uvxl	7	28	for	for	IN
cord-328352-l1q4uvxl	7	29	Disease	Disease	NNP
cord-328352-l1q4uvxl	7	30	Control	Control	NNP
cord-328352-l1q4uvxl	7	31	and	and	CC
cord-328352-l1q4uvxl	7	32	Prevention	Prevention	NNP
cord-328352-l1q4uvxl	7	33	for	for	IN
cord-328352-l1q4uvxl	7	34	limiting	limit	VBG
cord-328352-l1q4uvxl	7	35	the	the	DT
cord-328352-l1q4uvxl	7	36	spread	spread	NN
cord-328352-l1q4uvxl	7	37	of	of	IN
cord-328352-l1q4uvxl	7	38	the	the	DT
cord-328352-l1q4uvxl	7	39	virus	virus	NN
cord-328352-l1q4uvxl	7	40	.	.	.
cord-328352-l1q4uvxl	8	1	Weakened	weakened	JJ
cord-328352-l1q4uvxl	8	2	immune	immune	JJ
cord-328352-l1q4uvxl	8	3	system	system	NN
cord-328352-l1q4uvxl	8	4	and	and	CC
cord-328352-l1q4uvxl	8	5	aberrant	aberrant	JJ
cord-328352-l1q4uvxl	8	6	inflammation	inflammation	NN
cord-328352-l1q4uvxl	8	7	represent	represent	VBP
cord-328352-l1q4uvxl	8	8	a	a	DT
cord-328352-l1q4uvxl	8	9	major	major	JJ
cord-328352-l1q4uvxl	8	10	pathological	pathological	JJ
cord-328352-l1q4uvxl	8	11	symptom	symptom	NN
cord-328352-l1q4uvxl	8	12	of	of	IN
cord-328352-l1q4uvxl	8	13	COVID-19	covid-19	JJ
cord-328352-l1q4uvxl	8	14	patients	patient	NNS
cord-328352-l1q4uvxl	8	15	.	.	.
cord-328352-l1q4uvxl	9	1	Based	base	VBN
cord-328352-l1q4uvxl	9	2	on	on	IN
cord-328352-l1q4uvxl	9	3	the	the	DT
cord-328352-l1q4uvxl	9	4	unique	unique	JJ
cord-328352-l1q4uvxl	9	5	immunomodulatory	immunomodulatory	JJ
cord-328352-l1q4uvxl	9	6	properties	property	NNS
cord-328352-l1q4uvxl	9	7	of	of	IN
cord-328352-l1q4uvxl	9	8	both	both	DT
cord-328352-l1q4uvxl	9	9	convalescent	convalescent	JJ
cord-328352-l1q4uvxl	9	10	plasma	plasma	NN
cord-328352-l1q4uvxl	9	11	and	and	CC
cord-328352-l1q4uvxl	9	12	stem	stem	NN
cord-328352-l1q4uvxl	9	13	cells	cell	NNS
cord-328352-l1q4uvxl	9	14	,	,	,
cord-328352-l1q4uvxl	9	15	we	-PRON-	PRP
cord-328352-l1q4uvxl	9	16	discuss	discuss	VBP
cord-328352-l1q4uvxl	9	17	here	here	RB
cord-328352-l1q4uvxl	9	18	their	-PRON-	PRP$
cord-328352-l1q4uvxl	9	19	potential	potential	JJ
cord-328352-l1q4uvxl	9	20	use	use	NN
cord-328352-l1q4uvxl	9	21	for	for	IN
cord-328352-l1q4uvxl	9	22	treating	treat	VBG
cord-328352-l1q4uvxl	9	23	COVID-19	covid-19	NN
cord-328352-l1q4uvxl	9	24	.	.	.
cord-328352-l1q4uvxl	10	1	may	may	MD
cord-328352-l1q4uvxl	10	2	be	be	VB
cord-328352-l1q4uvxl	10	3	likely	likely	RB
cord-328352-l1q4uvxl	10	4	accounted	account	VBN
cord-328352-l1q4uvxl	10	5	for	for	IN
cord-328352-l1q4uvxl	10	6	by	by	IN
cord-328352-l1q4uvxl	10	7	human	human	JJ
cord-328352-l1q4uvxl	10	8	behavior	behavior	NN
cord-328352-l1q4uvxl	10	9	,	,	,
cord-328352-l1q4uvxl	10	10	especially	especially	RB
cord-328352-l1q4uvxl	10	11	those	those	DT
cord-328352-l1q4uvxl	10	12	who	who	WP
cord-328352-l1q4uvxl	10	13	do	do	VBP
cord-328352-l1q4uvxl	10	14	not	not	RB
cord-328352-l1q4uvxl	10	15	take	take	VB
cord-328352-l1q4uvxl	10	16	seriously	seriously	RB
cord-328352-l1q4uvxl	10	17	the	the	DT
cord-328352-l1q4uvxl	10	18	Centers	Centers	NNPS
cord-328352-l1q4uvxl	10	19	for	for	IN
cord-328352-l1q4uvxl	10	20	Disease	Disease	NNP
cord-328352-l1q4uvxl	10	21	Control	Control	NNP
cord-328352-l1q4uvxl	10	22	and	and	CC
cord-328352-l1q4uvxl	10	23	Prevention	Prevention	NNP
cord-328352-l1q4uvxl	10	24	(	(	-LRB-
cord-328352-l1q4uvxl	10	25	CDC)-recommended	cdc)-recommende	VBN
cord-328352-l1q4uvxl	10	26	public	public	JJ
cord-328352-l1q4uvxl	10	27	health	health	NN
cord-328352-l1q4uvxl	10	28	practices	practice	NNS
cord-328352-l1q4uvxl	10	29	of	of	IN
cord-328352-l1q4uvxl	10	30	social	social	JJ
cord-328352-l1q4uvxl	10	31	distancing	distancing	NN
cord-328352-l1q4uvxl	10	32	and	and	CC
cord-328352-l1q4uvxl	10	33	proper	proper	JJ
cord-328352-l1q4uvxl	10	34	hygiene	hygiene	NN
cord-328352-l1q4uvxl	10	35	,	,	,
cord-328352-l1q4uvxl	10	36	i.e.	i.e.	FW
cord-328352-l1q4uvxl	10	37	,	,	,
cord-328352-l1q4uvxl	10	38	washing	washing	NN
cord-328352-l1q4uvxl	10	39	of	of	IN
cord-328352-l1q4uvxl	10	40	hands	hand	NNS
cord-328352-l1q4uvxl	10	41	with	with	IN
cord-328352-l1q4uvxl	10	42	soap	soap	NN
cord-328352-l1q4uvxl	10	43	and	and	CC
cord-328352-l1q4uvxl	10	44	water	water	NN
cord-328352-l1q4uvxl	10	45	.	.	.
cord-328352-l1q4uvxl	11	1	Moreover	moreover	RB
cord-328352-l1q4uvxl	11	2	,	,	,
cord-328352-l1q4uvxl	11	3	the	the	DT
cord-328352-l1q4uvxl	11	4	virusassociated	virusassociated	JJ
cord-328352-l1q4uvxl	11	5	microdroplets	microdroplet	NNS
cord-328352-l1q4uvxl	11	6	can	can	MD
cord-328352-l1q4uvxl	11	7	stay	stay	VB
cord-328352-l1q4uvxl	11	8	airborne	airborne	JJ
cord-328352-l1q4uvxl	11	9	for	for	IN
cord-328352-l1q4uvxl	11	10	up	up	IN
cord-328352-l1q4uvxl	11	11	to	to	TO
cord-328352-l1q4uvxl	11	12	3	3	CD
cord-328352-l1q4uvxl	11	13	h	h	NN
cord-328352-l1q4uvxl	11	14	6	6	CD
cord-328352-l1q4uvxl	11	15	,	,	,
cord-328352-l1q4uvxl	11	16	necessitating	necessitate	VBG
cord-328352-l1q4uvxl	11	17	the	the	DT
cord-328352-l1q4uvxl	11	18	need	need	NN
cord-328352-l1q4uvxl	11	19	for	for	IN
cord-328352-l1q4uvxl	11	20	wearing	wear	VBG
cord-328352-l1q4uvxl	11	21	a	a	DT
cord-328352-l1q4uvxl	11	22	face	face	NN
cord-328352-l1q4uvxl	11	23	mask	mask	NN
cord-328352-l1q4uvxl	11	24	to	to	TO
cord-328352-l1q4uvxl	11	25	protect	protect	VB
cord-328352-l1q4uvxl	11	26	ourselves	-PRON-	PRP
cord-328352-l1q4uvxl	11	27	and	and	CC
cord-328352-l1q4uvxl	11	28	others	other	NNS
cord-328352-l1q4uvxl	11	29	.	.	.
cord-328352-l1q4uvxl	12	1	The	the	DT
cord-328352-l1q4uvxl	12	2	combination	combination	NN
cord-328352-l1q4uvxl	12	3	of	of	IN
cord-328352-l1q4uvxl	12	4	6-feet	6-feet	CD
cord-328352-l1q4uvxl	12	5	social	social	JJ
cord-328352-l1q4uvxl	12	6	distancing	distancing	NN
cord-328352-l1q4uvxl	12	7	,	,	,
cord-328352-l1q4uvxl	12	8	20-s	20-s	CD
cord-328352-l1q4uvxl	12	9	hand	hand	NN
cord-328352-l1q4uvxl	12	10	washing	washing	NN
cord-328352-l1q4uvxl	12	11	,	,	,
cord-328352-l1q4uvxl	12	12	and	and	CC
cord-328352-l1q4uvxl	12	13	wearing	wear	VBG
cord-328352-l1q4uvxl	12	14	N-95	N-95	NNP
cord-328352-l1q4uvxl	12	15	or	or	CC
cord-328352-l1q4uvxl	12	16	other	other	JJ
cord-328352-l1q4uvxl	12	17	CDC	CDC	NNP
cord-328352-l1q4uvxl	12	18	-	-	HYPH
cord-328352-l1q4uvxl	12	19	recommended	recommend	VBN
cord-328352-l1q4uvxl	12	20	face	face	NN
cord-328352-l1q4uvxl	12	21	masks	mask	NNS
cord-328352-l1q4uvxl	12	22	has	have	VBZ
cord-328352-l1q4uvxl	12	23	been	be	VBN
cord-328352-l1q4uvxl	12	24	reported	report	VBN
cord-328352-l1q4uvxl	12	25	to	to	TO
cord-328352-l1q4uvxl	12	26	curve	curve	VB
cord-328352-l1q4uvxl	12	27	the	the	DT
cord-328352-l1q4uvxl	12	28	spread	spread	NN
cord-328352-l1q4uvxl	12	29	of	of	IN
cord-328352-l1q4uvxl	12	30	virus	virus	NN
cord-328352-l1q4uvxl	12	31	7	7	CD
cord-328352-l1q4uvxl	12	32	,	,	,
cord-328352-l1q4uvxl	12	33	8	8	CD
cord-328352-l1q4uvxl	12	34	,	,	,
cord-328352-l1q4uvxl	12	35	but	but	CC
cord-328352-l1q4uvxl	12	36	quantifying	quantify	VBG
cord-328352-l1q4uvxl	12	37	the	the	DT
cord-328352-l1q4uvxl	12	38	risk	risk	NN
cord-328352-l1q4uvxl	12	39	of	of	IN
cord-328352-l1q4uvxl	12	40	reducing	reduce	VBG
cord-328352-l1q4uvxl	12	41	these	these	DT
cord-328352-l1q4uvxl	12	42	strategies	strategy	NNS
cord-328352-l1q4uvxl	12	43	remains	remain	VBZ
cord-328352-l1q4uvxl	12	44	debatable	debatable	JJ
cord-328352-l1q4uvxl	12	45	.	.	.
cord-328352-l1q4uvxl	13	1	Notwithstanding	notwithstanding	IN
cord-328352-l1q4uvxl	13	2	,	,	,
cord-328352-l1q4uvxl	13	3	the	the	DT
cord-328352-l1q4uvxl	13	4	CDC	CDC	NNP
cord-328352-l1q4uvxl	13	5	continues	continue	VBZ
cord-328352-l1q4uvxl	13	6	to	to	TO
cord-328352-l1q4uvxl	13	7	stress	stress	VB
cord-328352-l1q4uvxl	13	8	practicing	practice	VBG
cord-328352-l1q4uvxl	13	9	social	social	JJ
cord-328352-l1q4uvxl	13	10	distancing	distancing	NN
cord-328352-l1q4uvxl	13	11	,	,	,
cord-328352-l1q4uvxl	13	12	hand	hand	NN
cord-328352-l1q4uvxl	13	13	washing	washing	NN
cord-328352-l1q4uvxl	13	14	,	,	,
cord-328352-l1q4uvxl	13	15	and	and	CC
cord-328352-l1q4uvxl	13	16	wearing	wear	VBG
cord-328352-l1q4uvxl	13	17	a	a	DT
cord-328352-l1q4uvxl	13	18	face	face	NN
cord-328352-l1q4uvxl	13	19	mask	mask	NN
cord-328352-l1q4uvxl	13	20	in	in	IN
cord-328352-l1q4uvxl	13	21	order	order	NN
cord-328352-l1q4uvxl	13	22	to	to	TO
cord-328352-l1q4uvxl	13	23	inhibit	inhibit	VB
cord-328352-l1q4uvxl	13	24	future	future	JJ
cord-328352-l1q4uvxl	13	25	deaths	death	NNS
cord-328352-l1q4uvxl	13	26	from	from	IN
cord-328352-l1q4uvxl	13	27	the	the	DT
cord-328352-l1q4uvxl	13	28	virus	virus	NN
cord-328352-l1q4uvxl	13	29	.	.	.
cord-328352-l1q4uvxl	14	1	Otherwise	otherwise	RB
cord-328352-l1q4uvxl	14	2	,	,	,
cord-328352-l1q4uvxl	14	3	we	-PRON-	PRP
cord-328352-l1q4uvxl	14	4	are	be	VBP
cord-328352-l1q4uvxl	14	5	living	live	VBG
cord-328352-l1q4uvxl	14	6	in	in	IN
cord-328352-l1q4uvxl	14	7	our	-PRON-	PRP$
cord-328352-l1q4uvxl	14	8	"	"	``
cord-328352-l1q4uvxl	14	9	disillusioned	disillusioned	JJ
cord-328352-l1q4uvxl	14	10	comfort	comfort	NN
cord-328352-l1q4uvxl	14	11	,	,	,
cord-328352-l1q4uvxl	14	12	"	"	''
cord-328352-l1q4uvxl	14	13	similar	similar	JJ
cord-328352-l1q4uvxl	14	14	to	to	IN
cord-328352-l1q4uvxl	14	15	the	the	DT
cord-328352-l1q4uvxl	14	16	misguided	misguided	JJ
cord-328352-l1q4uvxl	14	17	security	security	NN
cord-328352-l1q4uvxl	14	18	blanket	blanket	NN
cord-328352-l1q4uvxl	14	19	we	-PRON-	PRP
cord-328352-l1q4uvxl	14	20	afford	afford	VBP
cord-328352-l1q4uvxl	14	21	to	to	IN
cord-328352-l1q4uvxl	14	22	negative	negative	JJ
cord-328352-l1q4uvxl	14	23	consequences	consequence	NNS
cord-328352-l1q4uvxl	14	24	of	of	IN
cord-328352-l1q4uvxl	14	25	smoking	smoking	NN
cord-328352-l1q4uvxl	14	26	,	,	,
cord-328352-l1q4uvxl	14	27	gambling	gambling	NN
cord-328352-l1q4uvxl	14	28	,	,	,
cord-328352-l1q4uvxl	14	29	and	and	CC
cord-328352-l1q4uvxl	14	30	riding	ride	VBG
cord-328352-l1q4uvxl	14	31	a	a	DT
cord-328352-l1q4uvxl	14	32	motorcycle	motorcycle	NN
cord-328352-l1q4uvxl	14	33	.	.	.
cord-328352-l1q4uvxl	15	1	A	a	DT
cord-328352-l1q4uvxl	15	2	historical	historical	JJ
cord-328352-l1q4uvxl	15	3	review	review	NN
cord-328352-l1q4uvxl	15	4	of	of	IN
cord-328352-l1q4uvxl	15	5	virus	virus	NN
cord-328352-l1q4uvxl	15	6	-	-	HYPH
cord-328352-l1q4uvxl	15	7	related	relate	VBN
cord-328352-l1q4uvxl	15	8	pandemics	pandemic	NNS
cord-328352-l1q4uvxl	15	9	reminds	remind	VBZ
cord-328352-l1q4uvxl	15	10	us	-PRON-	PRP
cord-328352-l1q4uvxl	15	11	of	of	IN
cord-328352-l1q4uvxl	15	12	the	the	DT
cord-328352-l1q4uvxl	15	13	1918	1918	CD
cord-328352-l1q4uvxl	15	14	Spanish	spanish	JJ
cord-328352-l1q4uvxl	15	15	flu	flu	NN
cord-328352-l1q4uvxl	15	16	,	,	,
cord-328352-l1q4uvxl	15	17	which	which	WDT
cord-328352-l1q4uvxl	15	18	infected	infect	VBD
cord-328352-l1q4uvxl	15	19	500	500	CD
cord-328352-l1q4uvxl	15	20	million	million	CD
cord-328352-l1q4uvxl	15	21	and	and	CC
cord-328352-l1q4uvxl	15	22	estimated	estimate	VBN
cord-328352-l1q4uvxl	15	23	to	to	TO
cord-328352-l1q4uvxl	15	24	have	have	VB
cord-328352-l1q4uvxl	15	25	killed	kill	VBN
cord-328352-l1q4uvxl	15	26	about	about	RB
cord-328352-l1q4uvxl	15	27	17	17	CD
cord-328352-l1q4uvxl	15	28	million	million	CD
cord-328352-l1q4uvxl	15	29	to	to	TO
cord-328352-l1q4uvxl	15	30	50	50	CD
cord-328352-l1q4uvxl	15	31	million	million	CD
cord-328352-l1q4uvxl	15	32	people	people	NNS
cord-328352-l1q4uvxl	15	33	9	9	CD
cord-328352-l1q4uvxl	15	34	.	.	.
cord-328352-l1q4uvxl	16	1	The	the	DT
cord-328352-l1q4uvxl	16	2	Spanish	spanish	JJ
cord-328352-l1q4uvxl	16	3	flu	flu	NN
cord-328352-l1q4uvxl	16	4	resembles	resemble	VBZ
cord-328352-l1q4uvxl	16	5	COVID-19	covid-19	VB
cord-328352-l1q4uvxl	16	6	:	:	:
cord-328352-l1q4uvxl	16	7	both	both	DT
cord-328352-l1q4uvxl	16	8	are	be	VBP
cord-328352-l1q4uvxl	16	9	respiratory	respiratory	JJ
cord-328352-l1q4uvxl	16	10	viruses	virus	NNS
cord-328352-l1q4uvxl	16	11	with	with	IN
cord-328352-l1q4uvxl	16	12	the	the	DT
cord-328352-l1q4uvxl	16	13	precursor	precursor	NN
cord-328352-l1q4uvxl	16	14	viruses	virus	NNS
cord-328352-l1q4uvxl	16	15	mutating	mutate	VBG
cord-328352-l1q4uvxl	16	16	in	in	IN
cord-328352-l1q4uvxl	16	17	animals	animal	NNS
cord-328352-l1q4uvxl	16	18	thereafter	thereafter	RB
cord-328352-l1q4uvxl	16	19	infecting	infect	VBG
cord-328352-l1q4uvxl	16	20	humans	human	NNS
cord-328352-l1q4uvxl	16	21	,	,	,
cord-328352-l1q4uvxl	16	22	and	and	CC
cord-328352-l1q4uvxl	16	23	with	with	IN
cord-328352-l1q4uvxl	16	24	fast	fast	JJ
cord-328352-l1q4uvxl	16	25	-	-	HYPH
cord-328352-l1q4uvxl	16	26	progressive	progressive	JJ
cord-328352-l1q4uvxl	16	27	cases	case	NNS
cord-328352-l1q4uvxl	16	28	from	from	IN
cord-328352-l1q4uvxl	16	29	infection	infection	NN
cord-328352-l1q4uvxl	16	30	to	to	IN
cord-328352-l1q4uvxl	16	31	symptom	symptom	NN
cord-328352-l1q4uvxl	16	32	onset	onset	NN
cord-328352-l1q4uvxl	16	33	with	with	IN
cord-328352-l1q4uvxl	16	34	viral	viral	JJ
cord-328352-l1q4uvxl	16	35	consolidation	consolidation	NN
cord-328352-l1q4uvxl	16	36	in	in	IN
cord-328352-l1q4uvxl	16	37	the	the	DT
cord-328352-l1q4uvxl	16	38	lung	lung	NN
cord-328352-l1q4uvxl	16	39	and	and	CC
cord-328352-l1q4uvxl	16	40	eventually	eventually	RB
cord-328352-l1q4uvxl	16	41	mortality	mortality	NN
cord-328352-l1q4uvxl	16	42	primarily	primarily	RB
cord-328352-l1q4uvxl	16	43	from	from	IN
cord-328352-l1q4uvxl	16	44	pneumonia	pneumonia	NN
cord-328352-l1q4uvxl	16	45	9	9	CD
cord-328352-l1q4uvxl	16	46	-	-	SYM
cord-328352-l1q4uvxl	16	47	12	12	CD
cord-328352-l1q4uvxl	16	48	.	.	.
cord-328352-l1q4uvxl	17	1	Eerily	eerily	RB
cord-328352-l1q4uvxl	17	2	enough	enough	RB
cord-328352-l1q4uvxl	17	3	,	,	,
cord-328352-l1q4uvxl	17	4	the	the	DT
cord-328352-l1q4uvxl	17	5	key	key	JJ
cord-328352-l1q4uvxl	17	6	promoters	promoter	NNS
cord-328352-l1q4uvxl	17	7	of	of	IN
cord-328352-l1q4uvxl	17	8	such	such	JJ
cord-328352-l1q4uvxl	17	9	high	high	JJ
cord-328352-l1q4uvxl	17	10	mortality	mortality	NN
cord-328352-l1q4uvxl	17	11	rate	rate	NN
cord-328352-l1q4uvxl	17	12	of	of	IN
cord-328352-l1q4uvxl	17	13	Spanish	spanish	JJ
cord-328352-l1q4uvxl	17	14	flu	flu	NN
cord-328352-l1q4uvxl	17	15	were	be	VBD
cord-328352-l1q4uvxl	17	16	overcrowding	overcrowd	VBG
cord-328352-l1q4uvxl	17	17	and	and	CC
cord-328352-l1q4uvxl	17	18	poor	poor	JJ
cord-328352-l1q4uvxl	17	19	hygiene	hygiene	NN
cord-328352-l1q4uvxl	17	20	-	-	,
cord-328352-l1q4uvxl	17	21	the	the	DT
cord-328352-l1q4uvxl	17	22	same	same	JJ
cord-328352-l1q4uvxl	17	23	two	two	CD
cord-328352-l1q4uvxl	17	24	factors	factor	NNS
cord-328352-l1q4uvxl	17	25	that	that	WDT
cord-328352-l1q4uvxl	17	26	define	define	VBP
cord-328352-l1q4uvxl	17	27	our	-PRON-	PRP$
cord-328352-l1q4uvxl	17	28	disillusioned	disillusioned	JJ
cord-328352-l1q4uvxl	17	29	comfort	comfort	NN
cord-328352-l1q4uvxl	17	30	for	for	IN
cord-328352-l1q4uvxl	17	31	COVID-19	COVID-19	NNP
cord-328352-l1q4uvxl	17	32	.	.	.
cord-328352-l1q4uvxl	18	1	Human	human	JJ
cord-328352-l1q4uvxl	18	2	behavior	behavior	NN
cord-328352-l1q4uvxl	18	3	to	to	IN
cord-328352-l1q4uvxl	18	4	the	the	DT
cord-328352-l1q4uvxl	18	5	Spanish	spanish	JJ
cord-328352-l1q4uvxl	18	6	flu	flu	NN
cord-328352-l1q4uvxl	18	7	outbreak	outbreak	NN
cord-328352-l1q4uvxl	18	8	stands	stand	VBZ
cord-328352-l1q4uvxl	18	9	as	as	IN
cord-328352-l1q4uvxl	18	10	the	the	DT
cord-328352-l1q4uvxl	18	11	major	major	JJ
cord-328352-l1q4uvxl	18	12	determinant	determinant	NN
cord-328352-l1q4uvxl	18	13	for	for	IN
cord-328352-l1q4uvxl	18	14	the	the	DT
cord-328352-l1q4uvxl	18	15	pattern	pattern	NN
cord-328352-l1q4uvxl	18	16	of	of	IN
cord-328352-l1q4uvxl	18	17	the	the	DT
cord-328352-l1q4uvxl	18	18	pandemic	pandemic	NN
cord-328352-l1q4uvxl	18	19	's	's	POS
cord-328352-l1q4uvxl	18	20	high	high	JJ
cord-328352-l1q4uvxl	18	21	mortality	mortality	NN
cord-328352-l1q4uvxl	18	22	rate	rate	NN
cord-328352-l1q4uvxl	18	23	13	13	CD
cord-328352-l1q4uvxl	18	24	.	.	.
cord-328352-l1q4uvxl	19	1	Again	again	RB
cord-328352-l1q4uvxl	19	2	,	,	,
cord-328352-l1q4uvxl	19	3	the	the	DT
cord-328352-l1q4uvxl	19	4	same	same	JJ
cord-328352-l1q4uvxl	19	5	human	human	JJ
cord-328352-l1q4uvxl	19	6	response	response	NN
cord-328352-l1q4uvxl	19	7	,	,	,
cord-328352-l1q4uvxl	19	8	or	or	CC
cord-328352-l1q4uvxl	19	9	lack	lack	NN
cord-328352-l1q4uvxl	19	10	thereof	thereof	RB
cord-328352-l1q4uvxl	19	11	,	,	,
cord-328352-l1q4uvxl	19	12	that	that	WDT
cord-328352-l1q4uvxl	19	13	faces	face	VBZ
cord-328352-l1q4uvxl	19	14	COVID-19	covid-19	VB
cord-328352-l1q4uvxl	19	15	.	.	.
cord-328352-l1q4uvxl	20	1	A	a	DT
cord-328352-l1q4uvxl	20	2	Spanish	spanish	JJ
cord-328352-l1q4uvxl	20	3	flu	flu	NN
cord-328352-l1q4uvxl	20	4	vaccine	vaccine	NN
cord-328352-l1q4uvxl	20	5	was	be	VBD
cord-328352-l1q4uvxl	20	6	not	not	RB
cord-328352-l1q4uvxl	20	7	available	available	JJ
cord-328352-l1q4uvxl	20	8	during	during	IN
cord-328352-l1q4uvxl	20	9	the	the	DT
cord-328352-l1q4uvxl	20	10	1918	1918	CD
cord-328352-l1q4uvxl	20	11	pandemic	pandemic	NN
cord-328352-l1q4uvxl	20	12	,	,	,
cord-328352-l1q4uvxl	20	13	with	with	IN
cord-328352-l1q4uvxl	20	14	the	the	DT
cord-328352-l1q4uvxl	20	15	virus	virus	NN
cord-328352-l1q4uvxl	20	16	remaining	remain	VBG
cord-328352-l1q4uvxl	20	17	largely	largely	RB
cord-328352-l1q4uvxl	20	18	unknown	unknown	JJ
cord-328352-l1q4uvxl	20	19	for	for	IN
cord-328352-l1q4uvxl	20	20	almost	almost	RB
cord-328352-l1q4uvxl	20	21	a	a	DT
cord-328352-l1q4uvxl	20	22	century	century	NN
cord-328352-l1q4uvxl	20	23	when	when	WRB
cord-328352-l1q4uvxl	20	24	the	the	DT
cord-328352-l1q4uvxl	20	25	molecular	molecular	JJ
cord-328352-l1q4uvxl	20	26	underpinnings	underpinning	NNS
cord-328352-l1q4uvxl	20	27	of	of	IN
cord-328352-l1q4uvxl	20	28	the	the	DT
cord-328352-l1q4uvxl	20	29	virus	virus	NN
cord-328352-l1q4uvxl	20	30	were	be	VBD
cord-328352-l1q4uvxl	20	31	finally	finally	RB
cord-328352-l1q4uvxl	20	32	characterized	characterize	VBN
cord-328352-l1q4uvxl	20	33	in	in	IN
cord-328352-l1q4uvxl	20	34	2005	2005	CD
cord-328352-l1q4uvxl	20	35	14	14	CD
cord-328352-l1q4uvxl	20	36	.	.	.
cord-328352-l1q4uvxl	21	1	Similar	similar	JJ
cord-328352-l1q4uvxl	21	2	to	to	IN
cord-328352-l1q4uvxl	21	3	COVID-19	covid-19	VB
cord-328352-l1q4uvxl	21	4	,	,	,
cord-328352-l1q4uvxl	21	5	the	the	DT
cord-328352-l1q4uvxl	21	6	1918	1918	CD
cord-328352-l1q4uvxl	21	7	Spanish	spanish	JJ
cord-328352-l1q4uvxl	21	8	flu	flu	NN
cord-328352-l1q4uvxl	21	9	was	be	VBD
cord-328352-l1q4uvxl	21	10	first	first	RB
cord-328352-l1q4uvxl	21	11	detected	detect	VBN
cord-328352-l1q4uvxl	21	12	in	in	IN
cord-328352-l1q4uvxl	21	13	the	the	DT
cord-328352-l1q4uvxl	21	14	month	month	NN
cord-328352-l1q4uvxl	21	15	of	of	IN
cord-328352-l1q4uvxl	21	16	January	January	NNP
cord-328352-l1q4uvxl	21	17	,	,	,
cord-328352-l1q4uvxl	21	18	but	but	CC
cord-328352-l1q4uvxl	21	19	after	after	IN
cord-328352-l1q4uvxl	21	20	the	the	DT
cord-328352-l1q4uvxl	21	21	second	second	JJ
cord-328352-l1q4uvxl	21	22	wave	wave	NN
cord-328352-l1q4uvxl	21	23	in	in	IN
cord-328352-l1q4uvxl	21	24	August	August	NNP
cord-328352-l1q4uvxl	21	25	of	of	IN
cord-328352-l1q4uvxl	21	26	that	that	DT
cord-328352-l1q4uvxl	21	27	year	year	NN
cord-328352-l1q4uvxl	21	28	,	,	,
cord-328352-l1q4uvxl	21	29	the	the	DT
cord-328352-l1q4uvxl	21	30	number	number	NN
cord-328352-l1q4uvxl	21	31	of	of	IN
cord-328352-l1q4uvxl	21	32	cases	case	NNS
cord-328352-l1q4uvxl	21	33	dropped	drop	VBD
cord-328352-l1q4uvxl	21	34	significantly	significantly	RB
cord-328352-l1q4uvxl	21	35	and	and	CC
cord-328352-l1q4uvxl	21	36	almost	almost	RB
cord-328352-l1q4uvxl	21	37	disappeared	disappear	VBD
cord-328352-l1q4uvxl	21	38	by	by	IN
cord-328352-l1q4uvxl	21	39	the	the	DT
cord-328352-l1q4uvxl	21	40	year	year	NN
cord-328352-l1q4uvxl	21	41	's	's	POS
cord-328352-l1q4uvxl	21	42	end	end	NN
cord-328352-l1q4uvxl	21	43	.	.	.
cord-328352-l1q4uvxl	22	1	Without	without	IN
cord-328352-l1q4uvxl	22	2	a	a	DT
cord-328352-l1q4uvxl	22	3	vaccine	vaccine	NN
cord-328352-l1q4uvxl	22	4	,	,	,
cord-328352-l1q4uvxl	22	5	the	the	DT
cord-328352-l1q4uvxl	22	6	rapid	rapid	JJ
cord-328352-l1q4uvxl	22	7	decline	decline	NN
cord-328352-l1q4uvxl	22	8	in	in	IN
cord-328352-l1q4uvxl	22	9	infection	infection	NN
cord-328352-l1q4uvxl	22	10	and	and	CC
cord-328352-l1q4uvxl	22	11	mortality	mortality	NN
cord-328352-l1q4uvxl	22	12	after	after	IN
cord-328352-l1q4uvxl	22	13	the	the	DT
cord-328352-l1q4uvxl	22	14	second	second	NN
cord-328352-l1q4uvxl	22	15	of	of	IN
cord-328352-l1q4uvxl	22	16	the	the	DT
cord-328352-l1q4uvxl	22	17	two	two	CD
cord-328352-l1q4uvxl	22	18	lethal	lethal	JJ
cord-328352-l1q4uvxl	22	19	waves	wave	NNS
cord-328352-l1q4uvxl	22	20	of	of	IN
cord-328352-l1q4uvxl	22	21	Spanish	spanish	JJ
cord-328352-l1q4uvxl	22	22	flu	flu	NN
cord-328352-l1q4uvxl	22	23	was	be	VBD
cord-328352-l1q4uvxl	22	24	attributed	attribute	VBN
cord-328352-l1q4uvxl	22	25	to	to	IN
cord-328352-l1q4uvxl	22	26	better	well	JJR
cord-328352-l1q4uvxl	22	27	treatment	treatment	NN
cord-328352-l1q4uvxl	22	28	of	of	IN
cord-328352-l1q4uvxl	22	29	pneumonia	pneumonia	NN
cord-328352-l1q4uvxl	22	30	and	and	CC
cord-328352-l1q4uvxl	22	31	the	the	DT
cord-328352-l1q4uvxl	22	32	virus	virus	NN
cord-328352-l1q4uvxl	22	33	mutating	mutate	VBG
cord-328352-l1q4uvxl	22	34	to	to	IN
cord-328352-l1q4uvxl	22	35	a	a	DT
cord-328352-l1q4uvxl	22	36	less	less	RBR
cord-328352-l1q4uvxl	22	37	dangerous	dangerous	JJ
cord-328352-l1q4uvxl	22	38	strain	strain	NN
cord-328352-l1q4uvxl	22	39	.	.	.
cord-328352-l1q4uvxl	23	1	Three	three	CD
cord-328352-l1q4uvxl	23	2	key	key	JJ
cord-328352-l1q4uvxl	23	3	lessons	lesson	NNS
cord-328352-l1q4uvxl	23	4	from	from	IN
cord-328352-l1q4uvxl	23	5	the	the	DT
cord-328352-l1q4uvxl	23	6	Spanish	spanish	JJ
cord-328352-l1q4uvxl	23	7	flu	flu	NN
cord-328352-l1q4uvxl	23	8	pandemic	pandemic	NN
cord-328352-l1q4uvxl	23	9	are	be	VBP
cord-328352-l1q4uvxl	23	10	worthy	worthy	JJ
cord-328352-l1q4uvxl	23	11	of	of	IN
cord-328352-l1q4uvxl	23	12	consideration	consideration	NN
cord-328352-l1q4uvxl	23	13	.	.	.
cord-328352-l1q4uvxl	24	1	First	first	RB
cord-328352-l1q4uvxl	24	2	,	,	,
cord-328352-l1q4uvxl	24	3	those	those	DT
cord-328352-l1q4uvxl	24	4	who	who	WP
cord-328352-l1q4uvxl	24	5	survived	survive	VBD
cord-328352-l1q4uvxl	24	6	the	the	DT
cord-328352-l1q4uvxl	24	7	first	first	JJ
cord-328352-l1q4uvxl	24	8	wave	wave	NN
cord-328352-l1q4uvxl	24	9	developed	develop	VBN
cord-328352-l1q4uvxl	24	10	immunity	immunity	NN
cord-328352-l1q4uvxl	24	11	against	against	IN
cord-328352-l1q4uvxl	24	12	the	the	DT
cord-328352-l1q4uvxl	24	13	virus	virus	NN
cord-328352-l1q4uvxl	24	14	;	;	:
cord-328352-l1q4uvxl	24	15	thus	thus	RB
cord-328352-l1q4uvxl	24	16	,	,	,
cord-328352-l1q4uvxl	24	17	these	these	DT
cord-328352-l1q4uvxl	24	18	individuals	individual	NNS
cord-328352-l1q4uvxl	24	19	were	be	VBD
cord-328352-l1q4uvxl	24	20	immune	immune	JJ
cord-328352-l1q4uvxl	24	21	to	to	IN
cord-328352-l1q4uvxl	24	22	the	the	DT
cord-328352-l1q4uvxl	24	23	second	second	JJ
cord-328352-l1q4uvxl	24	24	wave	wave	NN
cord-328352-l1q4uvxl	24	25	of	of	IN
cord-328352-l1q4uvxl	24	26	the	the	DT
cord-328352-l1q4uvxl	24	27	Spanish	spanish	JJ
cord-328352-l1q4uvxl	24	28	flu	flu	NN
cord-328352-l1q4uvxl	24	29	,	,	,
cord-328352-l1q4uvxl	24	30	providing	provide	VBG
cord-328352-l1q4uvxl	24	31	us	-PRON-	PRP
cord-328352-l1q4uvxl	24	32	a	a	DT
cord-328352-l1q4uvxl	24	33	glimpse	glimpse	NN
cord-328352-l1q4uvxl	24	34	on	on	IN
cord-328352-l1q4uvxl	24	35	the	the	DT
cord-328352-l1q4uvxl	24	36	future	future	NN
cord-328352-l1q4uvxl	24	37	of	of	IN
cord-328352-l1q4uvxl	24	38	passive	passive	JJ
cord-328352-l1q4uvxl	24	39	immunitybased	immunitybase	VBN
cord-328352-l1q4uvxl	24	40	treatment	treatment	NN
cord-328352-l1q4uvxl	24	41	against	against	IN
cord-328352-l1q4uvxl	24	42	the	the	DT
cord-328352-l1q4uvxl	24	43	virus	virus	NN
cord-328352-l1q4uvxl	24	44	.	.	.
cord-328352-l1q4uvxl	25	1	Indeed	indeed	RB
cord-328352-l1q4uvxl	25	2	,	,	,
cord-328352-l1q4uvxl	25	3	clinical	clinical	JJ
cord-328352-l1q4uvxl	25	4	trials	trial	NNS
cord-328352-l1q4uvxl	25	5	have	have	VBP
cord-328352-l1q4uvxl	25	6	recently	recently	RB
cord-328352-l1q4uvxl	25	7	been	be	VBN
cord-328352-l1q4uvxl	25	8	initiated	initiate	VBN
cord-328352-l1q4uvxl	25	9	using	use	VBG
cord-328352-l1q4uvxl	25	10	plasma	plasma	NN
cord-328352-l1q4uvxl	25	11	collected	collect	VBN
cord-328352-l1q4uvxl	25	12	from	from	IN
cord-328352-l1q4uvxl	25	13	recovered	recover	VBN
cord-328352-l1q4uvxl	25	14	COVID-19	COVID-19	NNP
cord-328352-l1q4uvxl	25	15	patients	patient	NNS
cord-328352-l1q4uvxl	25	16	based	base	VBN
cord-328352-l1q4uvxl	25	17	on	on	IN
cord-328352-l1q4uvxl	25	18	the	the	DT
cord-328352-l1q4uvxl	25	19	concept	concept	NN
cord-328352-l1q4uvxl	25	20	that	that	IN
cord-328352-l1q4uvxl	25	21	these	these	DT
cord-328352-l1q4uvxl	25	22	individuals	individual	NNS
cord-328352-l1q4uvxl	25	23	have	have	VBP
cord-328352-l1q4uvxl	25	24	likely	likely	RB
cord-328352-l1q4uvxl	25	25	harbored	harbor	VBN
cord-328352-l1q4uvxl	25	26	strong	strong	JJ
cord-328352-l1q4uvxl	25	27	immune	immune	JJ
cord-328352-l1q4uvxl	25	28	responses	response	NNS
cord-328352-l1q4uvxl	25	29	such	such	JJ
cord-328352-l1q4uvxl	25	30	as	as	IN
cord-328352-l1q4uvxl	25	31	antibodies	antibody	NNS
cord-328352-l1q4uvxl	25	32	that	that	WDT
cord-328352-l1q4uvxl	25	33	target	target	VBP
cord-328352-l1q4uvxl	25	34	the	the	DT
cord-328352-l1q4uvxl	25	35	proteins	protein	NNS
cord-328352-l1q4uvxl	25	36	found	find	VBN
cord-328352-l1q4uvxl	25	37	on	on	IN
cord-328352-l1q4uvxl	25	38	COVID-19	COVID-19	NNP
cord-328352-l1q4uvxl	25	39	15	15	CD
cord-328352-l1q4uvxl	25	40	.	.	.
cord-328352-l1q4uvxl	26	1	Second	second	RB
cord-328352-l1q4uvxl	26	2	,	,	,
cord-328352-l1q4uvxl	26	3	that	that	IN
cord-328352-l1q4uvxl	26	4	the	the	DT
cord-328352-l1q4uvxl	26	5	end	end	NN
cord-328352-l1q4uvxl	26	6	of	of	IN
cord-328352-l1q4uvxl	26	7	Spanish	spanish	JJ
cord-328352-l1q4uvxl	26	8	flu	flu	NN
cord-328352-l1q4uvxl	26	9	cases	case	NNS
cord-328352-l1q4uvxl	26	10	by	by	IN
cord-328352-l1q4uvxl	26	11	1920	1920	CD
cord-328352-l1q4uvxl	26	12	might	may	MD
cord-328352-l1q4uvxl	26	13	have	have	VB
cord-328352-l1q4uvxl	26	14	signaled	signal	VBN
cord-328352-l1q4uvxl	26	15	the	the	DT
cord-328352-l1q4uvxl	26	16	eradication	eradication	NN
cord-328352-l1q4uvxl	26	17	of	of	IN
cord-328352-l1q4uvxl	26	18	the	the	DT
cord-328352-l1q4uvxl	26	19	pandemic	pandemic	NN
cord-328352-l1q4uvxl	26	20	may	may	MD
cord-328352-l1q4uvxl	26	21	not	not	RB
cord-328352-l1q4uvxl	26	22	be	be	VB
cord-328352-l1q4uvxl	26	23	completely	completely	RB
cord-328352-l1q4uvxl	26	24	true	true	JJ
cord-328352-l1q4uvxl	26	25	.	.	.
cord-328352-l1q4uvxl	27	1	Evidence	evidence	NN
cord-328352-l1q4uvxl	27	2	of	of	IN
cord-328352-l1q4uvxl	27	3	slow	slow	JJ
cord-328352-l1q4uvxl	27	4	-	-	HYPH
cord-328352-l1q4uvxl	27	5	progressive	progressive	JJ
cord-328352-l1q4uvxl	27	6	cases	case	NNS
cord-328352-l1q4uvxl	27	7	of	of	IN
cord-328352-l1q4uvxl	27	8	Spanish	spanish	JJ
cord-328352-l1q4uvxl	27	9	flu	flu	NN
cord-328352-l1q4uvxl	27	10	has	have	VBZ
cord-328352-l1q4uvxl	27	11	been	be	VBN
cord-328352-l1q4uvxl	27	12	linked	link	VBN
cord-328352-l1q4uvxl	27	13	to	to	IN
cord-328352-l1q4uvxl	27	14	secondary	secondary	JJ
cord-328352-l1q4uvxl	27	15	bacterial	bacterial	JJ
cord-328352-l1q4uvxl	27	16	pneumonia	pneumonia	NN
cord-328352-l1q4uvxl	27	17	,	,	,
cord-328352-l1q4uvxl	27	18	possibly	possibly	RB
cord-328352-l1q4uvxl	27	19	affecting	affect	VBG
cord-328352-l1q4uvxl	27	20	the	the	DT
cord-328352-l1q4uvxl	27	21	brain	brain	NN
cord-328352-l1q4uvxl	27	22	,	,	,
cord-328352-l1q4uvxl	27	23	which	which	WDT
cord-328352-l1q4uvxl	27	24	results	result	VBZ
cord-328352-l1q4uvxl	27	25	in	in	IN
cord-328352-l1q4uvxl	27	26	neurological	neurological	JJ
cord-328352-l1q4uvxl	27	27	disorders	disorder	NNS
cord-328352-l1q4uvxl	27	28	,	,	,
cord-328352-l1q4uvxl	27	29	in	in	IN
cord-328352-l1q4uvxl	27	30	particular	particular	JJ
cord-328352-l1q4uvxl	27	31	encephalitis	encephalitis	RB
cord-328352-l1q4uvxl	27	32	lethargica	lethargica	NNP
cord-328352-l1q4uvxl	27	33	,	,	,
cord-328352-l1q4uvxl	27	34	that	that	WDT
cord-328352-l1q4uvxl	27	35	recorded	record	VBD
cord-328352-l1q4uvxl	27	36	its	-PRON-	PRP$
cord-328352-l1q4uvxl	27	37	outbreak	outbreak	NN
cord-328352-l1q4uvxl	27	38	in	in	IN
cord-328352-l1q4uvxl	27	39	the	the	DT
cord-328352-l1q4uvxl	27	40	1920s	1920	NNS
cord-328352-l1q4uvxl	27	41	,	,	,
cord-328352-l1q4uvxl	27	42	in	in	IN
cord-328352-l1q4uvxl	27	43	children	child	NNS
cord-328352-l1q4uvxl	27	44	16	16	CD
cord-328352-l1q4uvxl	27	45	,	,	,
cord-328352-l1q4uvxl	27	46	which	which	WDT
cord-328352-l1q4uvxl	27	47	was	be	VBD
cord-328352-l1q4uvxl	27	48	suggested	suggest	VBN
cord-328352-l1q4uvxl	27	49	to	to	TO
cord-328352-l1q4uvxl	27	50	manifest	manifest	VB
cord-328352-l1q4uvxl	27	51	in	in	IN
cord-328352-l1q4uvxl	27	52	adulthood	adulthood	NN
cord-328352-l1q4uvxl	27	53	as	as	IN
cord-328352-l1q4uvxl	27	54	Parkinson	Parkinson	NNP
cord-328352-l1q4uvxl	27	55	's	's	POS
cord-328352-l1q4uvxl	27	56	disease	disease	NN
cord-328352-l1q4uvxl	27	57	17	17	CD
cord-328352-l1q4uvxl	27	58	but	but	CC
cord-328352-l1q4uvxl	27	59	such	such	PDT
cord-328352-l1q4uvxl	27	60	a	a	DT
cord-328352-l1q4uvxl	27	61	pathological	pathological	JJ
cord-328352-l1q4uvxl	27	62	link	link	NN
cord-328352-l1q4uvxl	27	63	being	be	VBG
cord-328352-l1q4uvxl	27	64	merely	merely	RB
cord-328352-l1q4uvxl	27	65	coincidental	coincidental	JJ
cord-328352-l1q4uvxl	27	66	has	have	VBZ
cord-328352-l1q4uvxl	27	67	been	be	VBN
cord-328352-l1q4uvxl	27	68	debated	debate	VBN
cord-328352-l1q4uvxl	27	69	18	18	CD
cord-328352-l1q4uvxl	27	70	.	.	.
cord-328352-l1q4uvxl	28	1	Similarly	similarly	RB
cord-328352-l1q4uvxl	28	2	,	,	,
cord-328352-l1q4uvxl	28	3	the	the	DT
cord-328352-l1q4uvxl	28	4	potential	potential	JJ
cord-328352-l1q4uvxl	28	5	long	long	JJ
cord-328352-l1q4uvxl	28	6	-	-	HYPH
cord-328352-l1q4uvxl	28	7	term	term	NN
cord-328352-l1q4uvxl	28	8	consequences	consequence	NNS
cord-328352-l1q4uvxl	28	9	of	of	IN
cord-328352-l1q4uvxl	28	10	COVID-19	covid-19	NN
cord-328352-l1q4uvxl	28	11	to	to	IN
cord-328352-l1q4uvxl	28	12	brain	brain	NN
cord-328352-l1q4uvxl	28	13	disorders	disorder	NNS
cord-328352-l1q4uvxl	28	14	,	,	,
cord-328352-l1q4uvxl	28	15	and	and	CC
cord-328352-l1q4uvxl	28	16	other	other	JJ
cord-328352-l1q4uvxl	28	17	comorbid	comorbid	NN
cord-328352-l1q4uvxl	28	18	diseases	disease	NNS
cord-328352-l1q4uvxl	28	19	,	,	,
cord-328352-l1q4uvxl	28	20	warrant	warrant	VB
cord-328352-l1q4uvxl	28	21	critical	critical	JJ
cord-328352-l1q4uvxl	28	22	research	research	NN
cord-328352-l1q4uvxl	28	23	avenues	avenue	NNS
cord-328352-l1q4uvxl	28	24	as	as	IN
cord-328352-l1q4uvxl	28	25	we	-PRON-	PRP
cord-328352-l1q4uvxl	28	26	tackle	tackle	VBP
cord-328352-l1q4uvxl	28	27	this	this	DT
cord-328352-l1q4uvxl	28	28	pandemic	pandemic	NN
cord-328352-l1q4uvxl	28	29	and	and	CC
cord-328352-l1q4uvxl	28	30	its	-PRON-	PRP$
cord-328352-l1q4uvxl	28	31	associated	associate	VBN
cord-328352-l1q4uvxl	28	32	not	not	RB
cord-328352-l1q4uvxl	28	33	-	-	HYPH
cord-328352-l1q4uvxl	28	34	so	so	RB
cord-328352-l1q4uvxl	28	35	-	-	HYPH
cord-328352-l1q4uvxl	28	36	apparent	apparent	JJ
cord-328352-l1q4uvxl	28	37	mini	mini	JJ
cord-328352-l1q4uvxl	28	38	outbreaks	outbreak	NNS
cord-328352-l1q4uvxl	28	39	.	.	.
cord-328352-l1q4uvxl	29	1	Third	third	RB
cord-328352-l1q4uvxl	29	2	,	,	,
cord-328352-l1q4uvxl	29	3	that	that	IN
cord-328352-l1q4uvxl	29	4	overcrowding	overcrowding	NN
cord-328352-l1q4uvxl	29	5	in	in	IN
cord-328352-l1q4uvxl	29	6	military	military	JJ
cord-328352-l1q4uvxl	29	7	camps	camp	NNS
cord-328352-l1q4uvxl	29	8	and	and	CC
cord-328352-l1q4uvxl	29	9	lack	lack	NN
cord-328352-l1q4uvxl	29	10	of	of	IN
cord-328352-l1q4uvxl	29	11	sanitation	sanitation	NN
cord-328352-l1q4uvxl	29	12	due	due	IN
cord-328352-l1q4uvxl	29	13	to	to	IN
cord-328352-l1q4uvxl	29	14	poverty	poverty	NN
cord-328352-l1q4uvxl	29	15	during	during	IN
cord-328352-l1q4uvxl	29	16	World	World	NNP
cord-328352-l1q4uvxl	29	17	War	War	NNP
cord-328352-l1q4uvxl	30	1	I	-PRON-	PRP
cord-328352-l1q4uvxl	30	2	contributed	contribute	VBD
cord-328352-l1q4uvxl	30	3	to	to	IN
cord-328352-l1q4uvxl	30	4	Spanish	spanish	JJ
cord-328352-l1q4uvxl	30	5	flu	flu	NN
cord-328352-l1q4uvxl	30	6	pandemic	pandemic	NN
cord-328352-l1q4uvxl	31	1	draws	draw	VBZ
cord-328352-l1q4uvxl	31	2	our	-PRON-	PRP$
cord-328352-l1q4uvxl	31	3	attention	attention	NN
cord-328352-l1q4uvxl	31	4	to	to	IN
cord-328352-l1q4uvxl	31	5	the	the	DT
cord-328352-l1q4uvxl	31	6	key	key	JJ
cord-328352-l1q4uvxl	31	7	pressing	press	VBG
cord-328352-l1q4uvxl	31	8	issue	issue	NN
cord-328352-l1q4uvxl	31	9	of	of	IN
cord-328352-l1q4uvxl	31	10	human	human	JJ
cord-328352-l1q4uvxl	31	11	behavior	behavior	NN
cord-328352-l1q4uvxl	31	12	.	.	.
cord-328352-l1q4uvxl	32	1	Regenerative	regenerative	JJ
cord-328352-l1q4uvxl	32	2	medicine	medicine	NN
cord-328352-l1q4uvxl	32	3	may	may	MD
cord-328352-l1q4uvxl	32	4	play	play	VB
cord-328352-l1q4uvxl	32	5	a	a	DT
cord-328352-l1q4uvxl	32	6	key	key	JJ
cord-328352-l1q4uvxl	32	7	role	role	NN
cord-328352-l1q4uvxl	32	8	in	in	IN
cord-328352-l1q4uvxl	32	9	treating	treat	VBG
cord-328352-l1q4uvxl	32	10	COVID-19	covid-19	NN
cord-328352-l1q4uvxl	32	11	.	.	.
cord-328352-l1q4uvxl	33	1	The	the	DT
cord-328352-l1q4uvxl	33	2	ongoing	ongoing	JJ
cord-328352-l1q4uvxl	33	3	clinical	clinical	JJ
cord-328352-l1q4uvxl	33	4	trials	trial	NNS
cord-328352-l1q4uvxl	33	5	of	of	IN
cord-328352-l1q4uvxl	33	6	infusing	infuse	VBG
cord-328352-l1q4uvxl	33	7	convalescent	convalescent	JJ
cord-328352-l1q4uvxl	33	8	plasma	plasma	NN
cord-328352-l1q4uvxl	33	9	stand	stand	NN
cord-328352-l1q4uvxl	33	10	as	as	IN
cord-328352-l1q4uvxl	33	11	a	a	DT
cord-328352-l1q4uvxl	33	12	potent	potent	JJ
cord-328352-l1q4uvxl	33	13	cell	cell	NN
cord-328352-l1q4uvxl	33	14	therapy	therapy	NN
cord-328352-l1q4uvxl	33	15	for	for	IN
cord-328352-l1q4uvxl	33	16	COVID-19	COVID-19	NNP
cord-328352-l1q4uvxl	33	17	patients	patient	NNS
cord-328352-l1q4uvxl	33	18	.	.	.
cord-328352-l1q4uvxl	34	1	This	this	DT
cord-328352-l1q4uvxl	34	2	investigational	investigational	JJ
cord-328352-l1q4uvxl	34	3	treatment	treatment	NN
cord-328352-l1q4uvxl	34	4	uses	use	VBZ
cord-328352-l1q4uvxl	34	5	plasma	plasma	NN
cord-328352-l1q4uvxl	34	6	that	that	WDT
cord-328352-l1q4uvxl	34	7	contains	contain	VBZ
cord-328352-l1q4uvxl	34	8	antibodies	antibody	NNS
cord-328352-l1q4uvxl	34	9	to	to	TO
cord-328352-l1q4uvxl	34	10	severe	severe	JJ
cord-328352-l1q4uvxl	34	11	acute	acute	JJ
cord-328352-l1q4uvxl	34	12	respiratory	respiratory	JJ
cord-328352-l1q4uvxl	34	13	syndrome	syndrome	NN
cord-328352-l1q4uvxl	34	14	coronavirus	coronavirus	NN
cord-328352-l1q4uvxl	34	15	2	2	CD
cord-328352-l1q4uvxl	34	16	or	or	CC
cord-328352-l1q4uvxl	34	17	SARS	SARS	NNP
cord-328352-l1q4uvxl	34	18	-	-	HYPH
cord-328352-l1q4uvxl	34	19	CoV-2	CoV-2	NNP
cord-328352-l1q4uvxl	34	20	,	,	,
cord-328352-l1q4uvxl	34	21	the	the	DT
cord-328352-l1q4uvxl	34	22	virus	virus	NN
cord-328352-l1q4uvxl	34	23	that	that	WDT
cord-328352-l1q4uvxl	34	24	causes	cause	VBZ
cord-328352-l1q4uvxl	34	25	COVID-19	COVID-19	NNP
cord-328352-l1q4uvxl	34	26	.	.	.
cord-328352-l1q4uvxl	35	1	Plasma	plasma	NN
cord-328352-l1q4uvxl	35	2	therapy	therapy	NN
cord-328352-l1q4uvxl	35	3	entails	entail	VBZ
cord-328352-l1q4uvxl	35	4	the	the	DT
cord-328352-l1q4uvxl	35	5	use	use	NN
cord-328352-l1q4uvxl	35	6	of	of	IN
cord-328352-l1q4uvxl	35	7	plasma	plasma	NN
cord-328352-l1q4uvxl	35	8	or	or	CC
cord-328352-l1q4uvxl	35	9	specific	specific	JJ
cord-328352-l1q4uvxl	35	10	,	,	,
cord-328352-l1q4uvxl	35	11	fractioned	fractioned	JJ
cord-328352-l1q4uvxl	35	12	,	,	,
cord-328352-l1q4uvxl	35	13	antibodies	antibody	NNS
cord-328352-l1q4uvxl	35	14	,	,	,
cord-328352-l1q4uvxl	35	15	along	along	IN
cord-328352-l1q4uvxl	35	16	with	with	IN
cord-328352-l1q4uvxl	35	17	other	other	JJ
cord-328352-l1q4uvxl	35	18	immunoglobulins	immunoglobulin	NNS
cord-328352-l1q4uvxl	35	19	(	(	-LRB-
cord-328352-l1q4uvxl	35	20	IGs	IGs	NNP
cord-328352-l1q4uvxl	35	21	)	)	-RRB-
cord-328352-l1q4uvxl	35	22	and	and	CC
cord-328352-l1q4uvxl	35	23	possibly	possibly	RB
cord-328352-l1q4uvxl	35	24	other	other	JJ
cord-328352-l1q4uvxl	35	25	therapeutic	therapeutic	JJ
cord-328352-l1q4uvxl	35	26	molecules	molecule	NNS
cord-328352-l1q4uvxl	35	27	harvested	harvest	VBN
cord-328352-l1q4uvxl	35	28	from	from	IN
cord-328352-l1q4uvxl	35	29	immunized	immunize	VBN
cord-328352-l1q4uvxl	35	30	individuals	individual	NNS
cord-328352-l1q4uvxl	35	31	or	or	CC
cord-328352-l1q4uvxl	35	32	convalescent	convalescent	JJ
cord-328352-l1q4uvxl	35	33	persons	person	NNS
cord-328352-l1q4uvxl	35	34	19	19	CD
cord-328352-l1q4uvxl	35	35	.	.	.
cord-328352-l1q4uvxl	36	1	Plasma	plasma	NN
cord-328352-l1q4uvxl	36	2	therapy	therapy	NN
cord-328352-l1q4uvxl	36	3	has	have	VBZ
cord-328352-l1q4uvxl	36	4	a	a	DT
cord-328352-l1q4uvxl	36	5	long	long	JJ
cord-328352-l1q4uvxl	36	6	history	history	NN
cord-328352-l1q4uvxl	36	7	of	of	IN
cord-328352-l1q4uvxl	36	8	safety	safety	NN
cord-328352-l1q4uvxl	36	9	,	,	,
cord-328352-l1q4uvxl	36	10	and	and	CC
cord-328352-l1q4uvxl	36	11	even	even	RB
cord-328352-l1q4uvxl	36	12	efficacy	efficacy	NN
cord-328352-l1q4uvxl	36	13	,	,	,
cord-328352-l1q4uvxl	36	14	since	since	IN
cord-328352-l1q4uvxl	36	15	the	the	DT
cord-328352-l1q4uvxl	36	16	Spanish	spanish	JJ
cord-328352-l1q4uvxl	36	17	flu	flu	NN
cord-328352-l1q4uvxl	36	18	in	in	IN
cord-328352-l1q4uvxl	36	19	1917	1917	CD
cord-328352-l1q4uvxl	36	20	-	-	SYM
cord-328352-l1q4uvxl	36	21	1918	1918	CD
cord-328352-l1q4uvxl	36	22	19	19	CD
cord-328352-l1q4uvxl	36	23	,	,	,
cord-328352-l1q4uvxl	36	24	20	20	CD
cord-328352-l1q4uvxl	36	25	.	.	.
cord-328352-l1q4uvxl	37	1	While	while	IN
cord-328352-l1q4uvxl	37	2	the	the	DT
cord-328352-l1q4uvxl	37	3	mechanism	mechanism	NN
cord-328352-l1q4uvxl	37	4	of	of	IN
cord-328352-l1q4uvxl	37	5	action	action	NN
cord-328352-l1q4uvxl	37	6	of	of	IN
cord-328352-l1q4uvxl	37	7	plasma	plasma	NN
cord-328352-l1q4uvxl	37	8	therapy	therapy	NN
cord-328352-l1q4uvxl	37	9	remains	remain	VBZ
cord-328352-l1q4uvxl	37	10	not	not	RB
cord-328352-l1q4uvxl	37	11	fully	fully	RB
cord-328352-l1q4uvxl	37	12	understood	understand	VBN
cord-328352-l1q4uvxl	37	13	,	,	,
cord-328352-l1q4uvxl	37	14	the	the	DT
cord-328352-l1q4uvxl	37	15	functional	functional	JJ
cord-328352-l1q4uvxl	37	16	benefits	benefit	NNS
cord-328352-l1q4uvxl	37	17	have	have	VBP
cord-328352-l1q4uvxl	37	18	been	be	VBN
cord-328352-l1q4uvxl	37	19	largely	largely	RB
cord-328352-l1q4uvxl	37	20	ascribed	ascribe	VBN
cord-328352-l1q4uvxl	37	21	to	to	IN
cord-328352-l1q4uvxl	37	22	the	the	DT
cord-328352-l1q4uvxl	37	23	purified	purify	VBN
cord-328352-l1q4uvxl	37	24	neutralizing	neutralize	VBG
cord-328352-l1q4uvxl	37	25	antibodies	antibody	NNS
cord-328352-l1q4uvxl	37	26	of	of	IN
cord-328352-l1q4uvxl	37	27	the	the	DT
cord-328352-l1q4uvxl	37	28	convalescent	convalescent	JJ
cord-328352-l1q4uvxl	37	29	plasma	plasma	NN
cord-328352-l1q4uvxl	37	30	19	19	CD
cord-328352-l1q4uvxl	37	31	,	,	,
cord-328352-l1q4uvxl	37	32	20	20	CD
cord-328352-l1q4uvxl	37	33	.	.	.
cord-328352-l1q4uvxl	38	1	A	a	DT
cord-328352-l1q4uvxl	38	2	meta	meta	JJ
cord-328352-l1q4uvxl	38	3	-	-	HYPH
cord-328352-l1q4uvxl	38	4	analysis	analysis	NN
cord-328352-l1q4uvxl	38	5	of	of	IN
cord-328352-l1q4uvxl	38	6	English	english	JJ
cord-328352-l1q4uvxl	38	7	-	-	HYPH
cord-328352-l1q4uvxl	38	8	language	language	NN
cord-328352-l1q4uvxl	38	9	journals	journal	NNS
cord-328352-l1q4uvxl	38	10	from	from	IN
cord-328352-l1q4uvxl	38	11	1918	1918	CD
cord-328352-l1q4uvxl	38	12	to	to	IN
cord-328352-l1q4uvxl	38	13	1925	1925	CD
cord-328352-l1q4uvxl	38	14	reveals	reveal	VBZ
cord-328352-l1q4uvxl	38	15	that	that	IN
cord-328352-l1q4uvxl	38	16	the	the	DT
cord-328352-l1q4uvxl	38	17	overall	overall	JJ
cord-328352-l1q4uvxl	38	18	mortality	mortality	NN
cord-328352-l1q4uvxl	38	19	rate	rate	NN
cord-328352-l1q4uvxl	38	20	was	be	VBD
cord-328352-l1q4uvxl	38	21	16	16	CD
cord-328352-l1q4uvxl	38	22	%	%	NN
cord-328352-l1q4uvxl	38	23	among	among	IN
cord-328352-l1q4uvxl	38	24	treated	treat	VBN
cord-328352-l1q4uvxl	38	25	patients	patient	NNS
cord-328352-l1q4uvxl	38	26	compared	compare	VBN
cord-328352-l1q4uvxl	38	27	to	to	IN
cord-328352-l1q4uvxl	38	28	37	37	CD
cord-328352-l1q4uvxl	38	29	%	%	NN
cord-328352-l1q4uvxl	38	30	among	among	IN
cord-328352-l1q4uvxl	38	31	controls	control	NNS
cord-328352-l1q4uvxl	38	32	,	,	,
cord-328352-l1q4uvxl	38	33	indicating	indicate	VBG
cord-328352-l1q4uvxl	38	34	difference	difference	NN
cord-328352-l1q4uvxl	38	35	in	in	IN
cord-328352-l1q4uvxl	38	36	fatality	fatality	NN
cord-328352-l1q4uvxl	38	37	between	between	IN
cord-328352-l1q4uvxl	38	38	the	the	DT
cord-328352-l1q4uvxl	38	39	treatment	treatment	NN
cord-328352-l1q4uvxl	38	40	and	and	CC
cord-328352-l1q4uvxl	38	41	control	control	NN
cord-328352-l1q4uvxl	38	42	groups	group	NNS
cord-328352-l1q4uvxl	38	43	at	at	IN
cord-328352-l1q4uvxl	38	44	8	8	CD
cord-328352-l1q4uvxl	38	45	%	%	NN
cord-328352-l1q4uvxl	38	46	to	to	IN
cord-328352-l1q4uvxl	38	47	26	26	CD
cord-328352-l1q4uvxl	38	48	%	%	NN
cord-328352-l1q4uvxl	38	49	20	20	CD
cord-328352-l1q4uvxl	38	50	.	.	.
cord-328352-l1q4uvxl	39	1	Note	note	VB
cord-328352-l1q4uvxl	39	2	that	that	IN
cord-328352-l1q4uvxl	39	3	the	the	DT
cord-328352-l1q4uvxl	39	4	meta	meta	NNP
cord-328352-l1q4uvxl	39	5	-	-	HYPH
cord-328352-l1q4uvxl	39	6	analysis	analysis	NN
cord-328352-l1q4uvxl	39	7	study	study	NN
cord-328352-l1q4uvxl	39	8	20	20	CD
cord-328352-l1q4uvxl	39	9	was	be	VBD
cord-328352-l1q4uvxl	39	10	based	base	VBN
cord-328352-l1q4uvxl	39	11	on	on	IN
cord-328352-l1q4uvxl	39	12	only	only	RB
cord-328352-l1q4uvxl	39	13	eight	eight	CD
cord-328352-l1q4uvxl	39	14	studies	study	NNS
cord-328352-l1q4uvxl	39	15	with	with	IN
cord-328352-l1q4uvxl	39	16	many	many	JJ
cord-328352-l1q4uvxl	39	17	methodologic	methodologic	JJ
cord-328352-l1q4uvxl	39	18	limitations	limitation	NNS
cord-328352-l1q4uvxl	39	19	,	,	,
cord-328352-l1q4uvxl	39	20	including	include	VBG
cord-328352-l1q4uvxl	39	21	lack	lack	NN
cord-328352-l1q4uvxl	39	22	of	of	IN
cord-328352-l1q4uvxl	39	23	blinding	blind	VBG
cord-328352-l1q4uvxl	39	24	,	,	,
cord-328352-l1q4uvxl	39	25	randomization	randomization	NN
cord-328352-l1q4uvxl	39	26	,	,	,
cord-328352-l1q4uvxl	39	27	or	or	CC
cord-328352-l1q4uvxl	39	28	placebo	placebo	NN
cord-328352-l1q4uvxl	39	29	-	-	HYPH
cord-328352-l1q4uvxl	39	30	controlled	control	VBN
cord-328352-l1q4uvxl	39	31	arm	arm	NN
cord-328352-l1q4uvxl	39	32	.	.	.
cord-328352-l1q4uvxl	40	1	Subsequent	subsequent	JJ
cord-328352-l1q4uvxl	40	2	to	to	IN
cord-328352-l1q4uvxl	40	3	the	the	DT
cord-328352-l1q4uvxl	40	4	Spanish	spanish	JJ
cord-328352-l1q4uvxl	40	5	flu	flu	NN
cord-328352-l1q4uvxl	40	6	pandemic	pandemic	NN
cord-328352-l1q4uvxl	40	7	,	,	,
cord-328352-l1q4uvxl	40	8	the	the	DT
cord-328352-l1q4uvxl	40	9	treatment	treatment	NN
cord-328352-l1q4uvxl	40	10	with	with	IN
cord-328352-l1q4uvxl	40	11	convalescent	convalescent	JJ
cord-328352-l1q4uvxl	40	12	plasma	plasma	NN
cord-328352-l1q4uvxl	40	13	has	have	VBZ
cord-328352-l1q4uvxl	40	14	been	be	VBN
cord-328352-l1q4uvxl	40	15	studied	study	VBN
cord-328352-l1q4uvxl	40	16	in	in	IN
cord-328352-l1q4uvxl	40	17	similar	similar	JJ
cord-328352-l1q4uvxl	40	18	outbreaks	outbreak	NNS
cord-328352-l1q4uvxl	40	19	of	of	IN
cord-328352-l1q4uvxl	40	20	respiratory	respiratory	JJ
cord-328352-l1q4uvxl	40	21	infections	infection	NNS
cord-328352-l1q4uvxl	40	22	,	,	,
cord-328352-l1q4uvxl	40	23	such	such	JJ
cord-328352-l1q4uvxl	40	24	as	as	IN
cord-328352-l1q4uvxl	40	25	the	the	DT
cord-328352-l1q4uvxl	40	26	2003	2003	CD
cord-328352-l1q4uvxl	40	27	SARS	SARS	NNP
cord-328352-l1q4uvxl	40	28	-	-	HYPH
cord-328352-l1q4uvxl	40	29	CoV-1	CoV-1	NNP
cord-328352-l1q4uvxl	40	30	epidemic	epidemic	NN
cord-328352-l1q4uvxl	40	31	,	,	,
cord-328352-l1q4uvxl	40	32	the	the	DT
cord-328352-l1q4uvxl	40	33	2009	2009	CD
cord-328352-l1q4uvxl	40	34	-	-	SYM
cord-328352-l1q4uvxl	40	35	2010	2010	CD
cord-328352-l1q4uvxl	40	36	H1N1	H1N1	NNP
cord-328352-l1q4uvxl	40	37	influenza	influenza	NN
cord-328352-l1q4uvxl	40	38	virus	virus	NN
cord-328352-l1q4uvxl	40	39	pandemic	pandemic	NN
cord-328352-l1q4uvxl	40	40	,	,	,
cord-328352-l1q4uvxl	40	41	and	and	CC
cord-328352-l1q4uvxl	40	42	the	the	DT
cord-328352-l1q4uvxl	40	43	2012	2012	CD
cord-328352-l1q4uvxl	40	44	MERS	MERS	NNP
cord-328352-l1q4uvxl	40	45	-	-	HYPH
cord-328352-l1q4uvxl	40	46	CoV	CoV	NNP
cord-328352-l1q4uvxl	40	47	epidemic	epidemic	NN
cord-328352-l1q4uvxl	40	48	19	19	CD
cord-328352-l1q4uvxl	40	49	,	,	,
cord-328352-l1q4uvxl	40	50	20	20	CD
cord-328352-l1q4uvxl	40	51	.	.	.
cord-328352-l1q4uvxl	41	1	Whereas	whereas	IN
cord-328352-l1q4uvxl	41	2	small	small	JJ
cord-328352-l1q4uvxl	41	3	clinical	clinical	JJ
cord-328352-l1q4uvxl	41	4	trials	trial	NNS
cord-328352-l1q4uvxl	41	5	and	and	CC
cord-328352-l1q4uvxl	41	6	anecdotal	anecdotal	JJ
cord-328352-l1q4uvxl	41	7	accounts	account	NNS
cord-328352-l1q4uvxl	41	8	of	of	IN
cord-328352-l1q4uvxl	41	9	convalescent	convalescent	JJ
cord-328352-l1q4uvxl	41	10	plasma	plasma	NN
cord-328352-l1q4uvxl	41	11	suggest	suggest	VBP
cord-328352-l1q4uvxl	41	12	safety	safety	NN
cord-328352-l1q4uvxl	41	13	and	and	CC
cord-328352-l1q4uvxl	41	14	efficacy	efficacy	NN
cord-328352-l1q4uvxl	41	15	of	of	IN
cord-328352-l1q4uvxl	41	16	plasma	plasma	NN
cord-328352-l1q4uvxl	41	17	treatment	treatment	NN
cord-328352-l1q4uvxl	41	18	in	in	IN
cord-328352-l1q4uvxl	41	19	these	these	DT
cord-328352-l1q4uvxl	41	20	previous	previous	JJ
cord-328352-l1q4uvxl	41	21	outbreaks	outbreak	NNS
cord-328352-l1q4uvxl	41	22	21	21	CD
cord-328352-l1q4uvxl	41	23	,	,	,
cord-328352-l1q4uvxl	41	24	its	-PRON-	PRP$
cord-328352-l1q4uvxl	41	25	potency	potency	NN
cord-328352-l1q4uvxl	41	26	in	in	IN
cord-328352-l1q4uvxl	41	27	COVID-19	COVID-19	NNP
cord-328352-l1q4uvxl	41	28	requires	require	VBZ
cord-328352-l1q4uvxl	41	29	carefully	carefully	RB
cord-328352-l1q4uvxl	41	30	designed	design	VBN
cord-328352-l1q4uvxl	41	31	and	and	CC
cord-328352-l1q4uvxl	41	32	rigorous	rigorous	JJ
cord-328352-l1q4uvxl	41	33	assessment	assessment	NN
cord-328352-l1q4uvxl	41	34	of	of	IN
cord-328352-l1q4uvxl	41	35	these	these	DT
cord-328352-l1q4uvxl	41	36	clinical	clinical	JJ
cord-328352-l1q4uvxl	41	37	trials	trial	NNS
cord-328352-l1q4uvxl	41	38	as	as	IN
cord-328352-l1q4uvxl	41	39	discussed	discuss	VBN
cord-328352-l1q4uvxl	41	40	subsequently	subsequently	RB
cord-328352-l1q4uvxl	41	41	.	.	.
cord-328352-l1q4uvxl	42	1	The	the	DT
cord-328352-l1q4uvxl	42	2	still	still	RB
cord-328352-l1q4uvxl	42	3	limited	limited	JJ
cord-328352-l1q4uvxl	42	4	evidence	evidence	NN
cord-328352-l1q4uvxl	42	5	but	but	CC
cord-328352-l1q4uvxl	42	6	massively	massively	RB
cord-328352-l1q4uvxl	42	7	accumulating	accumulate	VBG
cord-328352-l1q4uvxl	42	8	interest	interest	NN
cord-328352-l1q4uvxl	42	9	in	in	IN
cord-328352-l1q4uvxl	42	10	the	the	DT
cord-328352-l1q4uvxl	42	11	safety	safety	NN
cord-328352-l1q4uvxl	42	12	and	and	CC
cord-328352-l1q4uvxl	42	13	efficacy	efficacy	NN
cord-328352-l1q4uvxl	42	14	of	of	IN
cord-328352-l1q4uvxl	42	15	convalescent	convalescent	JJ
cord-328352-l1q4uvxl	42	16	plasma	plasma	NN
cord-328352-l1q4uvxl	42	17	treatments	treatment	NNS
cord-328352-l1q4uvxl	42	18	may	may	MD
cord-328352-l1q4uvxl	42	19	provide	provide	VB
cord-328352-l1q4uvxl	42	20	the	the	DT
cord-328352-l1q4uvxl	42	21	basis	basis	NN
cord-328352-l1q4uvxl	42	22	for	for	IN
cord-328352-l1q4uvxl	42	23	compassionate	compassionate	JJ
cord-328352-l1q4uvxl	42	24	use	use	NN
cord-328352-l1q4uvxl	42	25	of	of	IN
cord-328352-l1q4uvxl	42	26	these	these	DT
cord-328352-l1q4uvxl	42	27	therapies	therapy	NNS
cord-328352-l1q4uvxl	42	28	for	for	IN
cord-328352-l1q4uvxl	42	29	COVID-19	covid-19	CD
cord-328352-l1q4uvxl	42	30	in	in	IN
cord-328352-l1q4uvxl	42	31	the	the	DT
cord-328352-l1q4uvxl	42	32	United	United	NNP
cord-328352-l1q4uvxl	42	33	States	States	NNP
cord-328352-l1q4uvxl	42	34	.	.	.
cord-328352-l1q4uvxl	43	1	Indeed	indeed	RB
cord-328352-l1q4uvxl	43	2	,	,	,
cord-328352-l1q4uvxl	43	3	a	a	DT
cord-328352-l1q4uvxl	43	4	review	review	NN
cord-328352-l1q4uvxl	43	5	of	of	IN
cord-328352-l1q4uvxl	43	6	the	the	DT
cord-328352-l1q4uvxl	43	7	literature	literature	NN
cord-328352-l1q4uvxl	43	8	from	from	IN
cord-328352-l1q4uvxl	43	9	2020	2020	CD
cord-328352-l1q4uvxl	43	10	alone	alone	RB
cord-328352-l1q4uvxl	43	11	shows	show	VBZ
cord-328352-l1q4uvxl	43	12	that	that	IN
cord-328352-l1q4uvxl	43	13	there	there	EX
cord-328352-l1q4uvxl	43	14	are	be	VBP
cord-328352-l1q4uvxl	43	15	already	already	RB
cord-328352-l1q4uvxl	43	16	152	152	CD
cord-328352-l1q4uvxl	43	17	publications	publication	NNS
cord-328352-l1q4uvxl	43	18	,	,	,
cord-328352-l1q4uvxl	43	19	although	although	IN
cord-328352-l1q4uvxl	43	20	most	most	JJS
cord-328352-l1q4uvxl	43	21	are	be	VBP
cord-328352-l1q4uvxl	43	22	review	review	NN
cord-328352-l1q4uvxl	43	23	and	and	CC
cord-328352-l1q4uvxl	43	24	commentary	commentary	NN
cord-328352-l1q4uvxl	43	25	articles	article	NNS
cord-328352-l1q4uvxl	43	26	,	,	,
cord-328352-l1q4uvxl	43	27	and	and	CC
cord-328352-l1q4uvxl	43	28	protocol	protocol	NN
cord-328352-l1q4uvxl	43	29	descriptions	description	NNS
cord-328352-l1q4uvxl	43	30	,	,	,
cord-328352-l1q4uvxl	43	31	on	on	IN
cord-328352-l1q4uvxl	43	32	the	the	DT
cord-328352-l1q4uvxl	43	33	theme	theme	NN
cord-328352-l1q4uvxl	43	34	of	of	IN
cord-328352-l1q4uvxl	43	35	convalescent	convalescent	JJ
cord-328352-l1q4uvxl	43	36	plasma	plasma	NN
cord-328352-l1q4uvxl	43	37	treatments	treatment	NNS
cord-328352-l1q4uvxl	43	38	for	for	IN
cord-328352-l1q4uvxl	43	39	COVID-19	covid-19	NN
cord-328352-l1q4uvxl	43	40	.	.	.
cord-328352-l1q4uvxl	44	1	Notable	notable	JJ
cord-328352-l1q4uvxl	44	2	clinical	clinical	JJ
cord-328352-l1q4uvxl	44	3	research	research	NN
cord-328352-l1q4uvxl	44	4	reports	report	NNS
cord-328352-l1q4uvxl	44	5	include	include	VBP
cord-328352-l1q4uvxl	44	6	:	:	:
cord-328352-l1q4uvxl	44	7	(	(	-LRB-
cord-328352-l1q4uvxl	44	8	1	1	LS
cord-328352-l1q4uvxl	44	9	)	)	-RRB-
cord-328352-l1q4uvxl	45	1	The	the	DT
cord-328352-l1q4uvxl	45	2	small	small	JJ
cord-328352-l1q4uvxl	45	3	study	study	NN
cord-328352-l1q4uvxl	45	4	on	on	IN
cord-328352-l1q4uvxl	45	5	six	six	CD
cord-328352-l1q4uvxl	45	6	Chinese	chinese	JJ
cord-328352-l1q4uvxl	45	7	patients	patient	NNS
cord-328352-l1q4uvxl	45	8	diagnosed	diagnose	VBN
cord-328352-l1q4uvxl	45	9	with	with	IN
cord-328352-l1q4uvxl	45	10	COVID-19	COVID-19	NNP
cord-328352-l1q4uvxl	45	11	,	,	,
cord-328352-l1q4uvxl	45	12	who	who	WP
cord-328352-l1q4uvxl	45	13	subsequently	subsequently	RB
cord-328352-l1q4uvxl	45	14	received	receive	VBD
cord-328352-l1q4uvxl	45	15	ABO	ABO	NNP
cord-328352-l1q4uvxl	45	16	-	-	HYPH
cord-328352-l1q4uvxl	45	17	compatible	compatible	JJ
cord-328352-l1q4uvxl	45	18	convalescent	convalescent	JJ
cord-328352-l1q4uvxl	45	19	plasma	plasma	NN
cord-328352-l1q4uvxl	45	20	,	,	,
cord-328352-l1q4uvxl	45	21	demonstrating	demonstrate	VBG
cord-328352-l1q4uvxl	45	22	immediate	immediate	JJ
cord-328352-l1q4uvxl	45	23	increase	increase	NN
cord-328352-l1q4uvxl	45	24	of	of	IN
cord-328352-l1q4uvxl	45	25	antibody	antibody	NN
cord-328352-l1q4uvxl	45	26	titers	titer	NNS
cord-328352-l1q4uvxl	45	27	in	in	IN
cord-328352-l1q4uvxl	45	28	two	two	CD
cord-328352-l1q4uvxl	45	29	patients	patient	NNS
cord-328352-l1q4uvxl	45	30	and	and	CC
cord-328352-l1q4uvxl	45	31	elimination	elimination	NN
cord-328352-l1q4uvxl	45	32	of	of	IN
cord-328352-l1q4uvxl	45	33	the	the	DT
cord-328352-l1q4uvxl	45	34	virus	virus	NN
cord-328352-l1q4uvxl	45	35	in	in	IN
cord-328352-l1q4uvxl	45	36	two	two	CD
cord-328352-l1q4uvxl	45	37	other	other	JJ
cord-328352-l1q4uvxl	45	38	patients	patient	NNS
cord-328352-l1q4uvxl	45	39	22	22	CD
cord-328352-l1q4uvxl	45	40	.	.	.
cord-328352-l1q4uvxl	46	1	(	(	-LRB-
cord-328352-l1q4uvxl	46	2	2	2	LS
cord-328352-l1q4uvxl	46	3	)	)	-RRB-
cord-328352-l1q4uvxl	47	1	Another	another	DT
cord-328352-l1q4uvxl	47	2	small	small	JJ
cord-328352-l1q4uvxl	47	3	study	study	NN
cord-328352-l1q4uvxl	47	4	on	on	IN
cord-328352-l1q4uvxl	47	5	ten	ten	CD
cord-328352-l1q4uvxl	47	6	severe	severe	JJ
cord-328352-l1q4uvxl	47	7	COVID-19	covid-19	JJ
cord-328352-l1q4uvxl	47	8	Chinese	chinese	JJ
cord-328352-l1q4uvxl	47	9	patients	patient	NNS
cord-328352-l1q4uvxl	47	10	revealed	reveal	VBD
cord-328352-l1q4uvxl	47	11	that	that	IN
cord-328352-l1q4uvxl	47	12	nine	nine	CD
cord-328352-l1q4uvxl	47	13	patients	patient	NNS
cord-328352-l1q4uvxl	47	14	displayed	display	VBD
cord-328352-l1q4uvxl	47	15	increased	increase	VBN
cord-328352-l1q4uvxl	47	16	neutralizing	neutralize	VBG
cord-328352-l1q4uvxl	47	17	antibody	antibody	NN
cord-328352-l1q4uvxl	47	18	titers	titer	NNS
cord-328352-l1q4uvxl	47	19	,	,	,
cord-328352-l1q4uvxl	47	20	and	and	CC
cord-328352-l1q4uvxl	47	21	the	the	DT
cord-328352-l1q4uvxl	47	22	viral	viral	JJ
cord-328352-l1q4uvxl	47	23	load	load	NN
cord-328352-l1q4uvxl	47	24	in	in	IN
cord-328352-l1q4uvxl	47	25	seven	seven	CD
cord-328352-l1q4uvxl	47	26	patients	patient	NNS
cord-328352-l1q4uvxl	47	27	becoming	become	VBG
cord-328352-l1q4uvxl	47	28	undetectable	undetectable	JJ
cord-328352-l1q4uvxl	47	29	by	by	IN
cord-328352-l1q4uvxl	47	30	day	day	NN
cord-328352-l1q4uvxl	47	31	seven	seven	CD
cord-328352-l1q4uvxl	47	32	post	post	JJ
cord-328352-l1q4uvxl	47	33	-	-	JJ
cord-328352-l1q4uvxl	47	34	infusion	infusion	NN
cord-328352-l1q4uvxl	47	35	of	of	IN
cord-328352-l1q4uvxl	47	36	convalescent	convalescent	JJ
cord-328352-l1q4uvxl	47	37	plasma	plasma	NN
cord-328352-l1q4uvxl	47	38	,	,	,
cord-328352-l1q4uvxl	47	39	but	but	CC
cord-328352-l1q4uvxl	47	40	only	only	RB
cord-328352-l1q4uvxl	47	41	3	3	CD
cord-328352-l1q4uvxl	47	42	exhibited	exhibit	VBD
cord-328352-l1q4uvxl	47	43	improved	improved	JJ
cord-328352-l1q4uvxl	47	44	respiratory	respiratory	JJ
cord-328352-l1q4uvxl	47	45	function	function	NN
cord-328352-l1q4uvxl	47	46	23	23	CD
cord-328352-l1q4uvxl	47	47	.	.	.
cord-328352-l1q4uvxl	48	1	(	(	-LRB-
cord-328352-l1q4uvxl	48	2	3	3	LS
cord-328352-l1q4uvxl	48	3	)	)	-RRB-
cord-328352-l1q4uvxl	49	1	Another	another	DT
cord-328352-l1q4uvxl	49	2	study	study	NN
cord-328352-l1q4uvxl	49	3	on	on	IN
cord-328352-l1q4uvxl	49	4	five	five	CD
cord-328352-l1q4uvxl	49	5	critically	critically	RB
cord-328352-l1q4uvxl	49	6	ill	ill	JJ
cord-328352-l1q4uvxl	50	1	COVID-19	covid-19	JJ
cord-328352-l1q4uvxl	50	2	patients	patient	NNS
cord-328352-l1q4uvxl	50	3	revealed	reveal	VBD
cord-328352-l1q4uvxl	50	4	viral	viral	JJ
cord-328352-l1q4uvxl	50	5	loads	load	NNS
cord-328352-l1q4uvxl	50	6	decreased	decrease	VBD
cord-328352-l1q4uvxl	50	7	and	and	CC
cord-328352-l1q4uvxl	50	8	became	become	VBD
cord-328352-l1q4uvxl	50	9	negative	negative	JJ
cord-328352-l1q4uvxl	50	10	by	by	IN
cord-328352-l1q4uvxl	50	11	day	day	NN
cord-328352-l1q4uvxl	50	12	12	12	CD
cord-328352-l1q4uvxl	50	13	,	,	,
cord-328352-l1q4uvxl	50	14	and	and	CC
cord-328352-l1q4uvxl	50	15	three	three	CD
cord-328352-l1q4uvxl	50	16	patients	patient	NNS
cord-328352-l1q4uvxl	50	17	were	be	VBD
cord-328352-l1q4uvxl	50	18	discharged	discharge	VBN
cord-328352-l1q4uvxl	50	19	by	by	IN
cord-328352-l1q4uvxl	50	20	about	about	RB
cord-328352-l1q4uvxl	50	21	50	50	CD
cord-328352-l1q4uvxl	50	22	days	day	NNS
cord-328352-l1q4uvxl	50	23	,	,	,
cord-328352-l1q4uvxl	50	24	while	while	IN
cord-328352-l1q4uvxl	50	25	2	2	CD
cord-328352-l1q4uvxl	50	26	patients	patient	NNS
cord-328352-l1q4uvxl	50	27	remained	remain	VBD
cord-328352-l1q4uvxl	50	28	in	in	IN
cord-328352-l1q4uvxl	50	29	stable	stable	JJ
cord-328352-l1q4uvxl	50	30	condition	condition	NN
cord-328352-l1q4uvxl	50	31	at	at	IN
cord-328352-l1q4uvxl	50	32	37	37	CD
cord-328352-l1q4uvxl	50	33	days	day	NNS
cord-328352-l1q4uvxl	50	34	after	after	IN
cord-328352-l1q4uvxl	50	35	convalescent	convalescent	JJ
cord-328352-l1q4uvxl	50	36	plasma	plasma	NN
cord-328352-l1q4uvxl	50	37	infusion	infusion	NN
cord-328352-l1q4uvxl	50	38	24	24	CD
cord-328352-l1q4uvxl	50	39	.	.	.
cord-328352-l1q4uvxl	51	1	(	(	-LRB-
cord-328352-l1q4uvxl	51	2	4	4	LS
cord-328352-l1q4uvxl	51	3	)	)	-RRB-
cord-328352-l1q4uvxl	52	1	In	in	IN
cord-328352-l1q4uvxl	52	2	six	six	CD
cord-328352-l1q4uvxl	52	3	end	end	NN
cord-328352-l1q4uvxl	52	4	-	-	HYPH
cord-328352-l1q4uvxl	52	5	stage	stage	NN
cord-328352-l1q4uvxl	52	6	COVID-19	covid-19	CD
cord-328352-l1q4uvxl	52	7	patients	patient	NNS
cord-328352-l1q4uvxl	52	8	,	,	,
cord-328352-l1q4uvxl	52	9	convalescent	convalescent	JJ
cord-328352-l1q4uvxl	52	10	plasma	plasma	NN
cord-328352-l1q4uvxl	52	11	effectively	effectively	RB
cord-328352-l1q4uvxl	52	12	induced	induce	VBD
cord-328352-l1q4uvxl	52	13	viral	viral	JJ
cord-328352-l1q4uvxl	52	14	shedding	shed	VBG
cord-328352-l1q4uvxl	52	15	with	with	IN
cord-328352-l1q4uvxl	52	16	the	the	DT
cord-328352-l1q4uvxl	52	17	SARS	SARS	NNP
cord-328352-l1q4uvxl	52	18	-	-	HYPH
cord-328352-l1q4uvxl	52	19	CoV-2	CoV-2	NNP
cord-328352-l1q4uvxl	52	20	RNA	RNA	NNP
cord-328352-l1q4uvxl	52	21	undetectable	undetectable	JJ
cord-328352-l1q4uvxl	52	22	by	by	IN
cord-328352-l1q4uvxl	52	23	day	day	NN
cord-328352-l1q4uvxl	52	24	3	3	CD
cord-328352-l1q4uvxl	52	25	post	post	NN
cord-328352-l1q4uvxl	52	26	-	-	JJ
cord-328352-l1q4uvxl	52	27	infusion	infusion	NN
cord-328352-l1q4uvxl	52	28	of	of	IN
cord-328352-l1q4uvxl	52	29	convalescent	convalescent	JJ
cord-328352-l1q4uvxl	52	30	plasma	plasma	NN
cord-328352-l1q4uvxl	52	31	,	,	,
cord-328352-l1q4uvxl	52	32	but	but	CC
cord-328352-l1q4uvxl	52	33	five	five	CD
cord-328352-l1q4uvxl	52	34	patients	patient	NNS
cord-328352-l1q4uvxl	52	35	eventually	eventually	RB
cord-328352-l1q4uvxl	52	36	died	die	VBD
cord-328352-l1q4uvxl	52	37	25	25	CD
cord-328352-l1q4uvxl	52	38	;	;	:
cord-328352-l1q4uvxl	52	39	(	(	-LRB-
cord-328352-l1q4uvxl	52	40	5	5	LS
cord-328352-l1q4uvxl	52	41	)	)	-RRB-
cord-328352-l1q4uvxl	53	1	In	in	IN
cord-328352-l1q4uvxl	53	2	South	South	NNP
cord-328352-l1q4uvxl	53	3	Korea	Korea	NNP
cord-328352-l1q4uvxl	53	4	,	,	,
cord-328352-l1q4uvxl	53	5	two	two	CD
cord-328352-l1q4uvxl	53	6	severe	severe	JJ
cord-328352-l1q4uvxl	53	7	COVID-19	COVID-19	NNP
cord-328352-l1q4uvxl	53	8	patients	patient	NNS
cord-328352-l1q4uvxl	53	9	treated	treat	VBN
cord-328352-l1q4uvxl	53	10	with	with	IN
cord-328352-l1q4uvxl	53	11	convalescent	convalescent	JJ
cord-328352-l1q4uvxl	53	12	plasma	plasma	NN
cord-328352-l1q4uvxl	53	13	with	with	IN
cord-328352-l1q4uvxl	53	14	both	both	DT
cord-328352-l1q4uvxl	53	15	showing	show	VBG
cord-328352-l1q4uvxl	53	16	favorable	favorable	JJ
cord-328352-l1q4uvxl	53	17	outcomes	outcome	NNS
cord-328352-l1q4uvxl	53	18	including	include	VBG
cord-328352-l1q4uvxl	53	19	being	be	VBG
cord-328352-l1q4uvxl	53	20	weaned	wean	VBN
cord-328352-l1q4uvxl	53	21	from	from	IN
cord-328352-l1q4uvxl	53	22	mechanical	mechanical	JJ
cord-328352-l1q4uvxl	53	23	ventilators	ventilator	NNS
cord-328352-l1q4uvxl	53	24	and/or	and/or	CC
cord-328352-l1q4uvxl	53	25	extubated	extubate	VBN
cord-328352-l1q4uvxl	53	26	with	with	IN
cord-328352-l1q4uvxl	53	27	SARS	SARS	NNP
cord-328352-l1q4uvxl	53	28	-	-	HYPH
cord-328352-l1q4uvxl	53	29	CoV-2	CoV-2	NNP
cord-328352-l1q4uvxl	53	30	negative	negative	JJ
cord-328352-l1q4uvxl	53	31	after	after	IN
cord-328352-l1q4uvxl	53	32	days	day	NNS
cord-328352-l1q4uvxl	53	33	20	20	CD
cord-328352-l1q4uvxl	53	34	-	-	SYM
cord-328352-l1q4uvxl	53	35	26	26	CD
cord-328352-l1q4uvxl	53	36	of	of	IN
cord-328352-l1q4uvxl	53	37	convalescent	convalescent	JJ
cord-328352-l1q4uvxl	53	38	plasma	plasma	NN
cord-328352-l1q4uvxl	53	39	infusion	infusion	NN
cord-328352-l1q4uvxl	53	40	26	26	CD
cord-328352-l1q4uvxl	53	41	.	.	.
cord-328352-l1q4uvxl	54	1	From	from	IN
cord-328352-l1q4uvxl	54	2	these	these	DT
cord-328352-l1q4uvxl	54	3	five	five	CD
cord-328352-l1q4uvxl	54	4	small	small	JJ
cord-328352-l1q4uvxl	54	5	clinical	clinical	JJ
cord-328352-l1q4uvxl	54	6	case	case	NN
cord-328352-l1q4uvxl	54	7	reports	report	NNS
cord-328352-l1q4uvxl	54	8	,	,	,
cord-328352-l1q4uvxl	54	9	the	the	DT
cord-328352-l1q4uvxl	54	10	following	follow	VBG
cord-328352-l1q4uvxl	54	11	protocol	protocol	NN
cord-328352-l1q4uvxl	54	12	specifics	specific	NNS
cord-328352-l1q4uvxl	54	13	may	may	MD
cord-328352-l1q4uvxl	54	14	require	require	VB
cord-328352-l1q4uvxl	54	15	optimization	optimization	NN
cord-328352-l1q4uvxl	54	16	in	in	IN
cord-328352-l1q4uvxl	54	17	order	order	NN
cord-328352-l1q4uvxl	54	18	to	to	TO
cord-328352-l1q4uvxl	54	19	further	further	RB
cord-328352-l1q4uvxl	54	20	assess	assess	VB
cord-328352-l1q4uvxl	54	21	the	the	DT
cord-328352-l1q4uvxl	54	22	safety	safety	NN
cord-328352-l1q4uvxl	54	23	and	and	CC
cord-328352-l1q4uvxl	54	24	efficacy	efficacy	NN
cord-328352-l1q4uvxl	54	25	of	of	IN
cord-328352-l1q4uvxl	54	26	convalescent	convalescent	JJ
cord-328352-l1q4uvxl	54	27	plasma	plasma	NN
cord-328352-l1q4uvxl	54	28	treatment	treatment	NN
cord-328352-l1q4uvxl	54	29	for	for	IN
cord-328352-l1q4uvxl	54	30	COVID-19	COVID-19	NNP
cord-328352-l1q4uvxl	54	31	.	.	.
cord-328352-l1q4uvxl	55	1	(	(	-LRB-
cord-328352-l1q4uvxl	55	2	1	1	CD
cord-328352-l1q4uvxl	55	3	)	)	-RRB-
cord-328352-l1q4uvxl	56	1	The	the	DT
cord-328352-l1q4uvxl	56	2	small	small	JJ
cord-328352-l1q4uvxl	56	3	number	number	NN
cord-328352-l1q4uvxl	56	4	of	of	IN
cord-328352-l1q4uvxl	56	5	patients	patient	NNS
cord-328352-l1q4uvxl	56	6	is	be	VBZ
cord-328352-l1q4uvxl	56	7	clearly	clearly	RB
cord-328352-l1q4uvxl	56	8	a	a	DT
cord-328352-l1q4uvxl	56	9	limiting	limit	VBG
cord-328352-l1q4uvxl	56	10	factor	factor	NN
cord-328352-l1q4uvxl	56	11	in	in	IN
cord-328352-l1q4uvxl	56	12	all	all	PDT
cord-328352-l1q4uvxl	56	13	these	these	DT
cord-328352-l1q4uvxl	56	14	studies	study	NNS
cord-328352-l1q4uvxl	56	15	.	.	.
cord-328352-l1q4uvxl	57	1	(	(	-LRB-
cord-328352-l1q4uvxl	57	2	2	2	LS
cord-328352-l1q4uvxl	57	3	)	)	-RRB-
cord-328352-l1q4uvxl	58	1	Once	once	RB
cord-328352-l1q4uvxl	58	2	the	the	DT
cord-328352-l1q4uvxl	58	3	number	number	NN
cord-328352-l1q4uvxl	58	4	of	of	IN
cord-328352-l1q4uvxl	58	5	patients	patient	NNS
cord-328352-l1q4uvxl	58	6	to	to	TO
cord-328352-l1q4uvxl	58	7	be	be	VB
cord-328352-l1q4uvxl	58	8	enrolled	enrol	VBN
cord-328352-l1q4uvxl	58	9	is	be	VBZ
cord-328352-l1q4uvxl	58	10	increased	increase	VBN
cord-328352-l1q4uvxl	58	11	,	,	,
cord-328352-l1q4uvxl	58	12	there	there	EX
cord-328352-l1q4uvxl	58	13	is	be	VBZ
cord-328352-l1q4uvxl	58	14	a	a	DT
cord-328352-l1q4uvxl	58	15	need	need	NN
cord-328352-l1q4uvxl	58	16	for	for	IN
cord-328352-l1q4uvxl	58	17	proper	proper	JJ
cord-328352-l1q4uvxl	58	18	control	control	NN
cord-328352-l1q4uvxl	58	19	and	and	CC
cord-328352-l1q4uvxl	58	20	randomization	randomization	NN
cord-328352-l1q4uvxl	58	21	of	of	IN
cord-328352-l1q4uvxl	58	22	treatments	treatment	NNS
cord-328352-l1q4uvxl	58	23	,	,	,
cord-328352-l1q4uvxl	58	24	as	as	RB
cord-328352-l1q4uvxl	58	25	well	well	RB
cord-328352-l1q4uvxl	58	26	as	as	IN
cord-328352-l1q4uvxl	58	27	blinding	blind	VBG
cord-328352-l1q4uvxl	58	28	of	of	IN
cord-328352-l1q4uvxl	58	29	the	the	DT
cord-328352-l1q4uvxl	58	30	treating	treat	VBG
cord-328352-l1q4uvxl	58	31	physicians	physician	NNS
cord-328352-l1q4uvxl	58	32	.	.	.
cord-328352-l1q4uvxl	59	1	(	(	-LRB-
cord-328352-l1q4uvxl	59	2	3	3	LS
cord-328352-l1q4uvxl	59	3	)	)	-RRB-
cord-328352-l1q4uvxl	60	1	The	the	DT
cord-328352-l1q4uvxl	60	2	timing	timing	NN
cord-328352-l1q4uvxl	60	3	of	of	IN
cord-328352-l1q4uvxl	60	4	convalescent	convalescent	JJ
cord-328352-l1q4uvxl	60	5	plasma	plasma	NN
cord-328352-l1q4uvxl	60	6	infusion	infusion	NN
cord-328352-l1q4uvxl	60	7	and	and	CC
cord-328352-l1q4uvxl	60	8	its	-PRON-	PRP$
cord-328352-l1q4uvxl	60	9	doses	dose	NNS
cord-328352-l1q4uvxl	60	10	and	and	CC
cord-328352-l1q4uvxl	60	11	the	the	DT
cord-328352-l1q4uvxl	60	12	need	need	NN
cord-328352-l1q4uvxl	60	13	for	for	IN
cord-328352-l1q4uvxl	60	14	booster	booster	NN
cord-328352-l1q4uvxl	60	15	shots	shot	NNS
cord-328352-l1q4uvxl	60	16	will	will	MD
cord-328352-l1q4uvxl	60	17	require	require	VB
cord-328352-l1q4uvxl	60	18	careful	careful	JJ
cord-328352-l1q4uvxl	60	19	considerations	consideration	NNS
cord-328352-l1q4uvxl	60	20	.	.	.
cord-328352-l1q4uvxl	61	1	For	for	IN
cord-328352-l1q4uvxl	61	2	example	example	NN
cord-328352-l1q4uvxl	61	3	,	,	,
cord-328352-l1q4uvxl	61	4	in	in	IN
cord-328352-l1q4uvxl	61	5	Duan	Duan	NNP
cord-328352-l1q4uvxl	61	6	's	's	POS
cord-328352-l1q4uvxl	61	7	study	study	NN
cord-328352-l1q4uvxl	61	8	23	23	CD
cord-328352-l1q4uvxl	61	9	,	,	,
cord-328352-l1q4uvxl	61	10	patients	patient	NNS
cord-328352-l1q4uvxl	61	11	were	be	VBD
cord-328352-l1q4uvxl	61	12	infused	infuse	VBN
cord-328352-l1q4uvxl	61	13	with	with	IN
cord-328352-l1q4uvxl	61	14	convalescent	convalescent	JJ
cord-328352-l1q4uvxl	61	15	plasma	plasma	NN
cord-328352-l1q4uvxl	61	16	at	at	IN
cord-328352-l1q4uvxl	61	17	around	around	IN
cord-328352-l1q4uvxl	61	18	16	16	CD
cord-328352-l1q4uvxl	61	19	days	day	NNS
cord-328352-l1q4uvxl	61	20	of	of	IN
cord-328352-l1q4uvxl	61	21	symptom	symptom	NN
cord-328352-l1q4uvxl	61	22	onset	onset	NN
cord-328352-l1q4uvxl	61	23	,	,	,
cord-328352-l1q4uvxl	61	24	while	while	IN
cord-328352-l1q4uvxl	61	25	in	in	IN
cord-328352-l1q4uvxl	61	26	Shen	Shen	NNP
cord-328352-l1q4uvxl	61	27	's	's	POS
cord-328352-l1q4uvxl	61	28	study	study	NN
cord-328352-l1q4uvxl	61	29	24	24	CD
cord-328352-l1q4uvxl	61	30	,	,	,
cord-328352-l1q4uvxl	61	31	patients	patient	NNS
cord-328352-l1q4uvxl	61	32	received	receive	VBD
cord-328352-l1q4uvxl	61	33	convalescent	convalescent	JJ
cord-328352-l1q4uvxl	61	34	plasma	plasma	NN
cord-328352-l1q4uvxl	61	35	at	at	IN
cord-328352-l1q4uvxl	61	36	around	around	IN
cord-328352-l1q4uvxl	61	37	21	21	CD
cord-328352-l1q4uvxl	61	38	days	day	NNS
cord-328352-l1q4uvxl	61	39	after	after	IN
cord-328352-l1q4uvxl	61	40	symptom	symptom	NN
cord-328352-l1q4uvxl	61	41	onset	onset	NN
cord-328352-l1q4uvxl	61	42	.	.	.
cord-328352-l1q4uvxl	62	1	The	the	DT
cord-328352-l1q4uvxl	62	2	recognition	recognition	NN
cord-328352-l1q4uvxl	62	3	of	of	IN
cord-328352-l1q4uvxl	62	4	positive	positive	JJ
cord-328352-l1q4uvxl	62	5	outcomes	outcome	NNS
cord-328352-l1q4uvxl	62	6	may	may	MD
cord-328352-l1q4uvxl	62	7	depend	depend	VB
cord-328352-l1q4uvxl	62	8	on	on	IN
cord-328352-l1q4uvxl	62	9	the	the	DT
cord-328352-l1q4uvxl	62	10	early	early	JJ
cord-328352-l1q4uvxl	62	11	initiation	initiation	NN
cord-328352-l1q4uvxl	62	12	of	of	IN
cord-328352-l1q4uvxl	62	13	convalescent	convalescent	JJ
cord-328352-l1q4uvxl	62	14	plasma	plasma	NN
cord-328352-l1q4uvxl	62	15	infusion	infusion	NN
cord-328352-l1q4uvxl	62	16	and	and	CC
cord-328352-l1q4uvxl	62	17	may	may	MD
cord-328352-l1q4uvxl	62	18	be	be	VB
cord-328352-l1q4uvxl	62	19	the	the	DT
cord-328352-l1q4uvxl	62	20	need	need	NN
cord-328352-l1q4uvxl	62	21	for	for	IN
cord-328352-l1q4uvxl	62	22	subsequent	subsequent	JJ
cord-328352-l1q4uvxl	62	23	booster	booster	NN
cord-328352-l1q4uvxl	62	24	treatment	treatment	NN
cord-328352-l1q4uvxl	62	25	.	.	.
cord-328352-l1q4uvxl	63	1	Additionally	additionally	RB
cord-328352-l1q4uvxl	63	2	,	,	,
cord-328352-l1q4uvxl	63	3	in	in	IN
cord-328352-l1q4uvxl	63	4	Duan	Duan	NNP
cord-328352-l1q4uvxl	63	5	's	's	POS
cord-328352-l1q4uvxl	63	6	study	study	NN
cord-328352-l1q4uvxl	63	7	23	23	CD
cord-328352-l1q4uvxl	63	8	,	,	,
cord-328352-l1q4uvxl	63	9	one	one	CD
cord-328352-l1q4uvxl	63	10	dose	dose	NN
cord-328352-l1q4uvxl	63	11	of	of	IN
cord-328352-l1q4uvxl	63	12	200	200	CD
cord-328352-l1q4uvxl	63	13	ml	ml	NNS
cord-328352-l1q4uvxl	63	14	of	of	IN
cord-328352-l1q4uvxl	63	15	convalescent	convalescent	JJ
cord-328352-l1q4uvxl	63	16	plasma	plasma	NN
cord-328352-l1q4uvxl	63	17	with	with	IN
cord-328352-l1q4uvxl	63	18	the	the	DT
cord-328352-l1q4uvxl	63	19	neutralizing	neutralize	VBG
cord-328352-l1q4uvxl	63	20	antibody	antibody	NN
cord-328352-l1q4uvxl	63	21	titers	titer	NNS
cord-328352-l1q4uvxl	63	22	above	above	IN
cord-328352-l1q4uvxl	63	23	1:640	1:640	CD
cord-328352-l1q4uvxl	63	24	was	be	VBD
cord-328352-l1q4uvxl	63	25	specified	specify	VBN
cord-328352-l1q4uvxl	63	26	.	.	.
cord-328352-l1q4uvxl	64	1	In	in	IN
cord-328352-l1q4uvxl	64	2	Shen	Shen	NNP
cord-328352-l1q4uvxl	64	3	's	's	POS
cord-328352-l1q4uvxl	64	4	study	study	NN
cord-328352-l1q4uvxl	64	5	24	24	CD
cord-328352-l1q4uvxl	64	6	,	,	,
cord-328352-l1q4uvxl	64	7	it	-PRON-	PRP
cord-328352-l1q4uvxl	64	8	was	be	VBD
cord-328352-l1q4uvxl	64	9	400	400	CD
cord-328352-l1q4uvxl	64	10	ml	ml	NNS
cord-328352-l1q4uvxl	64	11	of	of	IN
cord-328352-l1q4uvxl	64	12	convalescent	convalescent	JJ
cord-328352-l1q4uvxl	64	13	plasma	plasma	NN
cord-328352-l1q4uvxl	64	14	with	with	IN
cord-328352-l1q4uvxl	64	15	the	the	DT
cord-328352-l1q4uvxl	64	16	neutralizing	neutralize	VBG
cord-328352-l1q4uvxl	64	17	antibody	antibody	NN
cord-328352-l1q4uvxl	64	18	titer	titer	NN
cord-328352-l1q4uvxl	64	19	set	set	VBN
cord-328352-l1q4uvxl	64	20	at	at	IN
cord-328352-l1q4uvxl	64	21	1:1000	1:1000	CD
cord-328352-l1q4uvxl	64	22	.	.	.
cord-328352-l1q4uvxl	65	1	Finding	find	VBG
cord-328352-l1q4uvxl	65	2	the	the	DT
cord-328352-l1q4uvxl	65	3	optimal	optimal	JJ
cord-328352-l1q4uvxl	65	4	timing	timing	NN
cord-328352-l1q4uvxl	65	5	and	and	CC
cord-328352-l1q4uvxl	65	6	dose	dose	NN
cord-328352-l1q4uvxl	65	7	will	will	MD
cord-328352-l1q4uvxl	65	8	improve	improve	VB
cord-328352-l1q4uvxl	65	9	the	the	DT
cord-328352-l1q4uvxl	65	10	safety	safety	NN
cord-328352-l1q4uvxl	65	11	and	and	CC
cord-328352-l1q4uvxl	65	12	efficacy	efficacy	NN
cord-328352-l1q4uvxl	65	13	of	of	IN
cord-328352-l1q4uvxl	65	14	convalescent	convalescent	JJ
cord-328352-l1q4uvxl	65	15	plasma	plasma	NN
cord-328352-l1q4uvxl	65	16	.	.	.
cord-328352-l1q4uvxl	66	1	(	(	-LRB-
cord-328352-l1q4uvxl	66	2	4	4	LS
cord-328352-l1q4uvxl	66	3	)	)	-RRB-
cord-328352-l1q4uvxl	66	4	Related	relate	VBN
cord-328352-l1q4uvxl	66	5	to	to	IN
cord-328352-l1q4uvxl	66	6	the	the	DT
cord-328352-l1q4uvxl	66	7	timing	timing	NN
cord-328352-l1q4uvxl	66	8	of	of	IN
cord-328352-l1q4uvxl	66	9	convalescent	convalescent	JJ
cord-328352-l1q4uvxl	66	10	plasma	plasma	NN
cord-328352-l1q4uvxl	66	11	infusion	infusion	NN
cord-328352-l1q4uvxl	66	12	,	,	,
cord-328352-l1q4uvxl	66	13	the	the	DT
cord-328352-l1q4uvxl	66	14	severity	severity	NN
cord-328352-l1q4uvxl	66	15	of	of	IN
cord-328352-l1q4uvxl	66	16	the	the	DT
cord-328352-l1q4uvxl	66	17	disease	disease	NN
cord-328352-l1q4uvxl	66	18	is	be	VBZ
cord-328352-l1q4uvxl	66	19	likely	likely	JJ
cord-328352-l1q4uvxl	66	20	to	to	TO
cord-328352-l1q4uvxl	66	21	impact	impact	VB
cord-328352-l1q4uvxl	66	22	on	on	IN
cord-328352-l1q4uvxl	66	23	the	the	DT
cord-328352-l1q4uvxl	66	24	treatment	treatment	NN
cord-328352-l1q4uvxl	66	25	outcomes	outcome	NNS
cord-328352-l1q4uvxl	66	26	.	.	.
cord-328352-l1q4uvxl	67	1	In	in	IN
cord-328352-l1q4uvxl	67	2	all	all	PDT
cord-328352-l1q4uvxl	67	3	these	these	DT
cord-328352-l1q4uvxl	67	4	five	five	CD
cord-328352-l1q4uvxl	67	5	clinical	clinical	JJ
cord-328352-l1q4uvxl	67	6	studies	study	NNS
cord-328352-l1q4uvxl	67	7	,	,	,
cord-328352-l1q4uvxl	67	8	it	-PRON-	PRP
cord-328352-l1q4uvxl	67	9	is	be	VBZ
cord-328352-l1q4uvxl	67	10	understandable	understandable	JJ
cord-328352-l1q4uvxl	67	11	that	that	IN
cord-328352-l1q4uvxl	67	12	because	because	IN
cord-328352-l1q4uvxl	67	13	convalescent	convalescent	JJ
cord-328352-l1q4uvxl	67	14	plasma	plasma	NN
cord-328352-l1q4uvxl	67	15	treatment	treatment	NN
cord-328352-l1q4uvxl	67	16	remains	remain	VBZ
cord-328352-l1q4uvxl	67	17	experimental	experimental	JJ
cord-328352-l1q4uvxl	67	18	,	,	,
cord-328352-l1q4uvxl	67	19	the	the	DT
cord-328352-l1q4uvxl	67	20	target	target	NN
cord-328352-l1q4uvxl	67	21	population	population	NN
cord-328352-l1q4uvxl	67	22	is	be	VBZ
cord-328352-l1q4uvxl	67	23	initially	initially	RB
cord-328352-l1q4uvxl	67	24	the	the	DT
cord-328352-l1q4uvxl	67	25	severe	severe	JJ
cord-328352-l1q4uvxl	67	26	or	or	CC
cord-328352-l1q4uvxl	67	27	critically	critically	RB
cord-328352-l1q4uvxl	67	28	ill	ill	JJ
cord-328352-l1q4uvxl	67	29	patients	patient	NNS
cord-328352-l1q4uvxl	67	30	,	,	,
cord-328352-l1q4uvxl	67	31	who	who	WP
cord-328352-l1q4uvxl	67	32	have	have	VBP
cord-328352-l1q4uvxl	67	33	high	high	JJ
cord-328352-l1q4uvxl	67	34	mortality	mortality	NN
cord-328352-l1q4uvxl	67	35	and	and	CC
cord-328352-l1q4uvxl	67	36	worst	bad	JJS
cord-328352-l1q4uvxl	67	37	morbidity	morbidity	NN
cord-328352-l1q4uvxl	67	38	,	,	,
cord-328352-l1q4uvxl	67	39	which	which	WDT
cord-328352-l1q4uvxl	67	40	may	may	MD
cord-328352-l1q4uvxl	67	41	mask	mask	VB
cord-328352-l1q4uvxl	67	42	the	the	DT
cord-328352-l1q4uvxl	67	43	potential	potential	JJ
cord-328352-l1q4uvxl	67	44	functional	functional	JJ
cord-328352-l1q4uvxl	67	45	benefits	benefit	NNS
cord-328352-l1q4uvxl	67	46	of	of	IN
cord-328352-l1q4uvxl	67	47	the	the	DT
cord-328352-l1q4uvxl	67	48	treatment	treatment	NN
cord-328352-l1q4uvxl	67	49	.	.	.
cord-328352-l1q4uvxl	68	1	Future	future	JJ
cord-328352-l1q4uvxl	68	2	treatments	treatment	NNS
cord-328352-l1q4uvxl	68	3	may	may	MD
cord-328352-l1q4uvxl	68	4	need	need	VB
cord-328352-l1q4uvxl	68	5	to	to	TO
cord-328352-l1q4uvxl	68	6	enroll	enroll	VB
cord-328352-l1q4uvxl	68	7	those	those	DT
cord-328352-l1q4uvxl	68	8	mild	mild	JJ
cord-328352-l1q4uvxl	68	9	COVID-19	covid-19	JJ
cord-328352-l1q4uvxl	68	10	patients	patient	NNS
cord-328352-l1q4uvxl	68	11	or	or	CC
cord-328352-l1q4uvxl	68	12	those	those	DT
cord-328352-l1q4uvxl	68	13	who	who	WP
cord-328352-l1q4uvxl	68	14	are	be	VBP
cord-328352-l1q4uvxl	68	15	in	in	IN
cord-328352-l1q4uvxl	68	16	the	the	DT
cord-328352-l1q4uvxl	68	17	early	early	JJ
cord-328352-l1q4uvxl	68	18	stages	stage	NNS
cord-328352-l1q4uvxl	68	19	of	of	IN
cord-328352-l1q4uvxl	68	20	the	the	DT
cord-328352-l1q4uvxl	68	21	disease	disease	NN
cord-328352-l1q4uvxl	68	22	.	.	.
cord-328352-l1q4uvxl	69	1	(	(	-LRB-
cord-328352-l1q4uvxl	69	2	5	5	LS
cord-328352-l1q4uvxl	69	3	)	)	-RRB-
cord-328352-l1q4uvxl	70	1	The	the	DT
cord-328352-l1q4uvxl	70	2	treatment	treatment	NN
cord-328352-l1q4uvxl	70	3	profile	profile	NN
cord-328352-l1q4uvxl	70	4	of	of	IN
cord-328352-l1q4uvxl	70	5	the	the	DT
cord-328352-l1q4uvxl	70	6	patients	patient	NNS
cord-328352-l1q4uvxl	70	7	will	will	MD
cord-328352-l1q4uvxl	70	8	need	need	VB
cord-328352-l1q4uvxl	70	9	to	to	TO
cord-328352-l1q4uvxl	70	10	be	be	VB
cord-328352-l1q4uvxl	70	11	carefully	carefully	RB
cord-328352-l1q4uvxl	70	12	charted	chart	VBN
cord-328352-l1q4uvxl	70	13	,	,	,
cord-328352-l1q4uvxl	70	14	noting	note	VBG
cord-328352-l1q4uvxl	70	15	the	the	DT
cord-328352-l1q4uvxl	70	16	drugs	drug	NNS
cord-328352-l1q4uvxl	70	17	and	and	CC
cord-328352-l1q4uvxl	70	18	ventilator	ventilator	NN
cord-328352-l1q4uvxl	70	19	supportive	supportive	JJ
cord-328352-l1q4uvxl	70	20	care	care	NN
cord-328352-l1q4uvxl	70	21	among	among	IN
cord-328352-l1q4uvxl	70	22	others	other	NNS
cord-328352-l1q4uvxl	70	23	,	,	,
cord-328352-l1q4uvxl	70	24	in	in	IN
cord-328352-l1q4uvxl	70	25	order	order	NN
cord-328352-l1q4uvxl	70	26	to	to	TO
cord-328352-l1q4uvxl	70	27	delineate	delineate	VB
cord-328352-l1q4uvxl	70	28	the	the	DT
cord-328352-l1q4uvxl	70	29	true	true	JJ
cord-328352-l1q4uvxl	70	30	effects	effect	NNS
cord-328352-l1q4uvxl	70	31	of	of	IN
cord-328352-l1q4uvxl	70	32	convalescent	convalescent	JJ
cord-328352-l1q4uvxl	70	33	plasma	plasma	NN
cord-328352-l1q4uvxl	70	34	infusion	infusion	NN
cord-328352-l1q4uvxl	70	35	or	or	CC
cord-328352-l1q4uvxl	70	36	the	the	DT
cord-328352-l1q4uvxl	70	37	possibility	possibility	NN
cord-328352-l1q4uvxl	70	38	of	of	IN
cord-328352-l1q4uvxl	70	39	additive	additive	NN
cord-328352-l1q4uvxl	70	40	effects	effect	NNS
cord-328352-l1q4uvxl	70	41	of	of	IN
cord-328352-l1q4uvxl	70	42	convalescent	convalescent	JJ
cord-328352-l1q4uvxl	70	43	plasma	plasma	NN
cord-328352-l1q4uvxl	70	44	with	with	IN
cord-328352-l1q4uvxl	70	45	antiviral	antiviral	JJ
cord-328352-l1q4uvxl	70	46	agents	agent	NNS
cord-328352-l1q4uvxl	70	47	and	and	CC
cord-328352-l1q4uvxl	70	48	immunomodulatory	immunomodulatory	JJ
cord-328352-l1q4uvxl	70	49	drugs	drug	NNS
cord-328352-l1q4uvxl	70	50	.	.	.
cord-328352-l1q4uvxl	71	1	(	(	-LRB-
cord-328352-l1q4uvxl	71	2	6	6	CD
cord-328352-l1q4uvxl	71	3	)	)	-RRB-
cord-328352-l1q4uvxl	72	1	The	the	DT
cord-328352-l1q4uvxl	72	2	patient	patient	NN
cord-328352-l1q4uvxl	72	3	's	's	POS
cord-328352-l1q4uvxl	72	4	preexisting	preexisting	JJ
cord-328352-l1q4uvxl	72	5	health	health	NN
cord-328352-l1q4uvxl	72	6	condition	condition	NN
cord-328352-l1q4uvxl	72	7	is	be	VBZ
cord-328352-l1q4uvxl	72	8	equally	equally	RB
cord-328352-l1q4uvxl	72	9	an	an	DT
cord-328352-l1q4uvxl	72	10	important	important	JJ
cord-328352-l1q4uvxl	72	11	factor	factor	NN
cord-328352-l1q4uvxl	72	12	in	in	IN
cord-328352-l1q4uvxl	72	13	treatment	treatment	NN
cord-328352-l1q4uvxl	72	14	outcomes	outcome	NNS
cord-328352-l1q4uvxl	72	15	and	and	CC
cord-328352-l1q4uvxl	72	16	disease	disease	NN
cord-328352-l1q4uvxl	72	17	progression	progression	NN
cord-328352-l1q4uvxl	72	18	.	.	.
cord-328352-l1q4uvxl	73	1	In	in	IN
cord-328352-l1q4uvxl	73	2	addition	addition	NN
cord-328352-l1q4uvxl	73	3	to	to	IN
cord-328352-l1q4uvxl	73	4	COVID-19	covid-19	VB
cord-328352-l1q4uvxl	73	5	,	,	,
cord-328352-l1q4uvxl	73	6	immune	immune	NN
cord-328352-l1q4uvxl	73	7	-	-	HYPH
cord-328352-l1q4uvxl	73	8	related	relate	VBN
cord-328352-l1q4uvxl	73	9	diseases	disease	NNS
cord-328352-l1q4uvxl	73	10	may	may	MD
cord-328352-l1q4uvxl	73	11	worsen	worsen	VB
cord-328352-l1q4uvxl	73	12	the	the	DT
cord-328352-l1q4uvxl	73	13	presenting	present	VBG
cord-328352-l1q4uvxl	73	14	pathology	pathology	NN
cord-328352-l1q4uvxl	73	15	,	,	,
cord-328352-l1q4uvxl	73	16	which	which	WDT
cord-328352-l1q4uvxl	73	17	will	will	MD
cord-328352-l1q4uvxl	73	18	likely	likely	RB
cord-328352-l1q4uvxl	73	19	require	require	VB
cord-328352-l1q4uvxl	73	20	not	not	RB
cord-328352-l1q4uvxl	73	21	only	only	RB
cord-328352-l1q4uvxl	73	22	eliminating	eliminate	VBG
cord-328352-l1q4uvxl	73	23	SARS	SARS	NNP
cord-328352-l1q4uvxl	73	24	-	-	HYPH
cord-328352-l1q4uvxl	73	25	CoV-2	CoV-2	NNP
cord-328352-l1q4uvxl	73	26	but	but	CC
cord-328352-l1q4uvxl	73	27	also	also	RB
cord-328352-l1q4uvxl	73	28	addressing	address	VBG
cord-328352-l1q4uvxl	73	29	the	the	DT
cord-328352-l1q4uvxl	73	30	multifactorial	multifactorial	JJ
cord-328352-l1q4uvxl	73	31	manifestations	manifestation	NNS
cord-328352-l1q4uvxl	73	32	of	of	IN
cord-328352-l1q4uvxl	73	33	disease	disease	NN
cord-328352-l1q4uvxl	73	34	.	.	.
cord-328352-l1q4uvxl	74	1	(	(	-LRB-
cord-328352-l1q4uvxl	74	2	7	7	CD
cord-328352-l1q4uvxl	74	3	)	)	-RRB-
cord-328352-l1q4uvxl	75	1	The	the	DT
cord-328352-l1q4uvxl	75	2	age	age	NN
cord-328352-l1q4uvxl	75	3	,	,	,
cord-328352-l1q4uvxl	75	4	gender	gender	NN
cord-328352-l1q4uvxl	75	5	,	,	,
cord-328352-l1q4uvxl	75	6	ethnicity	ethnicity	NN
cord-328352-l1q4uvxl	75	7	,	,	,
cord-328352-l1q4uvxl	75	8	genetic	genetic	JJ
cord-328352-l1q4uvxl	75	9	factors	factor	NNS
cord-328352-l1q4uvxl	75	10	,	,	,
cord-328352-l1q4uvxl	75	11	and	and	CC
cord-328352-l1q4uvxl	75	12	other	other	JJ
cord-328352-l1q4uvxl	75	13	pertinent	pertinent	JJ
cord-328352-l1q4uvxl	75	14	patient	patient	NN
cord-328352-l1q4uvxl	75	15	profiles	profile	NNS
cord-328352-l1q4uvxl	75	16	will	will	MD
cord-328352-l1q4uvxl	75	17	need	need	VB
cord-328352-l1q4uvxl	75	18	to	to	TO
cord-328352-l1q4uvxl	75	19	be	be	VB
cord-328352-l1q4uvxl	75	20	factored	factor	VBN
cord-328352-l1q4uvxl	75	21	into	into	IN
cord-328352-l1q4uvxl	75	22	the	the	DT
cord-328352-l1q4uvxl	75	23	final	final	JJ
cord-328352-l1q4uvxl	75	24	analysis	analysis	NN
cord-328352-l1q4uvxl	75	25	of	of	IN
cord-328352-l1q4uvxl	75	26	the	the	DT
cord-328352-l1q4uvxl	75	27	treatment	treatment	NN
cord-328352-l1q4uvxl	75	28	outcomes	outcome	NNS
cord-328352-l1q4uvxl	75	29	as	as	IN
cord-328352-l1q4uvxl	75	30	this	this	DT
cord-328352-l1q4uvxl	75	31	will	will	MD
cord-328352-l1q4uvxl	75	32	further	further	RB
cord-328352-l1q4uvxl	75	33	guide	guide	VB
cord-328352-l1q4uvxl	75	34	optimization	optimization	NN
cord-328352-l1q4uvxl	75	35	of	of	IN
cord-328352-l1q4uvxl	75	36	the	the	DT
cord-328352-l1q4uvxl	75	37	convalescent	convalescent	JJ
cord-328352-l1q4uvxl	75	38	plasma	plasma	NN
cord-328352-l1q4uvxl	75	39	treatment	treatment	NN
cord-328352-l1q4uvxl	75	40	.	.	.
cord-328352-l1q4uvxl	76	1	Clearly	clearly	RB
cord-328352-l1q4uvxl	76	2	,	,	,
cord-328352-l1q4uvxl	76	3	there	there	EX
cord-328352-l1q4uvxl	76	4	remain	remain	VBP
cord-328352-l1q4uvxl	76	5	several	several	JJ
cord-328352-l1q4uvxl	76	6	factors	factor	NNS
cord-328352-l1q4uvxl	76	7	in	in	IN
cord-328352-l1q4uvxl	76	8	order	order	NN
cord-328352-l1q4uvxl	76	9	to	to	TO
cord-328352-l1q4uvxl	76	10	advance	advance	VB
cord-328352-l1q4uvxl	76	11	the	the	DT
cord-328352-l1q4uvxl	76	12	widespread	widespread	JJ
cord-328352-l1q4uvxl	76	13	use	use	NN
cord-328352-l1q4uvxl	76	14	of	of	IN
cord-328352-l1q4uvxl	76	15	convalescent	convalescent	JJ
cord-328352-l1q4uvxl	76	16	plasma	plasma	NN
cord-328352-l1q4uvxl	76	17	for	for	IN
cord-328352-l1q4uvxl	76	18	treating	treat	VBG
cord-328352-l1q4uvxl	76	19	COVID-19	covid-19	NN
cord-328352-l1q4uvxl	76	20	.	.	.
cord-328352-l1q4uvxl	77	1	However	however	RB
cord-328352-l1q4uvxl	77	2	,	,	,
cord-328352-l1q4uvxl	77	3	at	at	IN
cord-328352-l1q4uvxl	77	4	the	the	DT
cord-328352-l1q4uvxl	77	5	minimum	minimum	NN
cord-328352-l1q4uvxl	77	6	,	,	,
cord-328352-l1q4uvxl	77	7	the	the	DT
cord-328352-l1q4uvxl	77	8	transparency	transparency	NN
cord-328352-l1q4uvxl	77	9	in	in	IN
cord-328352-l1q4uvxl	77	10	reporting	report	VBG
cord-328352-l1q4uvxl	77	11	the	the	DT
cord-328352-l1q4uvxl	77	12	detailed	detailed	JJ
cord-328352-l1q4uvxl	77	13	methods	method	NNS
cord-328352-l1q4uvxl	77	14	and	and	CC
cord-328352-l1q4uvxl	77	15	treatment	treatment	NN
cord-328352-l1q4uvxl	77	16	outcomes	outcome	NNS
cord-328352-l1q4uvxl	77	17	will	will	MD
cord-328352-l1q4uvxl	77	18	ensure	ensure	VB
cord-328352-l1q4uvxl	77	19	rigorous	rigorous	JJ
cord-328352-l1q4uvxl	77	20	assessment	assessment	NN
cord-328352-l1q4uvxl	77	21	of	of	IN
cord-328352-l1q4uvxl	77	22	the	the	DT
cord-328352-l1q4uvxl	77	23	true	true	JJ
cord-328352-l1q4uvxl	77	24	functional	functional	JJ
cord-328352-l1q4uvxl	77	25	effects	effect	NNS
cord-328352-l1q4uvxl	77	26	of	of	IN
cord-328352-l1q4uvxl	77	27	convalescent	convalescent	JJ
cord-328352-l1q4uvxl	77	28	plasma	plasma	NN
cord-328352-l1q4uvxl	77	29	.	.	.
cord-328352-l1q4uvxl	78	1	A	a	DT
cord-328352-l1q4uvxl	78	2	glance	glance	NN
cord-328352-l1q4uvxl	78	3	at	at	IN
cord-328352-l1q4uvxl	78	4	the	the	DT
cord-328352-l1q4uvxl	78	5	clinicaltrials.gov	clinicaltrials.gov	NNP
cord-328352-l1q4uvxl	78	6	website	website	NN
cord-328352-l1q4uvxl	78	7	reveals	reveal	VBZ
cord-328352-l1q4uvxl	78	8	173	173	CD
cord-328352-l1q4uvxl	78	9	ongoing	ongoing	JJ
cord-328352-l1q4uvxl	78	10	clinical	clinical	JJ
cord-328352-l1q4uvxl	78	11	trials	trial	NNS
cord-328352-l1q4uvxl	78	12	on	on	IN
cord-328352-l1q4uvxl	78	13	the	the	DT
cord-328352-l1q4uvxl	78	14	use	use	NN
cord-328352-l1q4uvxl	78	15	of	of	IN
cord-328352-l1q4uvxl	78	16	convalescent	convalescent	JJ
cord-328352-l1q4uvxl	78	17	plasma	plasma	NN
cord-328352-l1q4uvxl	78	18	for	for	IN
cord-328352-l1q4uvxl	78	19	COVID-19	COVID-19	NNP
cord-328352-l1q4uvxl	78	20	.	.	.
cord-328352-l1q4uvxl	79	1	Recognition	recognition	NN
cord-328352-l1q4uvxl	79	2	of	of	IN
cord-328352-l1q4uvxl	79	3	the	the	DT
cord-328352-l1q4uvxl	79	4	factors	factor	NNS
cord-328352-l1q4uvxl	79	5	mentioned	mention	VBN
cord-328352-l1q4uvxl	79	6	earlier	early	RBR
cord-328352-l1q4uvxl	79	7	will	will	MD
cord-328352-l1q4uvxl	79	8	allow	allow	VB
cord-328352-l1q4uvxl	79	9	direct	direct	JJ
cord-328352-l1q4uvxl	79	10	comparisons	comparison	NNS
cord-328352-l1q4uvxl	79	11	of	of	IN
cord-328352-l1q4uvxl	79	12	protocols	protocol	NNS
cord-328352-l1q4uvxl	79	13	and	and	CC
cord-328352-l1q4uvxl	79	14	safety	safety	NN
cord-328352-l1q4uvxl	79	15	and	and	CC
cord-328352-l1q4uvxl	79	16	efficacy	efficacy	NN
cord-328352-l1q4uvxl	79	17	readouts	readout	NNS
cord-328352-l1q4uvxl	79	18	across	across	IN
cord-328352-l1q4uvxl	79	19	these	these	DT
cord-328352-l1q4uvxl	79	20	clinical	clinical	JJ
cord-328352-l1q4uvxl	79	21	trials	trial	NNS
cord-328352-l1q4uvxl	79	22	and	and	CC
cord-328352-l1q4uvxl	79	23	further	further	RB
cord-328352-l1q4uvxl	79	24	evaluate	evaluate	VB
cord-328352-l1q4uvxl	79	25	the	the	DT
cord-328352-l1q4uvxl	79	26	potential	potential	NN
cord-328352-l1q4uvxl	79	27	of	of	IN
cord-328352-l1q4uvxl	79	28	convalescent	convalescent	JJ
cord-328352-l1q4uvxl	79	29	plasma	plasma	NN
cord-328352-l1q4uvxl	79	30	for	for	IN
cord-328352-l1q4uvxl	79	31	COVID-19	COVID-19	NNP
cord-328352-l1q4uvxl	79	32	.	.	.
cord-328352-l1q4uvxl	80	1	As	as	IN
cord-328352-l1q4uvxl	80	2	noted	note	VBN
cord-328352-l1q4uvxl	80	3	earlier	early	RBR
cord-328352-l1q4uvxl	80	4	,	,	,
cord-328352-l1q4uvxl	80	5	plasma	plasma	NN
cord-328352-l1q4uvxl	80	6	therapy	therapy	NN
cord-328352-l1q4uvxl	80	7	involves	involve	VBZ
cord-328352-l1q4uvxl	80	8	the	the	DT
cord-328352-l1q4uvxl	80	9	use	use	NN
cord-328352-l1q4uvxl	80	10	of	of	IN
cord-328352-l1q4uvxl	80	11	convalescent	convalescent	JJ
cord-328352-l1q4uvxl	80	12	plasma	plasma	NN
cord-328352-l1q4uvxl	80	13	,	,	,
cord-328352-l1q4uvxl	80	14	but	but	CC
cord-328352-l1q4uvxl	80	15	also	also	RB
cord-328352-l1q4uvxl	80	16	the	the	DT
cord-328352-l1q4uvxl	80	17	plasma	plasma	NN
cord-328352-l1q4uvxl	80	18	-	-	HYPH
cord-328352-l1q4uvxl	80	19	active	active	JJ
cord-328352-l1q4uvxl	80	20	components	component	NNS
cord-328352-l1q4uvxl	80	21	specifically	specifically	RB
cord-328352-l1q4uvxl	80	22	IGs	IGs	NNP
cord-328352-l1q4uvxl	80	23	.	.	.
cord-328352-l1q4uvxl	81	1	Under	under	IN
cord-328352-l1q4uvxl	81	2	the	the	DT
cord-328352-l1q4uvxl	81	3	guise	guise	NN
cord-328352-l1q4uvxl	81	4	of	of	IN
cord-328352-l1q4uvxl	81	5	passive	passive	JJ
cord-328352-l1q4uvxl	81	6	immunity	immunity	NN
cord-328352-l1q4uvxl	81	7	against	against	IN
cord-328352-l1q4uvxl	81	8	pathogens	pathogen	NNS
cord-328352-l1q4uvxl	81	9	in	in	IN
cord-328352-l1q4uvxl	81	10	viral	viral	JJ
cord-328352-l1q4uvxl	81	11	epidemics	epidemic	NNS
cord-328352-l1q4uvxl	81	12	,	,	,
cord-328352-l1q4uvxl	81	13	convalescent	convalescent	JJ
cord-328352-l1q4uvxl	81	14	plasma	plasma	NN
cord-328352-l1q4uvxl	81	15	is	be	VBZ
cord-328352-l1q4uvxl	81	16	considered	consider	VBN
cord-328352-l1q4uvxl	81	17	the	the	DT
cord-328352-l1q4uvxl	81	18	first	first	JJ
cord-328352-l1q4uvxl	81	19	-	-	HYPH
cord-328352-l1q4uvxl	81	20	line	line	NN
cord-328352-l1q4uvxl	81	21	passive	passive	JJ
cord-328352-l1q4uvxl	81	22	immunotherapy	immunotherapy	NN
cord-328352-l1q4uvxl	81	23	since	since	IN
cord-328352-l1q4uvxl	81	24	the	the	DT
cord-328352-l1q4uvxl	81	25	1918	1918	CD
cord-328352-l1q4uvxl	81	26	Spanish	spanish	JJ
cord-328352-l1q4uvxl	81	27	flu	flu	NN
cord-328352-l1q4uvxl	81	28	and	and	CC
cord-328352-l1q4uvxl	81	29	the	the	DT
cord-328352-l1q4uvxl	81	30	modern	modern	JJ
cord-328352-l1q4uvxl	81	31	viral	viral	JJ
cord-328352-l1q4uvxl	81	32	epidemics	epidemic	NNS
cord-328352-l1q4uvxl	81	33	(	(	-LRB-
cord-328352-l1q4uvxl	81	34	2003	2003	CD
cord-328352-l1q4uvxl	81	35	SARS	SARS	NNP
cord-328352-l1q4uvxl	81	36	-	-	HYPH
cord-328352-l1q4uvxl	81	37	CoV-1	CoV-1	NNP
cord-328352-l1q4uvxl	81	38	,	,	,
cord-328352-l1q4uvxl	81	39	2009	2009	CD
cord-328352-l1q4uvxl	81	40	-	-	SYM
cord-328352-l1q4uvxl	81	41	2010	2010	CD
cord-328352-l1q4uvxl	81	42	H1N1	H1N1	NNP
cord-328352-l1q4uvxl	81	43	,	,	,
cord-328352-l1q4uvxl	81	44	and	and	CC
cord-328352-l1q4uvxl	81	45	2012	2012	CD
cord-328352-l1q4uvxl	81	46	MERS	MERS	NNP
cord-328352-l1q4uvxl	81	47	-	-	HYPH
cord-328352-l1q4uvxl	81	48	CoV	CoV	NNP
cord-328352-l1q4uvxl	81	49	)	)	-RRB-
cord-328352-l1q4uvxl	81	50	,	,	,
cord-328352-l1q4uvxl	81	51	and	and	CC
cord-328352-l1q4uvxl	81	52	now	now	RB
cord-328352-l1q4uvxl	81	53	Covid-19	Covid-19	NNP
cord-328352-l1q4uvxl	81	54	27	27	CD
cord-328352-l1q4uvxl	81	55	,	,	,
cord-328352-l1q4uvxl	81	56	28	28	CD
cord-328352-l1q4uvxl	81	57	.	.	.
cord-328352-l1q4uvxl	82	1	The	the	DT
cord-328352-l1q4uvxl	82	2	last	last	JJ
cord-328352-l1q4uvxl	82	3	several	several	JJ
cord-328352-l1q4uvxl	82	4	decades	decade	NNS
cord-328352-l1q4uvxl	82	5	have	have	VBP
cord-328352-l1q4uvxl	82	6	witnessed	witness	VBN
cord-328352-l1q4uvxl	82	7	advancements	advancement	NNS
cord-328352-l1q4uvxl	82	8	in	in	IN
cord-328352-l1q4uvxl	82	9	molecular	molecular	JJ
cord-328352-l1q4uvxl	82	10	technology	technology	NN
cord-328352-l1q4uvxl	82	11	toward	toward	IN
cord-328352-l1q4uvxl	82	12	the	the	DT
cord-328352-l1q4uvxl	82	13	purification	purification	NN
cord-328352-l1q4uvxl	82	14	and	and	CC
cord-328352-l1q4uvxl	82	15	manufacture	manufacture	NN
cord-328352-l1q4uvxl	82	16	of	of	IN
cord-328352-l1q4uvxl	82	17	plasma	plasma	NN
cord-328352-l1q4uvxl	82	18	-	-	HYPH
cord-328352-l1q4uvxl	82	19	derived	derive	VBN
cord-328352-l1q4uvxl	82	20	IG	IG	NNP
cord-328352-l1q4uvxl	82	21	as	as	IN
cord-328352-l1q4uvxl	82	22	a	a	DT
cord-328352-l1q4uvxl	82	23	drug	drug	NN
cord-328352-l1q4uvxl	82	24	therapy	therapy	NN
cord-328352-l1q4uvxl	82	25	27	27	CD
cord-328352-l1q4uvxl	82	26	,	,	,
cord-328352-l1q4uvxl	82	27	28	28	CD
cord-328352-l1q4uvxl	82	28	.	.	.
cord-328352-l1q4uvxl	83	1	Toward	toward	IN
cord-328352-l1q4uvxl	83	2	this	this	DT
cord-328352-l1q4uvxl	83	3	end	end	NN
cord-328352-l1q4uvxl	83	4	,	,	,
cord-328352-l1q4uvxl	83	5	human	human	JJ
cord-328352-l1q4uvxl	83	6	IG	ig	NN
cord-328352-l1q4uvxl	83	7	formulations	formulation	NNS
cord-328352-l1q4uvxl	83	8	have	have	VBP
cord-328352-l1q4uvxl	83	9	been	be	VBN
cord-328352-l1q4uvxl	83	10	advanced	advance	VBN
cord-328352-l1q4uvxl	83	11	as	as	IN
cord-328352-l1q4uvxl	83	12	the	the	DT
cord-328352-l1q4uvxl	83	13	second	second	JJ
cord-328352-l1q4uvxl	83	14	line	line	NN
cord-328352-l1q4uvxl	83	15	of	of	IN
cord-328352-l1q4uvxl	83	16	passive	passive	JJ
cord-328352-l1q4uvxl	83	17	immunotherapies	immunotherapy	NNS
cord-328352-l1q4uvxl	83	18	against	against	IN
cord-328352-l1q4uvxl	83	19	these	these	DT
cord-328352-l1q4uvxl	83	20	diseases	disease	NNS
cord-328352-l1q4uvxl	83	21	27	27	CD
cord-328352-l1q4uvxl	83	22	,	,	,
cord-328352-l1q4uvxl	83	23	28	28	CD
cord-328352-l1q4uvxl	83	24	.	.	.
cord-328352-l1q4uvxl	84	1	The	the	DT
cord-328352-l1q4uvxl	84	2	rationale	rationale	NN
cord-328352-l1q4uvxl	84	3	of	of	IN
cord-328352-l1q4uvxl	84	4	human	human	JJ
cord-328352-l1q4uvxl	84	5	IG	ig	NN
cord-328352-l1q4uvxl	84	6	for	for	IN
cord-328352-l1q4uvxl	84	7	intravenous	intravenous	JJ
cord-328352-l1q4uvxl	84	8	use	use	NN
cord-328352-l1q4uvxl	84	9	(	(	-LRB-
cord-328352-l1q4uvxl	84	10	IVIG	IVIG	NNP
cord-328352-l1q4uvxl	84	11	)	)	-RRB-
cord-328352-l1q4uvxl	84	12	is	be	VBZ
cord-328352-l1q4uvxl	84	13	thus	thus	RB
cord-328352-l1q4uvxl	84	14	based	base	VBN
cord-328352-l1q4uvxl	84	15	on	on	IN
cord-328352-l1q4uvxl	84	16	the	the	DT
cord-328352-l1q4uvxl	84	17	similar	similar	JJ
cord-328352-l1q4uvxl	84	18	etiology	etiology	NN
cord-328352-l1q4uvxl	84	19	and	and	CC
cord-328352-l1q4uvxl	84	20	inflammatory	inflammatory	JJ
cord-328352-l1q4uvxl	84	21	pathogenesis	pathogenesis	NN
cord-328352-l1q4uvxl	84	22	of	of	IN
cord-328352-l1q4uvxl	84	23	SARS	SARS	NNP
cord-328352-l1q4uvxl	84	24	-	-	HYPH
cord-328352-l1q4uvxl	84	25	CoV-2	CoV-2	NNP
cord-328352-l1q4uvxl	84	26	infection	infection	NN
cord-328352-l1q4uvxl	84	27	to	to	IN
cord-328352-l1q4uvxl	84	28	diseases	disease	NNS
cord-328352-l1q4uvxl	84	29	for	for	IN
cord-328352-l1q4uvxl	84	30	which	which	WDT
cord-328352-l1q4uvxl	84	31	the	the	DT
cord-328352-l1q4uvxl	84	32	use	use	NN
cord-328352-l1q4uvxl	84	33	of	of	IN
cord-328352-l1q4uvxl	84	34	IVIG	IVIG	NNP
cord-328352-l1q4uvxl	84	35	has	have	VBZ
cord-328352-l1q4uvxl	84	36	already	already	RB
cord-328352-l1q4uvxl	84	37	been	be	VBN
cord-328352-l1q4uvxl	84	38	approved	approve	VBN
cord-328352-l1q4uvxl	84	39	by	by	IN
cord-328352-l1q4uvxl	84	40	the	the	DT
cord-328352-l1q4uvxl	84	41	FDA	FDA	NNP
cord-328352-l1q4uvxl	84	42	29	29	CD
cord-328352-l1q4uvxl	84	43	.	.	.
cord-328352-l1q4uvxl	85	1	According	accord	VBG
cord-328352-l1q4uvxl	85	2	to	to	IN
cord-328352-l1q4uvxl	85	3	clinicaltrials.gov	clinicaltrials.gov	NNP
cord-328352-l1q4uvxl	85	4	,	,	,
cord-328352-l1q4uvxl	85	5	there	there	EX
cord-328352-l1q4uvxl	85	6	are	be	VBP
cord-328352-l1q4uvxl	85	7	40	40	CD
cord-328352-l1q4uvxl	85	8	trials	trial	NNS
cord-328352-l1q4uvxl	85	9	using	use	VBG
cord-328352-l1q4uvxl	85	10	IG	IG	NNP
cord-328352-l1q4uvxl	85	11	for	for	IN
cord-328352-l1q4uvxl	85	12	COVID-19	COVID-19	NNP
cord-328352-l1q4uvxl	85	13	.	.	.
cord-328352-l1q4uvxl	86	1	Similar	similar	JJ
cord-328352-l1q4uvxl	86	2	to	to	IN
cord-328352-l1q4uvxl	86	3	convalescent	convalescent	JJ
cord-328352-l1q4uvxl	86	4	plasma	plasma	NN
cord-328352-l1q4uvxl	86	5	treatment	treatment	NN
cord-328352-l1q4uvxl	86	6	,	,	,
cord-328352-l1q4uvxl	86	7	the	the	DT
cord-328352-l1q4uvxl	86	8	mechanism	mechanism	NN
cord-328352-l1q4uvxl	86	9	of	of	IN
cord-328352-l1q4uvxl	86	10	action	action	NN
cord-328352-l1q4uvxl	86	11	ascribed	ascribe	VBN
cord-328352-l1q4uvxl	86	12	to	to	IN
cord-328352-l1q4uvxl	86	13	IG	IG	NNP
cord-328352-l1q4uvxl	86	14	therapy	therapy	NN
cord-328352-l1q4uvxl	86	15	is	be	VBZ
cord-328352-l1q4uvxl	86	16	to	to	TO
cord-328352-l1q4uvxl	86	17	boost	boost	VB
cord-328352-l1q4uvxl	86	18	the	the	DT
cord-328352-l1q4uvxl	86	19	immune	immune	JJ
cord-328352-l1q4uvxl	86	20	response	response	NN
cord-328352-l1q4uvxl	86	21	of	of	IN
cord-328352-l1q4uvxl	86	22	the	the	DT
cord-328352-l1q4uvxl	86	23	body	body	NN
cord-328352-l1q4uvxl	86	24	against	against	IN
cord-328352-l1q4uvxl	86	25	SARS	SARS	NNP
cord-328352-l1q4uvxl	86	26	-	-	HYPH
cord-328352-l1q4uvxl	86	27	CoV-2	CoV-2	NNP
cord-328352-l1q4uvxl	86	28	.	.	.
cord-328352-l1q4uvxl	87	1	Along	along	IN
cord-328352-l1q4uvxl	87	2	this	this	DT
cord-328352-l1q4uvxl	87	3	line	line	NN
cord-328352-l1q4uvxl	87	4	of	of	IN
cord-328352-l1q4uvxl	87	5	boosting	boost	VBG
cord-328352-l1q4uvxl	87	6	the	the	DT
cord-328352-l1q4uvxl	87	7	immune	immune	JJ
cord-328352-l1q4uvxl	87	8	system	system	NN
cord-328352-l1q4uvxl	87	9	of	of	IN
cord-328352-l1q4uvxl	87	10	COVID-19	covid-19	JJ
cord-328352-l1q4uvxl	87	11	patients	patient	NNS
cord-328352-l1q4uvxl	87	12	,	,	,
cord-328352-l1q4uvxl	87	13	mesenchymal	mesenchymal	JJ
cord-328352-l1q4uvxl	87	14	stem	stem	NN
cord-328352-l1q4uvxl	87	15	cells	cell	NNS
cord-328352-l1q4uvxl	87	16	(	(	-LRB-
cord-328352-l1q4uvxl	87	17	MSCs	msc	NNS
cord-328352-l1q4uvxl	87	18	)	)	-RRB-
cord-328352-l1q4uvxl	87	19	possess	possess	VB
cord-328352-l1q4uvxl	87	20	secretory	secretory	JJ
cord-328352-l1q4uvxl	87	21	functions	function	NNS
cord-328352-l1q4uvxl	87	22	of	of	IN
cord-328352-l1q4uvxl	87	23	robust	robust	JJ
cord-328352-l1q4uvxl	87	24	immunomodulatory	immunomodulatory	JJ
cord-328352-l1q4uvxl	87	25	biologics	biologic	NNS
cord-328352-l1q4uvxl	87	26	[	[	-LRB-
cord-328352-l1q4uvxl	87	27	30	30	CD
cord-328352-l1q4uvxl	87	28	]	]	-RRB-
cord-328352-l1q4uvxl	88	1	[	[	-LRB-
cord-328352-l1q4uvxl	88	2	31	31	CD
cord-328352-l1q4uvxl	88	3	]	]	-RRB-
cord-328352-l1q4uvxl	88	4	[	[	-LRB-
cord-328352-l1q4uvxl	88	5	32	32	CD
cord-328352-l1q4uvxl	88	6	]	]	-RRB-
cord-328352-l1q4uvxl	89	1	[	[	-LRB-
cord-328352-l1q4uvxl	89	2	33	33	CD
cord-328352-l1q4uvxl	89	3	]	]	-RRB-
cord-328352-l1q4uvxl	89	4	[	[	-LRB-
cord-328352-l1q4uvxl	89	5	34	34	CD
cord-328352-l1q4uvxl	89	6	]	]	-RRB-
cord-328352-l1q4uvxl	89	7	.	.	.
cord-328352-l1q4uvxl	90	1	Because	because	IN
cord-328352-l1q4uvxl	90	2	COVID-19	COVID-19	NNP
cord-328352-l1q4uvxl	90	3	manifests	manifest	VBZ
cord-328352-l1q4uvxl	90	4	a	a	DT
cord-328352-l1q4uvxl	90	5	massive	massive	JJ
cord-328352-l1q4uvxl	90	6	inflammatory	inflammatory	JJ
cord-328352-l1q4uvxl	90	7	pathology	pathology	NN
cord-328352-l1q4uvxl	90	8	in	in	IN
cord-328352-l1q4uvxl	90	9	the	the	DT
cord-328352-l1q4uvxl	90	10	lung	lung	NN
cord-328352-l1q4uvxl	90	11	,	,	,
cord-328352-l1q4uvxl	90	12	characterized	characterize	VBN
cord-328352-l1q4uvxl	90	13	by	by	IN
cord-328352-l1q4uvxl	90	14	pulmonary	pulmonary	JJ
cord-328352-l1q4uvxl	90	15	edema	edema	NN
cord-328352-l1q4uvxl	90	16	and	and	CC
cord-328352-l1q4uvxl	90	17	an	an	DT
cord-328352-l1q4uvxl	90	18	over	over	IN
cord-328352-l1q4uvxl	90	19	-	-	HYPH
cord-328352-l1q4uvxl	90	20	reactive	reactive	JJ
cord-328352-l1q4uvxl	90	21	immune	immune	JJ
cord-328352-l1q4uvxl	90	22	response	response	NN
cord-328352-l1q4uvxl	90	23	,	,	,
cord-328352-l1q4uvxl	90	24	which	which	WDT
cord-328352-l1q4uvxl	90	25	can	can	MD
cord-328352-l1q4uvxl	90	26	lead	lead	VB
cord-328352-l1q4uvxl	90	27	to	to	IN
cord-328352-l1q4uvxl	90	28	hypoxia	hypoxia	NN
cord-328352-l1q4uvxl	90	29	,	,	,
cord-328352-l1q4uvxl	90	30	respiratory	respiratory	JJ
cord-328352-l1q4uvxl	90	31	distress	distress	NN
cord-328352-l1q4uvxl	90	32	,	,	,
cord-328352-l1q4uvxl	90	33	and	and	CC
cord-328352-l1q4uvxl	90	34	lung	lung	NN
cord-328352-l1q4uvxl	90	35	damage	damage	NN
cord-328352-l1q4uvxl	90	36	,	,	,
cord-328352-l1q4uvxl	90	37	finding	find	VBG
cord-328352-l1q4uvxl	90	38	a	a	DT
cord-328352-l1q4uvxl	90	39	treatment	treatment	NN
cord-328352-l1q4uvxl	90	40	designed	design	VBN
cord-328352-l1q4uvxl	90	41	to	to	TO
cord-328352-l1q4uvxl	90	42	sequester	sequester	VB
cord-328352-l1q4uvxl	90	43	this	this	DT
cord-328352-l1q4uvxl	90	44	aberrant	aberrant	JJ
cord-328352-l1q4uvxl	90	45	inflammation	inflammation	NN
cord-328352-l1q4uvxl	90	46	and	and	CC
cord-328352-l1q4uvxl	90	47	immune	immune	JJ
cord-328352-l1q4uvxl	90	48	response	response	NN
cord-328352-l1q4uvxl	90	49	may	may	MD
cord-328352-l1q4uvxl	90	50	prove	prove	VB
cord-328352-l1q4uvxl	90	51	beneficial	beneficial	JJ
cord-328352-l1q4uvxl	90	52	against	against	IN
cord-328352-l1q4uvxl	90	53	COVID-19	COVID-19	NNP
cord-328352-l1q4uvxl	90	54	33	33	CD
cord-328352-l1q4uvxl	90	55	.	.	.
cord-328352-l1q4uvxl	91	1	Accordingly	accordingly	RB
cord-328352-l1q4uvxl	91	2	,	,	,
cord-328352-l1q4uvxl	91	3	cognizant	cognizant	JJ
cord-328352-l1q4uvxl	91	4	that	that	IN
cord-328352-l1q4uvxl	91	5	abrogating	abrogate	VBG
cord-328352-l1q4uvxl	91	6	COVID-19	COVID-19	NNP
cord-328352-l1q4uvxl	91	7	may	may	MD
cord-328352-l1q4uvxl	91	8	depend	depend	VB
cord-328352-l1q4uvxl	91	9	on	on	IN
cord-328352-l1q4uvxl	91	10	the	the	DT
cord-328352-l1q4uvxl	91	11	patients	patient	NNS
cord-328352-l1q4uvxl	91	12	'	'	POS
cord-328352-l1q4uvxl	91	13	properly	properly	RB
cord-328352-l1q4uvxl	91	14	functioning	function	VBG
cord-328352-l1q4uvxl	91	15	immune	immune	JJ
cord-328352-l1q4uvxl	91	16	system	system	NN
cord-328352-l1q4uvxl	91	17	,	,	,
cord-328352-l1q4uvxl	91	18	the	the	DT
cord-328352-l1q4uvxl	91	19	transplantation	transplantation	NN
cord-328352-l1q4uvxl	91	20	of	of	IN
cord-328352-l1q4uvxl	91	21	MSCs	msc	NNS
cord-328352-l1q4uvxl	91	22	has	have	VBZ
cord-328352-l1q4uvxl	91	23	been	be	VBN
cord-328352-l1q4uvxl	91	24	proposed	propose	VBN
cord-328352-l1q4uvxl	91	25	to	to	TO
cord-328352-l1q4uvxl	91	26	propel	propel	VB
cord-328352-l1q4uvxl	91	27	the	the	DT
cord-328352-l1q4uvxl	91	28	host	host	NN
cord-328352-l1q4uvxl	91	29	immune	immune	JJ
cord-328352-l1q4uvxl	91	30	system	system	NN
cord-328352-l1q4uvxl	91	31	to	to	TO
cord-328352-l1q4uvxl	91	32	effectively	effectively	RB
cord-328352-l1q4uvxl	91	33	eliminate	eliminate	VB
cord-328352-l1q4uvxl	91	34	the	the	DT
cord-328352-l1q4uvxl	91	35	virus	virus	NN
cord-328352-l1q4uvxl	91	36	.	.	.
cord-328352-l1q4uvxl	92	1	MSCs	mscs	NN
cord-328352-l1q4uvxl	92	2	display	display	VBP
cord-328352-l1q4uvxl	92	3	potent	potent	JJ
cord-328352-l1q4uvxl	92	4	antiinflammatory	antiinflammatory	JJ
cord-328352-l1q4uvxl	92	5	and	and	CC
cord-328352-l1q4uvxl	92	6	immunomodulatory	immunomodulatory	JJ
cord-328352-l1q4uvxl	92	7	properties	property	NNS
cord-328352-l1q4uvxl	92	8	.	.	.
cord-328352-l1q4uvxl	93	1	Indeed	indeed	RB
cord-328352-l1q4uvxl	93	2	,	,	,
cord-328352-l1q4uvxl	93	3	our	-PRON-	PRP$
cord-328352-l1q4uvxl	93	4	group	group	NN
cord-328352-l1q4uvxl	93	5	and	and	CC
cord-328352-l1q4uvxl	93	6	many	many	JJ
cord-328352-l1q4uvxl	93	7	others	other	NNS
cord-328352-l1q4uvxl	93	8	have	have	VBP
cord-328352-l1q4uvxl	93	9	shown	show	VBN
cord-328352-l1q4uvxl	93	10	that	that	IN
cord-328352-l1q4uvxl	93	11	MSCs	msc	NNS
cord-328352-l1q4uvxl	93	12	exert	exert	VB
cord-328352-l1q4uvxl	93	13	anti	anti	JJ
cord-328352-l1q4uvxl	93	14	-	-	JJ
cord-328352-l1q4uvxl	93	15	inflammatory	inflammatory	JJ
cord-328352-l1q4uvxl	93	16	effects	effect	NNS
cord-328352-l1q4uvxl	93	17	and	and	CC
cord-328352-l1q4uvxl	93	18	even	even	RB
cord-328352-l1q4uvxl	93	19	repair	repair	VB
cord-328352-l1q4uvxl	93	20	lung	lung	NN
cord-328352-l1q4uvxl	93	21	damage	damage	NN
cord-328352-l1q4uvxl	93	22	34	34	CD
cord-328352-l1q4uvxl	93	23	.	.	.
cord-328352-l1q4uvxl	94	1	Although	although	IN
cord-328352-l1q4uvxl	94	2	MSCs	msc	NNS
cord-328352-l1q4uvxl	94	3	have	have	VBP
cord-328352-l1q4uvxl	94	4	been	be	VBN
cord-328352-l1q4uvxl	94	5	the	the	DT
cord-328352-l1q4uvxl	94	6	major	major	JJ
cord-328352-l1q4uvxl	94	7	cell	cell	NN
cord-328352-l1q4uvxl	94	8	type	type	NN
cord-328352-l1q4uvxl	94	9	for	for	IN
cord-328352-l1q4uvxl	94	10	cell	cell	NN
cord-328352-l1q4uvxl	94	11	therapy	therapy	NN
cord-328352-l1q4uvxl	94	12	in	in	IN
cord-328352-l1q4uvxl	94	13	COVID-19	COVID-19	NNP
cord-328352-l1q4uvxl	94	14	,	,	,
cord-328352-l1q4uvxl	94	15	non	non	JJ
cord-328352-l1q4uvxl	94	16	-	-	JJ
cord-328352-l1q4uvxl	94	17	MSC	msc	JJ
cord-328352-l1q4uvxl	94	18	stem	stem	NN
cord-328352-l1q4uvxl	94	19	cells	cell	NNS
cord-328352-l1q4uvxl	94	20	,	,	,
cord-328352-l1q4uvxl	94	21	such	such	JJ
cord-328352-l1q4uvxl	94	22	as	as	IN
cord-328352-l1q4uvxl	94	23	umbilical	umbilical	JJ
cord-328352-l1q4uvxl	94	24	cord	cord	NN
cord-328352-l1q4uvxl	94	25	blood	blood	NN
cord-328352-l1q4uvxl	94	26	monocytes	monocyte	VBZ
cord-328352-l1q4uvxl	94	27	35	35	CD
cord-328352-l1q4uvxl	94	28	,	,	,
cord-328352-l1q4uvxl	94	29	36	36	CD
cord-328352-l1q4uvxl	94	30	,	,	,
cord-328352-l1q4uvxl	94	31	that	that	WDT
cord-328352-l1q4uvxl	94	32	similarly	similarly	RB
cord-328352-l1q4uvxl	94	33	target	target	VBP
cord-328352-l1q4uvxl	94	34	the	the	DT
cord-328352-l1q4uvxl	94	35	inflammatory	inflammatory	JJ
cord-328352-l1q4uvxl	94	36	and	and	CC
cord-328352-l1q4uvxl	94	37	immune	immune	JJ
cord-328352-l1q4uvxl	94	38	pathways	pathway	NNS
cord-328352-l1q4uvxl	94	39	and	and	CC
cord-328352-l1q4uvxl	94	40	promote	promote	VB
cord-328352-l1q4uvxl	94	41	other	other	JJ
cord-328352-l1q4uvxl	94	42	regenerative	regenerative	JJ
cord-328352-l1q4uvxl	94	43	mechanisms	mechanism	NNS
cord-328352-l1q4uvxl	94	44	(	(	-LRB-
cord-328352-l1q4uvxl	94	45	e.g.	e.g.	RB
cord-328352-l1q4uvxl	94	46	,	,	,
cord-328352-l1q4uvxl	94	47	tissue	tissue	NN
cord-328352-l1q4uvxl	94	48	repair	repair	NN
cord-328352-l1q4uvxl	94	49	)	)	-RRB-
cord-328352-l1q4uvxl	94	50	,	,	,
cord-328352-l1q4uvxl	94	51	are	be	VBP
cord-328352-l1q4uvxl	94	52	also	also	RB
cord-328352-l1q4uvxl	94	53	being	be	VBG
cord-328352-l1q4uvxl	94	54	tested	test	VBN
cord-328352-l1q4uvxl	94	55	.	.	.
cord-328352-l1q4uvxl	95	1	Interestingly	interestingly	RB
cord-328352-l1q4uvxl	95	2	,	,	,
cord-328352-l1q4uvxl	95	3	intravenous	intravenous	JJ
cord-328352-l1q4uvxl	95	4	administration	administration	NN
cord-328352-l1q4uvxl	95	5	of	of	IN
cord-328352-l1q4uvxl	95	6	MSCs	MSCs	NNP
cord-328352-l1q4uvxl	95	7	has	have	VBZ
cord-328352-l1q4uvxl	95	8	the	the	DT
cord-328352-l1q4uvxl	95	9	natural	natural	JJ
cord-328352-l1q4uvxl	95	10	preponderance	preponderance	NN
cord-328352-l1q4uvxl	95	11	to	to	TO
cord-328352-l1q4uvxl	95	12	migrate	migrate	VB
cord-328352-l1q4uvxl	95	13	preferentially	preferentially	RB
cord-328352-l1q4uvxl	95	14	to	to	IN
cord-328352-l1q4uvxl	95	15	the	the	DT
cord-328352-l1q4uvxl	95	16	lungs	lung	NNS
cord-328352-l1q4uvxl	95	17	allowing	allow	VBG
cord-328352-l1q4uvxl	95	18	for	for	IN
cord-328352-l1q4uvxl	95	19	the	the	DT
cord-328352-l1q4uvxl	95	20	first	first	JJ
cord-328352-l1q4uvxl	95	21	-	-	HYPH
cord-328352-l1q4uvxl	95	22	pass	pass	NN
cord-328352-l1q4uvxl	95	23	treatment	treatment	NN
cord-328352-l1q4uvxl	95	24	of	of	IN
cord-328352-l1q4uvxl	95	25	pulmonary	pulmonary	JJ
cord-328352-l1q4uvxl	95	26	diseases	disease	NNS
cord-328352-l1q4uvxl	95	27	33	33	CD
cord-328352-l1q4uvxl	95	28	,	,	,
cord-328352-l1q4uvxl	95	29	34	34	CD
cord-328352-l1q4uvxl	95	30	,	,	,
cord-328352-l1q4uvxl	95	31	such	such	JJ
cord-328352-l1q4uvxl	95	32	as	as	IN
cord-328352-l1q4uvxl	95	33	COVID-19	COVID-19	NNP
cord-328352-l1q4uvxl	95	34	.	.	.
cord-328352-l1q4uvxl	96	1	Moreover	moreover	RB
cord-328352-l1q4uvxl	96	2	,	,	,
cord-328352-l1q4uvxl	96	3	the	the	DT
cord-328352-l1q4uvxl	96	4	long	long	JJ
cord-328352-l1q4uvxl	96	5	track	track	NN
cord-328352-l1q4uvxl	96	6	record	record	NN
cord-328352-l1q4uvxl	96	7	of	of	IN
cord-328352-l1q4uvxl	96	8	safety	safety	NN
cord-328352-l1q4uvxl	96	9	profile	profile	NN
cord-328352-l1q4uvxl	96	10	of	of	IN
cord-328352-l1q4uvxl	96	11	MSCs	msc	NNS
cord-328352-l1q4uvxl	96	12	for	for	IN
cord-328352-l1q4uvxl	96	13	hematologic	hematologic	JJ
cord-328352-l1q4uvxl	96	14	diseases	disease	NNS
cord-328352-l1q4uvxl	96	15	may	may	MD
cord-328352-l1q4uvxl	96	16	expedite	expedite	VB
cord-328352-l1q4uvxl	96	17	their	-PRON-	PRP$
cord-328352-l1q4uvxl	96	18	clinical	clinical	JJ
cord-328352-l1q4uvxl	96	19	entry	entry	NN
cord-328352-l1q4uvxl	96	20	for	for	IN
cord-328352-l1q4uvxl	96	21	novel	novel	JJ
cord-328352-l1q4uvxl	96	22	indications	indication	NNS
cord-328352-l1q4uvxl	96	23	;	;	:
cord-328352-l1q4uvxl	96	24	indeed	indeed	RB
cord-328352-l1q4uvxl	96	25	,	,	,
cord-328352-l1q4uvxl	96	26	clinicaltrials.gov	clinicaltrials.gov	NNP
cord-328352-l1q4uvxl	96	27	reveals	reveal	VBZ
cord-328352-l1q4uvxl	96	28	31	31	CD
cord-328352-l1q4uvxl	96	29	ongoing	ongoing	JJ
cord-328352-l1q4uvxl	96	30	studies	study	NNS
cord-328352-l1q4uvxl	96	31	using	use	VBG
cord-328352-l1q4uvxl	96	32	stem	stem	NN
cord-328352-l1q4uvxl	96	33	cell	cell	NN
cord-328352-l1q4uvxl	96	34	therapy	therapy	NN
cord-328352-l1q4uvxl	96	35	for	for	IN
cord-328352-l1q4uvxl	96	36	COVID-19	COVID-19	NNP
cord-328352-l1q4uvxl	96	37	.	.	.
cord-328352-l1q4uvxl	97	1	Preliminary	preliminary	JJ
cord-328352-l1q4uvxl	97	2	reports	report	NNS
cord-328352-l1q4uvxl	97	3	in	in	IN
cord-328352-l1q4uvxl	97	4	China	China	NNP
cord-328352-l1q4uvxl	97	5	and	and	CC
cord-328352-l1q4uvxl	97	6	the	the	DT
cord-328352-l1q4uvxl	97	7	United	United	NNP
cord-328352-l1q4uvxl	97	8	States	States	NNP
cord-328352-l1q4uvxl	97	9	suggest	suggest	VBP
cord-328352-l1q4uvxl	97	10	solid	solid	JJ
cord-328352-l1q4uvxl	97	11	safety	safety	NN
cord-328352-l1q4uvxl	97	12	outcomes	outcome	NNS
cord-328352-l1q4uvxl	97	13	in	in	IN
cord-328352-l1q4uvxl	97	14	patients	patient	NNS
cord-328352-l1q4uvxl	97	15	who	who	WP
cord-328352-l1q4uvxl	97	16	have	have	VBP
cord-328352-l1q4uvxl	97	17	received	receive	VBN
cord-328352-l1q4uvxl	97	18	MSCs	msc	NNS
cord-328352-l1q4uvxl	97	19	and	and	CC
cord-328352-l1q4uvxl	97	20	their	-PRON-	PRP$
cord-328352-l1q4uvxl	97	21	exosomes	exosome	NNS
cord-328352-l1q4uvxl	97	22	31	31	CD
cord-328352-l1q4uvxl	97	23	,	,	,
cord-328352-l1q4uvxl	97	24	32	32	CD
cord-328352-l1q4uvxl	97	25	.	.	.
cord-328352-l1q4uvxl	98	1	Together	together	RB
cord-328352-l1q4uvxl	98	2	with	with	IN
cord-328352-l1q4uvxl	98	3	convalescent	convalescent	JJ
cord-328352-l1q4uvxl	98	4	plasma	plasma	NN
cord-328352-l1q4uvxl	98	5	and	and	CC
cord-328352-l1q4uvxl	98	6	IG	IG	NNP
cord-328352-l1q4uvxl	98	7	treatments	treatment	NNS
cord-328352-l1q4uvxl	98	8	,	,	,
cord-328352-l1q4uvxl	98	9	stem	stem	NN
cord-328352-l1q4uvxl	98	10	cell	cell	NN
cord-328352-l1q4uvxl	98	11	therapies	therapy	NNS
cord-328352-l1q4uvxl	98	12	may	may	MD
cord-328352-l1q4uvxl	98	13	offer	offer	VB
cord-328352-l1q4uvxl	98	14	an	an	DT
cord-328352-l1q4uvxl	98	15	innovative	innovative	JJ
cord-328352-l1q4uvxl	98	16	approach	approach	NN
cord-328352-l1q4uvxl	98	17	in	in	IN
cord-328352-l1q4uvxl	98	18	fostering	foster	VBG
cord-328352-l1q4uvxl	98	19	immunomodulatory	immunomodulatory	JJ
cord-328352-l1q4uvxl	98	20	regulation	regulation	NN
cord-328352-l1q4uvxl	98	21	of	of	IN
cord-328352-l1q4uvxl	98	22	COVID-19	COVID-19	NNP
cord-328352-l1q4uvxl	98	23	.	.	.
cord-328352-l1q4uvxl	99	1	Moreover	moreover	RB
cord-328352-l1q4uvxl	99	2	,	,	,
cord-328352-l1q4uvxl	99	3	although	although	IN
cord-328352-l1q4uvxl	99	4	the	the	DT
cord-328352-l1q4uvxl	99	5	lung	lung	NN
cord-328352-l1q4uvxl	99	6	stands	stand	VBZ
cord-328352-l1q4uvxl	99	7	as	as	IN
cord-328352-l1q4uvxl	99	8	the	the	DT
cord-328352-l1q4uvxl	99	9	main	main	JJ
cord-328352-l1q4uvxl	99	10	pathological	pathological	JJ
cord-328352-l1q4uvxl	99	11	organ	organ	NN
cord-328352-l1q4uvxl	99	12	in	in	IN
cord-328352-l1q4uvxl	99	13	COVID-19	COVID-19	NNP
cord-328352-l1q4uvxl	99	14	,	,	,
cord-328352-l1q4uvxl	99	15	recent	recent	JJ
cord-328352-l1q4uvxl	99	16	studies	study	NNS
cord-328352-l1q4uvxl	99	17	have	have	VBP
cord-328352-l1q4uvxl	99	18	implicated	implicate	VBN
cord-328352-l1q4uvxl	99	19	extra	extra	JJ
cord-328352-l1q4uvxl	99	20	-	-	JJ
cord-328352-l1q4uvxl	99	21	lung	lung	NN
cord-328352-l1q4uvxl	99	22	organs	organ	NNS
cord-328352-l1q4uvxl	99	23	,	,	,
cord-328352-l1q4uvxl	99	24	including	include	VBG
cord-328352-l1q4uvxl	99	25	the	the	DT
cord-328352-l1q4uvxl	99	26	heart	heart	NN
cord-328352-l1q4uvxl	99	27	and	and	CC
cord-328352-l1q4uvxl	99	28	the	the	DT
cord-328352-l1q4uvxl	99	29	brain	brain	NN
cord-328352-l1q4uvxl	99	30	,	,	,
cord-328352-l1q4uvxl	99	31	as	as	RB
cord-328352-l1q4uvxl	99	32	well	well	RB
cord-328352-l1q4uvxl	99	33	as	as	IN
cord-328352-l1q4uvxl	99	34	the	the	DT
cord-328352-l1q4uvxl	99	35	gut	gut	NN
cord-328352-l1q4uvxl	99	36	,	,	,
cord-328352-l1q4uvxl	99	37	suggesting	suggest	VBG
cord-328352-l1q4uvxl	99	38	that	that	IN
cord-328352-l1q4uvxl	99	39	targeting	target	VBG
cord-328352-l1q4uvxl	99	40	these	these	DT
cord-328352-l1q4uvxl	99	41	organs	organ	NNS
cord-328352-l1q4uvxl	99	42	may	may	MD
cord-328352-l1q4uvxl	99	43	prove	prove	VB
cord-328352-l1q4uvxl	99	44	beneficial	beneficial	JJ
cord-328352-l1q4uvxl	99	45	in	in	IN
cord-328352-l1q4uvxl	99	46	treating	treat	VBG
cord-328352-l1q4uvxl	99	47	the	the	DT
cord-328352-l1q4uvxl	99	48	disease	disease	NN
cord-328352-l1q4uvxl	99	49	.	.	.
cord-328352-l1q4uvxl	100	1	Indeed	indeed	RB
cord-328352-l1q4uvxl	100	2	,	,	,
cord-328352-l1q4uvxl	100	3	combining	combine	VBG
cord-328352-l1q4uvxl	100	4	the	the	DT
cord-328352-l1q4uvxl	100	5	envisioned	envision	VBN
cord-328352-l1q4uvxl	100	6	vaccines	vaccine	NNS
cord-328352-l1q4uvxl	100	7	and	and	CC
cord-328352-l1q4uvxl	100	8	immunomodulatory	immunomodulatory	JJ
cord-328352-l1q4uvxl	100	9	treatments	treatment	NNS
cord-328352-l1q4uvxl	100	10	with	with	IN
cord-328352-l1q4uvxl	100	11	novel	novel	JJ
cord-328352-l1q4uvxl	100	12	strategies	strategy	NNS
cord-328352-l1q4uvxl	100	13	,	,	,
cord-328352-l1q4uvxl	100	14	such	such	JJ
cord-328352-l1q4uvxl	100	15	as	as	IN
cord-328352-l1q4uvxl	100	16	altering	alter	VBG
cord-328352-l1q4uvxl	100	17	the	the	DT
cord-328352-l1q4uvxl	100	18	gut	gut	NN
cord-328352-l1q4uvxl	100	19	microbiome	microbiome	NN
cord-328352-l1q4uvxl	100	20	37	37	CD
cord-328352-l1q4uvxl	100	21	-	-	SYM
cord-328352-l1q4uvxl	100	22	41	41	CD
cord-328352-l1q4uvxl	100	23	,	,	,
cord-328352-l1q4uvxl	100	24	will	will	MD
cord-328352-l1q4uvxl	100	25	likely	likely	RB
cord-328352-l1q4uvxl	100	26	enhance	enhance	VB
cord-328352-l1q4uvxl	100	27	the	the	DT
cord-328352-l1q4uvxl	100	28	overall	overall	JJ
cord-328352-l1q4uvxl	100	29	prognosis	prognosis	NN
cord-328352-l1q4uvxl	100	30	of	of	IN
cord-328352-l1q4uvxl	100	31	COVID-19	COVID-19	NNP
cord-328352-l1q4uvxl	100	32	.	.	.
cord-328352-l1q4uvxl	101	1	Science	science	NN
cord-328352-l1q4uvxl	101	2	and	and	CC
cord-328352-l1q4uvxl	101	3	medicine	medicine	NN
cord-328352-l1q4uvxl	101	4	may	may	MD
cord-328352-l1q4uvxl	101	5	take	take	VB
cord-328352-l1q4uvxl	101	6	time	time	NN
cord-328352-l1q4uvxl	101	7	to	to	TO
cord-328352-l1q4uvxl	101	8	advance	advance	VB
cord-328352-l1q4uvxl	101	9	a	a	DT
cord-328352-l1q4uvxl	101	10	vaccine	vaccine	NN
cord-328352-l1q4uvxl	101	11	,	,	,
cord-328352-l1q4uvxl	101	12	antiviral	antiviral	JJ
cord-328352-l1q4uvxl	101	13	drug	drug	NN
cord-328352-l1q4uvxl	101	14	,	,	,
cord-328352-l1q4uvxl	101	15	convalescent	convalescent	JJ
cord-328352-l1q4uvxl	101	16	plasma	plasma	NN
cord-328352-l1q4uvxl	101	17	treatment	treatment	NN
cord-328352-l1q4uvxl	101	18	,	,	,
cord-328352-l1q4uvxl	101	19	and	and	CC
cord-328352-l1q4uvxl	101	20	IG	ig	NN
cord-328352-l1q4uvxl	101	21	and	and	CC
cord-328352-l1q4uvxl	101	22	stem	stem	VB
cord-328352-l1q4uvxl	101	23	cell	cell	NN
cord-328352-l1q4uvxl	101	24	therapies	therapy	NNS
cord-328352-l1q4uvxl	101	25	to	to	IN
cord-328352-l1q4uvxl	101	26	the	the	DT
cord-328352-l1q4uvxl	101	27	clinic	clinic	NN
cord-328352-l1q4uvxl	101	28	.	.	.
cord-328352-l1q4uvxl	102	1	Mortality	mortality	NN
cord-328352-l1q4uvxl	102	2	rate	rate	NN
cord-328352-l1q4uvxl	102	3	ranges	range	NNS
cord-328352-l1q4uvxl	102	4	from	from	IN
cord-328352-l1q4uvxl	102	5	0.1	0.1	CD
cord-328352-l1q4uvxl	102	6	%	%	NN
cord-328352-l1q4uvxl	102	7	to	to	IN
cord-328352-l1q4uvxl	102	8	as	as	RB
cord-328352-l1q4uvxl	102	9	high	high	JJ
cord-328352-l1q4uvxl	102	10	as	as	IN
cord-328352-l1q4uvxl	102	11	10	10	CD
cord-328352-l1q4uvxl	102	12	%	%	NN
cord-328352-l1q4uvxl	102	13	,	,	,
cord-328352-l1q4uvxl	102	14	with	with	IN
cord-328352-l1q4uvxl	102	15	the	the	DT
cord-328352-l1q4uvxl	102	16	elderly	elderly	JJ
cord-328352-l1q4uvxl	102	17	(	(	-LRB-
cord-328352-l1q4uvxl	102	18	>	>	NFP
cord-328352-l1q4uvxl	102	19	65	65	CD
cord-328352-l1q4uvxl	102	20	years	year	NNS
cord-328352-l1q4uvxl	102	21	of	of	IN
cord-328352-l1q4uvxl	102	22	age	age	NN
cord-328352-l1q4uvxl	102	23	)	)	-RRB-
cord-328352-l1q4uvxl	102	24	and	and	CC
cord-328352-l1q4uvxl	102	25	those	those	DT
cord-328352-l1q4uvxl	102	26	with	with	IN
cord-328352-l1q4uvxl	102	27	preexisting	preexisting	JJ
cord-328352-l1q4uvxl	102	28	immune	immune	NN
cord-328352-l1q4uvxl	102	29	-	-	HYPH
cord-328352-l1q4uvxl	102	30	related	relate	VBN
cord-328352-l1q4uvxl	102	31	and	and	CC
cord-328352-l1q4uvxl	102	32	inflammatory	inflammatory	JJ
cord-328352-l1q4uvxl	102	33	diseases	disease	NNS
cord-328352-l1q4uvxl	102	34	(	(	-LRB-
cord-328352-l1q4uvxl	102	35	hypertension	hypertension	NN
cord-328352-l1q4uvxl	102	36	,	,	,
cord-328352-l1q4uvxl	102	37	diabetes	diabetes	NN
cord-328352-l1q4uvxl	102	38	,	,	,
cord-328352-l1q4uvxl	102	39	heart	heart	NN
cord-328352-l1q4uvxl	102	40	diseases	disease	NNS
cord-328352-l1q4uvxl	102	41	)	)	-RRB-
cord-328352-l1q4uvxl	102	42	,	,	,
cord-328352-l1q4uvxl	102	43	showing	show	VBG
cord-328352-l1q4uvxl	102	44	higher	high	JJR
cord-328352-l1q4uvxl	102	45	incidence	incidence	NN
cord-328352-l1q4uvxl	102	46	of	of	IN
cord-328352-l1q4uvxl	102	47	mortality	mortality	NN
cord-328352-l1q4uvxl	102	48	[	[	-LRB-
cord-328352-l1q4uvxl	102	49	42	42	CD
cord-328352-l1q4uvxl	102	50	]	]	-RRB-
cord-328352-l1q4uvxl	102	51	[	[	-LRB-
cord-328352-l1q4uvxl	102	52	43	43	CD
cord-328352-l1q4uvxl	102	53	]	]	-RRB-
cord-328352-l1q4uvxl	102	54	[	[	-LRB-
cord-328352-l1q4uvxl	102	55	44	44	CD
cord-328352-l1q4uvxl	102	56	]	]	-RRB-
cord-328352-l1q4uvxl	102	57	.	.	.
cord-328352-l1q4uvxl	103	1	Given	give	VBN
cord-328352-l1q4uvxl	103	2	the	the	DT
cord-328352-l1q4uvxl	103	3	morbidity	morbidity	NN
cord-328352-l1q4uvxl	103	4	not	not	RB
cord-328352-l1q4uvxl	103	5	only	only	RB
cord-328352-l1q4uvxl	103	6	in	in	IN
cord-328352-l1q4uvxl	103	7	the	the	DT
cord-328352-l1q4uvxl	103	8	acute	acute	JJ
cord-328352-l1q4uvxl	103	9	stage	stage	NN
cord-328352-l1q4uvxl	103	10	,	,	,
cord-328352-l1q4uvxl	103	11	but	but	CC
cord-328352-l1q4uvxl	103	12	the	the	DT
cord-328352-l1q4uvxl	103	13	realization	realization	NN
cord-328352-l1q4uvxl	103	14	of	of	IN
cord-328352-l1q4uvxl	103	15	equally	equally	RB
cord-328352-l1q4uvxl	103	16	devastating	devastating	JJ
cord-328352-l1q4uvxl	103	17	long	long	JJ
cord-328352-l1q4uvxl	103	18	-	-	HYPH
cord-328352-l1q4uvxl	103	19	term	term	NN
cord-328352-l1q4uvxl	103	20	effects	effect	NNS
cord-328352-l1q4uvxl	103	21	,	,	,
cord-328352-l1q4uvxl	103	22	including	include	VBG
cord-328352-l1q4uvxl	103	23	cardiovascular	cardiovascular	JJ
cord-328352-l1q4uvxl	103	24	and	and	CC
cord-328352-l1q4uvxl	103	25	cerebrovascular	cerebrovascular	JJ
cord-328352-l1q4uvxl	103	26	consequences	consequence	NNS
cord-328352-l1q4uvxl	103	27	[	[	-LRB-
cord-328352-l1q4uvxl	103	28	45	45	CD
cord-328352-l1q4uvxl	103	29	]	]	-RRB-
cord-328352-l1q4uvxl	103	30	[	[	-LRB-
cord-328352-l1q4uvxl	103	31	46	46	CD
cord-328352-l1q4uvxl	103	32	]	]	-RRB-
cord-328352-l1q4uvxl	103	33	[	[	-LRB-
cord-328352-l1q4uvxl	103	34	47	47	CD
cord-328352-l1q4uvxl	103	35	]	]	-RRB-
cord-328352-l1q4uvxl	103	36	[	[	-LRB-
cord-328352-l1q4uvxl	103	37	48	48	CD
cord-328352-l1q4uvxl	103	38	]	]	-RRB-
cord-328352-l1q4uvxl	103	39	[	[	-LRB-
cord-328352-l1q4uvxl	103	40	49	49	CD
cord-328352-l1q4uvxl	103	41	]	]	-RRB-
cord-328352-l1q4uvxl	103	42	,	,	,
cord-328352-l1q4uvxl	103	43	warrants	warrant	VBZ
cord-328352-l1q4uvxl	103	44	immediate	immediate	JJ
cord-328352-l1q4uvxl	103	45	action	action	NN
cord-328352-l1q4uvxl	103	46	to	to	IN
cord-328352-l1q4uvxl	103	47	at	at	IN
cord-328352-l1q4uvxl	103	48	least	least	JJS
cord-328352-l1q4uvxl	103	49	lessen	lessen	VB
cord-328352-l1q4uvxl	103	50	the	the	DT
cord-328352-l1q4uvxl	103	51	spread	spread	NN
cord-328352-l1q4uvxl	103	52	of	of	IN
cord-328352-l1q4uvxl	103	53	the	the	DT
cord-328352-l1q4uvxl	103	54	virus	virus	NN
cord-328352-l1q4uvxl	103	55	.	.	.
cord-328352-l1q4uvxl	104	1	Without	without	IN
cord-328352-l1q4uvxl	104	2	access	access	NN
cord-328352-l1q4uvxl	104	3	to	to	IN
cord-328352-l1q4uvxl	104	4	the	the	DT
cord-328352-l1q4uvxl	104	5	vaccine	vaccine	NN
cord-328352-l1q4uvxl	104	6	and	and	CC
cord-328352-l1q4uvxl	104	7	other	other	JJ
cord-328352-l1q4uvxl	104	8	proven	prove	VBN
cord-328352-l1q4uvxl	104	9	therapies	therapy	NNS
cord-328352-l1q4uvxl	104	10	,	,	,
cord-328352-l1q4uvxl	104	11	just	just	RB
cord-328352-l1q4uvxl	104	12	like	like	IN
cord-328352-l1q4uvxl	104	13	in	in	IN
cord-328352-l1q4uvxl	104	14	1918	1918	CD
cord-328352-l1q4uvxl	104	15	Spanish	spanish	JJ
cord-328352-l1q4uvxl	104	16	flu	flu	NN
cord-328352-l1q4uvxl	104	17	era	era	NN
cord-328352-l1q4uvxl	104	18	,	,	,
cord-328352-l1q4uvxl	104	19	the	the	DT
cord-328352-l1q4uvxl	104	20	best	good	JJS
cord-328352-l1q4uvxl	104	21	course	course	NN
cord-328352-l1q4uvxl	104	22	of	of	IN
cord-328352-l1q4uvxl	104	23	action	action	NN
cord-328352-l1q4uvxl	104	24	for	for	IN
cord-328352-l1q4uvxl	104	25	the	the	DT
cord-328352-l1q4uvxl	104	26	meantime	meantime	NN
cord-328352-l1q4uvxl	104	27	is	be	VBZ
cord-328352-l1q4uvxl	104	28	practicing	practice	VBG
cord-328352-l1q4uvxl	104	29	social	social	JJ
cord-328352-l1q4uvxl	104	30	distancing	distancing	NN
cord-328352-l1q4uvxl	104	31	and	and	CC
cord-328352-l1q4uvxl	104	32	good	good	JJ
cord-328352-l1q4uvxl	104	33	hygiene	hygiene	NN
cord-328352-l1q4uvxl	104	34	,	,	,
cord-328352-l1q4uvxl	104	35	which	which	WDT
cord-328352-l1q4uvxl	104	36	represents	represent	VBZ
cord-328352-l1q4uvxl	104	37	a	a	DT
cord-328352-l1q4uvxl	104	38	logical	logical	JJ
cord-328352-l1q4uvxl	104	39	strategy	strategy	NN
cord-328352-l1q4uvxl	104	40	to	to	TO
cord-328352-l1q4uvxl	104	41	curve	curve	VB
cord-328352-l1q4uvxl	104	42	the	the	DT
cord-328352-l1q4uvxl	104	43	course	course	NN
cord-328352-l1q4uvxl	104	44	and	and	CC
cord-328352-l1q4uvxl	104	45	to	to	TO
cord-328352-l1q4uvxl	104	46	address	address	VB
cord-328352-l1q4uvxl	104	47	the	the	DT
cord-328352-l1q4uvxl	104	48	disillusioned	disillusioned	JJ
cord-328352-l1q4uvxl	104	49	comfort	comfort	NN
cord-328352-l1q4uvxl	104	50	of	of	IN
cord-328352-l1q4uvxl	104	51	COVID-19	COVID-19	NNP
cord-328352-l1q4uvxl	104	52	.	.	.
cord-328352-l1q4uvxl	105	1	The	the	DT
cord-328352-l1q4uvxl	105	2	author(s	author(s	NNP
cord-328352-l1q4uvxl	105	3	)	)	-RRB-
cord-328352-l1q4uvxl	105	4	declared	declare	VBD
cord-328352-l1q4uvxl	105	5	no	no	DT
cord-328352-l1q4uvxl	105	6	potential	potential	JJ
cord-328352-l1q4uvxl	105	7	conflicts	conflict	NNS
cord-328352-l1q4uvxl	105	8	of	of	IN
cord-328352-l1q4uvxl	105	9	interest	interest	NN
cord-328352-l1q4uvxl	105	10	with	with	IN
cord-328352-l1q4uvxl	105	11	respect	respect	NN
cord-328352-l1q4uvxl	105	12	to	to	IN
cord-328352-l1q4uvxl	105	13	the	the	DT
cord-328352-l1q4uvxl	105	14	research	research	NN
cord-328352-l1q4uvxl	105	15	,	,	,
cord-328352-l1q4uvxl	105	16	authorship	authorship	NN
cord-328352-l1q4uvxl	105	17	,	,	,
cord-328352-l1q4uvxl	105	18	and/or	and/or	CC
cord-328352-l1q4uvxl	105	19	publication	publication	NN
cord-328352-l1q4uvxl	105	20	of	of	IN
cord-328352-l1q4uvxl	105	21	this	this	DT
cord-328352-l1q4uvxl	105	22	article	article	NN
cord-328352-l1q4uvxl	105	23	.	.	.
cord-328352-l1q4uvxl	106	1	The	the	DT
cord-328352-l1q4uvxl	106	2	author(s	author(s	NNP
cord-328352-l1q4uvxl	106	3	)	)	-RRB-
cord-328352-l1q4uvxl	106	4	received	receive	VBD
cord-328352-l1q4uvxl	106	5	no	no	DT
cord-328352-l1q4uvxl	106	6	financial	financial	JJ
cord-328352-l1q4uvxl	106	7	support	support	NN
cord-328352-l1q4uvxl	106	8	for	for	IN
cord-328352-l1q4uvxl	106	9	the	the	DT
cord-328352-l1q4uvxl	106	10	research	research	NN
cord-328352-l1q4uvxl	106	11	,	,	,
cord-328352-l1q4uvxl	106	12	authorship	authorship	NN
cord-328352-l1q4uvxl	106	13	,	,	,
cord-328352-l1q4uvxl	106	14	and/or	and/or	CC
cord-328352-l1q4uvxl	106	15	publication	publication	NN
cord-328352-l1q4uvxl	106	16	of	of	IN
cord-328352-l1q4uvxl	106	17	this	this	DT
cord-328352-l1q4uvxl	106	18	article	article	NN
cord-328352-l1q4uvxl	106	19	.	.	.
cord-328352-l1q4uvxl	107	1	Mia	Mia	NNP
cord-328352-l1q4uvxl	107	2	C.	C.	NNP
cord-328352-l1q4uvxl	107	3	Borlongan	Borlongan	NNP
cord-328352-l1q4uvxl	107	4	https://orcid.org/0000-0003-3223-8374	https://orcid.org/0000-0003-3223-8374	CD
cord-328352-l1q4uvxl	107	5	Lung	lung	NN
cord-328352-l1q4uvxl	107	6	cancer	cancer	NN
cord-328352-l1q4uvxl	107	7	mortality	mortality	NN
cord-328352-l1q4uvxl	107	8	associated	associate	VBN
cord-328352-l1q4uvxl	107	9	with	with	IN
cord-328352-l1q4uvxl	107	10	smoking	smoking	NN
cord-328352-l1q4uvxl	107	11	and	and	CC
cord-328352-l1q4uvxl	107	12	smoking	smoking	NN
cord-328352-l1q4uvxl	107	13	cessation	cessation	NN
cord-328352-l1q4uvxl	107	14	among	among	IN
cord-328352-l1q4uvxl	107	15	people	people	NNS
cord-328352-l1q4uvxl	107	16	living	live	VBG
cord-328352-l1q4uvxl	107	17	with	with	IN
cord-328352-l1q4uvxl	107	18	HIV	HIV	NNP
cord-328352-l1q4uvxl	107	19	in	in	IN
cord-328352-l1q4uvxl	107	20	the	the	DT
cord-328352-l1q4uvxl	107	21	United	United	NNP
cord-328352-l1q4uvxl	107	22	States	States	NNP
cord-328352-l1q4uvxl	107	23	.	.	.
cord-328352-l1q4uvxl	108	1	Version	version	NN
cord-328352-l1q4uvxl	108	2	2	2	CD
cord-328352-l1q4uvxl	108	3	Gender	gender	NN
cord-328352-l1q4uvxl	108	4	-	-	HYPH
cord-328352-l1q4uvxl	108	5	related	relate	VBN
cord-328352-l1q4uvxl	108	6	differences	difference	NNS
cord-328352-l1q4uvxl	108	7	in	in	IN
cord-328352-l1q4uvxl	108	8	the	the	DT
cord-328352-l1q4uvxl	108	9	characteristics	characteristic	NNS
cord-328352-l1q4uvxl	108	10	of	of	IN
cord-328352-l1q4uvxl	108	11	problem	problem	NN
cord-328352-l1q4uvxl	108	12	gamblers	gambler	NNS
cord-328352-l1q4uvxl	108	13	using	use	VBG
cord-328352-l1q4uvxl	108	14	a	a	DT
cord-328352-l1q4uvxl	108	15	gambling	gambling	NN
cord-328352-l1q4uvxl	108	16	helpline	helpline	NN
cord-328352-l1q4uvxl	108	17	Traffic	traffic	NN
cord-328352-l1q4uvxl	108	18	accident	accident	NN
cord-328352-l1q4uvxl	108	19	statistics	statistic	NNS
cord-328352-l1q4uvxl	108	20	and	and	CC
cord-328352-l1q4uvxl	108	21	risk	risk	NN
cord-328352-l1q4uvxl	108	22	perceptions	perception	NNS
cord-328352-l1q4uvxl	108	23	in	in	IN
cord-328352-l1q4uvxl	108	24	Japan	Japan	NNP
cord-328352-l1q4uvxl	108	25	and	and	CC
cord-328352-l1q4uvxl	108	26	the	the	DT
cord-328352-l1q4uvxl	108	27	United	United	NNP
cord-328352-l1q4uvxl	108	28	States	States	NNP
cord-328352-l1q4uvxl	108	29	Maps	Maps	NNPS
cord-328352-l1q4uvxl	108	30	&	&	CC
cord-328352-l1q4uvxl	108	31	trends-	trends-	NNP
cord-328352-l1q4uvxl	109	1	Tracking	track	VBG
cord-328352-l1q4uvxl	109	2	global	global	JJ
cord-328352-l1q4uvxl	109	3	cases	case	NNS
cord-328352-l1q4uvxl	109	4	and	and	CC
cord-328352-l1q4uvxl	109	5	tracking	track	VBG
cord-328352-l1q4uvxl	109	6	critical	critical	JJ
cord-328352-l1q4uvxl	109	7	data	datum	NNS
cord-328352-l1q4uvxl	109	8	Covid-19	covid-19	NN
cord-328352-l1q4uvxl	109	9	-navigating	-navigate	VBG
cord-328352-l1q4uvxl	109	10	the	the	DT
cord-328352-l1q4uvxl	109	11	uncharted	uncharted	JJ
cord-328352-l1q4uvxl	109	12	Airborne	airborne	JJ
cord-328352-l1q4uvxl	109	13	transmission	transmission	NN
cord-328352-l1q4uvxl	109	14	of	of	IN
cord-328352-l1q4uvxl	109	15	severe	severe	JJ
cord-328352-l1q4uvxl	109	16	acute	acute	JJ
cord-328352-l1q4uvxl	109	17	respiratory	respiratory	JJ
cord-328352-l1q4uvxl	109	18	syndrome	syndrome	NN
cord-328352-l1q4uvxl	109	19	coronavirus-2	coronavirus-2	NN
cord-328352-l1q4uvxl	109	20	to	to	IN
cord-328352-l1q4uvxl	109	21	healthcare	healthcare	NN
cord-328352-l1q4uvxl	109	22	workers	worker	NNS
cord-328352-l1q4uvxl	109	23	:	:	:
cord-328352-l1q4uvxl	109	24	a	a	DT
cord-328352-l1q4uvxl	109	25	narrative	narrative	NN
cord-328352-l1q4uvxl	109	26	review	review	NN
cord-328352-l1q4uvxl	109	27	Applying	apply	VBG
cord-328352-l1q4uvxl	109	28	principles	principle	NNS
cord-328352-l1q4uvxl	109	29	of	of	IN
cord-328352-l1q4uvxl	109	30	behaviour	behaviour	NN
cord-328352-l1q4uvxl	109	31	change	change	NN
cord-328352-l1q4uvxl	109	32	to	to	TO
cord-328352-l1q4uvxl	109	33	reduce	reduce	VB
cord-328352-l1q4uvxl	109	34	SARS	SARS	NNP
cord-328352-l1q4uvxl	109	35	-	-	HYPH
cord-328352-l1q4uvxl	109	36	CoV-2	CoV-2	NNP
cord-328352-l1q4uvxl	109	37	transmission	transmission	NN
cord-328352-l1q4uvxl	109	38	Respiratory	respiratory	JJ
cord-328352-l1q4uvxl	109	39	virus	virus	NN
cord-328352-l1q4uvxl	109	40	shedding	shed	VBG
cord-328352-l1q4uvxl	109	41	in	in	IN
cord-328352-l1q4uvxl	109	42	exhaled	exhaled	JJ
cord-328352-l1q4uvxl	109	43	breath	breath	NN
cord-328352-l1q4uvxl	109	44	and	and	CC
cord-328352-l1q4uvxl	109	45	efficacy	efficacy	NN
cord-328352-l1q4uvxl	109	46	of	of	IN
cord-328352-l1q4uvxl	109	47	face	face	NN
cord-328352-l1q4uvxl	109	48	masks	mask	NNS
cord-328352-l1q4uvxl	110	1	The	the	DT
cord-328352-l1q4uvxl	110	2	deadly	deadly	JJ
cord-328352-l1q4uvxl	110	3	coronaviruses	coronaviruse	NNS
cord-328352-l1q4uvxl	110	4	:	:	:
cord-328352-l1q4uvxl	110	5	the	the	DT
cord-328352-l1q4uvxl	110	6	2003	2003	CD
cord-328352-l1q4uvxl	110	7	SARS	SARS	NNP
cord-328352-l1q4uvxl	110	8	pandemic	pandemic	NN
cord-328352-l1q4uvxl	110	9	and	and	CC
cord-328352-l1q4uvxl	110	10	the	the	DT
cord-328352-l1q4uvxl	110	11	2020	2020	CD
cord-328352-l1q4uvxl	110	12	novel	novel	JJ
cord-328352-l1q4uvxl	110	13	coronavirus	coronavirus	NN
cord-328352-l1q4uvxl	110	14	epidemic	epidemic	NN
cord-328352-l1q4uvxl	110	15	in	in	IN
cord-328352-l1q4uvxl	110	16	China	China	NNP
cord-328352-l1q4uvxl	110	17	First	first	JJ
cord-328352-l1q4uvxl	110	18	cases	case	NNS
cord-328352-l1q4uvxl	110	19	of	of	IN
cord-328352-l1q4uvxl	110	20	coronavirus	coronavirus	NN
cord-328352-l1q4uvxl	110	21	disease	disease	NN
cord-328352-l1q4uvxl	110	22	2019	2019	CD
cord-328352-l1q4uvxl	110	23	(	(	-LRB-
cord-328352-l1q4uvxl	110	24	COVID-19	COVID-19	NNP
cord-328352-l1q4uvxl	110	25	)	)	-RRB-
cord-328352-l1q4uvxl	110	26	in	in	IN
cord-328352-l1q4uvxl	110	27	the	the	DT
cord-328352-l1q4uvxl	110	28	WHO	WHO	NNP
cord-328352-l1q4uvxl	110	29	European	European	NNP
cord-328352-l1q4uvxl	110	30	Region	Region	NNP
cord-328352-l1q4uvxl	110	31	SARS	SARS	NNP
cord-328352-l1q4uvxl	111	1	-CoV-2	-CoV-2	:
cord-328352-l1q4uvxl	111	2	:	:	:
cord-328352-l1q4uvxl	111	3	reasons	reason	NNS
cord-328352-l1q4uvxl	111	4	of	of	IN
cord-328352-l1q4uvxl	111	5	epidemiology	epidemiology	NN
cord-328352-l1q4uvxl	111	6	of	of	IN
cord-328352-l1q4uvxl	111	7	severe	severe	JJ
cord-328352-l1q4uvxl	111	8	ill	ill	JJ
cord-328352-l1q4uvxl	111	9	disease	disease	NN
cord-328352-l1q4uvxl	111	10	cases	case	NNS
cord-328352-l1q4uvxl	111	11	and	and	CC
cord-328352-l1q4uvxl	111	12	therapeutic	therapeutic	JJ
cord-328352-l1q4uvxl	111	13	approach	approach	NN
cord-328352-l1q4uvxl	111	14	using	use	VBG
cord-328352-l1q4uvxl	111	15	trivalent	trivalent	JJ
cord-328352-l1q4uvxl	111	16	vaccine	vaccine	NN
cord-328352-l1q4uvxl	111	17	(	(	-LRB-
cord-328352-l1q4uvxl	111	18	tetanus	tetanus	NN
cord-328352-l1q4uvxl	111	19	,	,	,
cord-328352-l1q4uvxl	111	20	diphtheria	diphtheria	NN
cord-328352-l1q4uvxl	111	21	and	and	CC
cord-328352-l1q4uvxl	111	22	Bordetella	Bordetella	NNP
cord-328352-l1q4uvxl	111	23	pertussis	pertussis	NN
cord-328352-l1q4uvxl	111	24	)	)	-RRB-
cord-328352-l1q4uvxl	111	25	.	.	.
cord-328352-l1q4uvxl	112	1	Med	Med	NNP
cord-328352-l1q4uvxl	112	2	Hypotheses	Hypotheses	NNPS
cord-328352-l1q4uvxl	112	3	Coronavirus	Coronavirus	NNP
cord-328352-l1q4uvxl	112	4	disease	disease	NN
cord-328352-l1q4uvxl	112	5	2019	2019	CD
cord-328352-l1q4uvxl	112	6	in	in	IN
cord-328352-l1q4uvxl	112	7	geriatrics	geriatric	NNS
cord-328352-l1q4uvxl	112	8	and	and	CC
cord-328352-l1q4uvxl	112	9	long	long	JJ
cord-328352-l1q4uvxl	112	10	-	-	HYPH
cord-328352-l1q4uvxl	112	11	term	term	NN
cord-328352-l1q4uvxl	112	12	care	care	NN
cord-328352-l1q4uvxl	112	13	:	:	:
cord-328352-l1q4uvxl	112	14	the	the	DT
cord-328352-l1q4uvxl	112	15	abcds	abcds	NNP
cord-328352-l1q4uvxl	112	16	of	of	IN
cord-328352-l1q4uvxl	112	17	COVID-19	COVID-19	NNP
cord-328352-l1q4uvxl	112	18	Pandemics	Pandemics	NNPS
cord-328352-l1q4uvxl	112	19	:	:	:
cord-328352-l1q4uvxl	113	1	avoiding	avoid	VBG
cord-328352-l1q4uvxl	113	2	the	the	DT
cord-328352-l1q4uvxl	113	3	mistakes	mistake	NNS
cord-328352-l1q4uvxl	113	4	of	of	IN
cord-328352-l1q4uvxl	113	5	1918	1918	CD
cord-328352-l1q4uvxl	113	6	A	a	DT
cord-328352-l1q4uvxl	113	7	year	year	NN
cord-328352-l1q4uvxl	113	8	of	of	IN
cord-328352-l1q4uvxl	113	9	terror	terror	NN
cord-328352-l1q4uvxl	113	10	and	and	CC
cord-328352-l1q4uvxl	113	11	a	a	DT
cord-328352-l1q4uvxl	113	12	century	century	NN
cord-328352-l1q4uvxl	113	13	of	of	IN
cord-328352-l1q4uvxl	113	14	reflection	reflection	NN
cord-328352-l1q4uvxl	113	15	:	:	:
cord-328352-l1q4uvxl	113	16	perspectives	perspective	NNS
cord-328352-l1q4uvxl	113	17	on	on	IN
cord-328352-l1q4uvxl	113	18	the	the	DT
cord-328352-l1q4uvxl	113	19	great	great	JJ
cord-328352-l1q4uvxl	113	20	influenza	influenza	NN
cord-328352-l1q4uvxl	113	21	pandemic	pandemic	NN
cord-328352-l1q4uvxl	113	22	of	of	IN
cord-328352-l1q4uvxl	113	23	1918	1918	CD
cord-328352-l1q4uvxl	113	24	-	-	SYM
cord-328352-l1q4uvxl	113	25	1919	1919	CD
cord-328352-l1q4uvxl	113	26	Deployment	Deployment	NNP
cord-328352-l1q4uvxl	113	27	of	of	IN
cord-328352-l1q4uvxl	113	28	convalescent	convalescent	JJ
cord-328352-l1q4uvxl	113	29	plasma	plasma	NN
cord-328352-l1q4uvxl	113	30	for	for	IN
cord-328352-l1q4uvxl	113	31	the	the	DT
cord-328352-l1q4uvxl	113	32	prevention	prevention	NN
cord-328352-l1q4uvxl	113	33	and	and	CC
cord-328352-l1q4uvxl	113	34	treatment	treatment	NN
cord-328352-l1q4uvxl	113	35	of	of	IN
cord-328352-l1q4uvxl	113	36	COVID-19	COVID-19	NNP
cord-328352-l1q4uvxl	113	37	Children	Children	NNPS
cord-328352-l1q4uvxl	113	38	and	and	CC
cord-328352-l1q4uvxl	113	39	encephalitis	encephalitis	RB
cord-328352-l1q4uvxl	113	40	lethargica	lethargica	NNP
cord-328352-l1q4uvxl	113	41	:	:	:
cord-328352-l1q4uvxl	113	42	a	a	DT
cord-328352-l1q4uvxl	113	43	historical	historical	JJ
cord-328352-l1q4uvxl	113	44	review	review	NN
cord-328352-l1q4uvxl	113	45	Influenza	Influenza	NNP
cord-328352-l1q4uvxl	113	46	virus	virus	NN
cord-328352-l1q4uvxl	113	47	and	and	CC
cord-328352-l1q4uvxl	113	48	neurological	neurological	JJ
cord-328352-l1q4uvxl	113	49	diseases	disease	NNS
cord-328352-l1q4uvxl	114	1	The	the	DT
cord-328352-l1q4uvxl	114	2	relationship	relationship	NN
cord-328352-l1q4uvxl	114	3	between	between	IN
cord-328352-l1q4uvxl	114	4	encephalitis	encephalitis	NNP
cord-328352-l1q4uvxl	114	5	lethargica	lethargica	NNP
cord-328352-l1q4uvxl	114	6	and	and	CC
cord-328352-l1q4uvxl	114	7	influenza	influenza	NN
cord-328352-l1q4uvxl	114	8	:	:	:
cord-328352-l1q4uvxl	114	9	a	a	DT
cord-328352-l1q4uvxl	114	10	critical	critical	JJ
cord-328352-l1q4uvxl	114	11	analysis	analysis	NN
cord-328352-l1q4uvxl	114	12	Plasma	plasma	NN
cord-328352-l1q4uvxl	114	13	therapy	therapy	NN
cord-328352-l1q4uvxl	114	14	against	against	IN
cord-328352-l1q4uvxl	114	15	infectious	infectious	JJ
cord-328352-l1q4uvxl	114	16	pathogens	pathogen	NNS
cord-328352-l1q4uvxl	114	17	,	,	,
cord-328352-l1q4uvxl	114	18	as	as	IN
cord-328352-l1q4uvxl	114	19	of	of	IN
cord-328352-l1q4uvxl	114	20	yesterday	yesterday	NN
cord-328352-l1q4uvxl	114	21	,	,	,
cord-328352-l1q4uvxl	114	22	today	today	NN
cord-328352-l1q4uvxl	114	23	and	and	CC
cord-328352-l1q4uvxl	114	24	tomorrow	tomorrow	NN
cord-328352-l1q4uvxl	114	25	Metaanalysis	metaanalysis	NN
cord-328352-l1q4uvxl	114	26	:	:	:
cord-328352-l1q4uvxl	114	27	convalescent	convalescent	JJ
cord-328352-l1q4uvxl	114	28	blood	blood	NN
cord-328352-l1q4uvxl	114	29	products	product	NNS
cord-328352-l1q4uvxl	114	30	for	for	IN
cord-328352-l1q4uvxl	114	31	Spanish	spanish	JJ
cord-328352-l1q4uvxl	114	32	influenza	influenza	NN
cord-328352-l1q4uvxl	114	33	pneumonia	pneumonia	NN
cord-328352-l1q4uvxl	114	34	:	:	:
cord-328352-l1q4uvxl	114	35	a	a	DT
cord-328352-l1q4uvxl	114	36	future	future	JJ
cord-328352-l1q4uvxl	114	37	H5N1	H5N1	NNP
cord-328352-l1q4uvxl	114	38	treatment	treatment	NN
cord-328352-l1q4uvxl	114	39	?	?	.
cord-328352-l1q4uvxl	115	1	Convalescent	convalescent	JJ
cord-328352-l1q4uvxl	115	2	plasma	plasma	NN
cord-328352-l1q4uvxl	115	3	study	study	NN
cord-328352-l1q4uvxl	115	4	group	group	NN
cord-328352-l1q4uvxl	115	5	.	.	.
cord-328352-l1q4uvxl	116	1	The	the	DT
cord-328352-l1q4uvxl	116	2	effectiveness	effectiveness	NN
cord-328352-l1q4uvxl	116	3	of	of	IN
cord-328352-l1q4uvxl	116	4	convalescent	convalescent	JJ
cord-328352-l1q4uvxl	116	5	plasma	plasma	NN
cord-328352-l1q4uvxl	116	6	and	and	CC
cord-328352-l1q4uvxl	116	7	hyperimmune	hyperimmune	NNP
cord-328352-l1q4uvxl	116	8	immunoglobulin	immunoglobulin	NN
cord-328352-l1q4uvxl	116	9	for	for	IN
cord-328352-l1q4uvxl	116	10	the	the	DT
cord-328352-l1q4uvxl	116	11	treatment	treatment	NN
cord-328352-l1q4uvxl	116	12	of	of	IN
cord-328352-l1q4uvxl	116	13	severe	severe	JJ
cord-328352-l1q4uvxl	116	14	acute	acute	JJ
cord-328352-l1q4uvxl	116	15	respiratory	respiratory	JJ
cord-328352-l1q4uvxl	116	16	infections	infection	NNS
cord-328352-l1q4uvxl	116	17	of	of	IN
cord-328352-l1q4uvxl	116	18	viral	viral	JJ
cord-328352-l1q4uvxl	116	19	etiology	etiology	NN
cord-328352-l1q4uvxl	116	20	:	:	:
cord-328352-l1q4uvxl	116	21	a	a	DT
cord-328352-l1q4uvxl	116	22	systematic	systematic	JJ
cord-328352-l1q4uvxl	116	23	review	review	NN
cord-328352-l1q4uvxl	116	24	and	and	CC
cord-328352-l1q4uvxl	116	25	exploratory	exploratory	JJ
cord-328352-l1q4uvxl	116	26	metaanalysis	metaanalysis	NNP
cord-328352-l1q4uvxl	116	27	Version	Version	NNP
cord-328352-l1q4uvxl	116	28	2	2	CD
cord-328352-l1q4uvxl	116	29	Treatment	Treatment	NNP
cord-328352-l1q4uvxl	116	30	with	with	IN
cord-328352-l1q4uvxl	116	31	convalescent	convalescent	JJ
cord-328352-l1q4uvxl	116	32	plasma	plasma	NN
cord-328352-l1q4uvxl	116	33	for	for	IN
cord-328352-l1q4uvxl	116	34	COVID-19	covid-19	JJ
cord-328352-l1q4uvxl	116	35	patients	patient	NNS
cord-328352-l1q4uvxl	116	36	in	in	IN
cord-328352-l1q4uvxl	116	37	Wuhan	Wuhan	NNP
cord-328352-l1q4uvxl	116	38	Effectiveness	Effectiveness	NNP
cord-328352-l1q4uvxl	116	39	of	of	IN
cord-328352-l1q4uvxl	116	40	convalescent	convalescent	JJ
cord-328352-l1q4uvxl	116	41	plasma	plasma	NN
cord-328352-l1q4uvxl	116	42	therapy	therapy	NN
cord-328352-l1q4uvxl	116	43	in	in	IN
cord-328352-l1q4uvxl	116	44	severe	severe	JJ
cord-328352-l1q4uvxl	116	45	COVID-19	COVID-19	NNP
cord-328352-l1q4uvxl	116	46	patients	patient	NNS
cord-328352-l1q4uvxl	116	47	Treatment	Treatment	NNP
cord-328352-l1q4uvxl	116	48	of	of	IN
cord-328352-l1q4uvxl	116	49	5	5	CD
cord-328352-l1q4uvxl	116	50	critically	critically	RB
cord-328352-l1q4uvxl	116	51	ill	ill	JJ
cord-328352-l1q4uvxl	116	52	patients	patient	NNS
cord-328352-l1q4uvxl	116	53	with	with	IN
cord-328352-l1q4uvxl	116	54	COVID-19	COVID-19	NNP
cord-328352-l1q4uvxl	116	55	with	with	IN
cord-328352-l1q4uvxl	116	56	convalescent	convalescent	JJ
cord-328352-l1q4uvxl	116	57	plasma	plasma	NN
cord-328352-l1q4uvxl	116	58	Effect	effect	NN
cord-328352-l1q4uvxl	116	59	of	of	IN
cord-328352-l1q4uvxl	116	60	convalescent	convalescent	JJ
cord-328352-l1q4uvxl	116	61	plasma	plasma	NN
cord-328352-l1q4uvxl	116	62	therapy	therapy	NN
cord-328352-l1q4uvxl	116	63	on	on	IN
cord-328352-l1q4uvxl	116	64	viral	viral	JJ
cord-328352-l1q4uvxl	116	65	shedding	shedding	NN
cord-328352-l1q4uvxl	116	66	and	and	CC
cord-328352-l1q4uvxl	116	67	survival	survival	NN
cord-328352-l1q4uvxl	116	68	in	in	IN
cord-328352-l1q4uvxl	116	69	covid-19	covid-19	CD
cord-328352-l1q4uvxl	116	70	patients	patient	NNS
cord-328352-l1q4uvxl	116	71	Use	Use	NNP
cord-328352-l1q4uvxl	116	72	of	of	IN
cord-328352-l1q4uvxl	116	73	Convalescent	convalescent	JJ
cord-328352-l1q4uvxl	116	74	plasma	plasma	NN
cord-328352-l1q4uvxl	116	75	therapy	therapy	NN
cord-328352-l1q4uvxl	116	76	in	in	IN
cord-328352-l1q4uvxl	116	77	two	two	CD
cord-328352-l1q4uvxl	116	78	covid-19	covid-19	CD
cord-328352-l1q4uvxl	116	79	patients	patient	NNS
cord-328352-l1q4uvxl	116	80	with	with	IN
cord-328352-l1q4uvxl	116	81	acute	acute	JJ
cord-328352-l1q4uvxl	116	82	respiratory	respiratory	JJ
cord-328352-l1q4uvxl	116	83	distress	distress	NN
cord-328352-l1q4uvxl	116	84	syndrome	syndrome	NN
cord-328352-l1q4uvxl	116	85	in	in	IN
cord-328352-l1q4uvxl	116	86	Korea	Korea	NNP
cord-328352-l1q4uvxl	116	87	Active	Active	NNP
cord-328352-l1q4uvxl	116	88	therapy	therapy	NN
cord-328352-l1q4uvxl	116	89	with	with	IN
cord-328352-l1q4uvxl	116	90	passive	passive	JJ
cord-328352-l1q4uvxl	116	91	immunotherapy	immunotherapy	NN
cord-328352-l1q4uvxl	116	92	may	may	MD
cord-328352-l1q4uvxl	116	93	be	be	VB
cord-328352-l1q4uvxl	116	94	effective	effective	JJ
cord-328352-l1q4uvxl	116	95	in	in	IN
cord-328352-l1q4uvxl	116	96	the	the	DT
cord-328352-l1q4uvxl	116	97	fight	fight	NN
cord-328352-l1q4uvxl	116	98	against	against	IN
cord-328352-l1q4uvxl	116	99	Covid-19	Covid-19	NNP
cord-328352-l1q4uvxl	116	100	Convalescent	Convalescent	NNP
cord-328352-l1q4uvxl	116	101	plasma	plasma	NN
cord-328352-l1q4uvxl	116	102	or	or	CC
cord-328352-l1q4uvxl	116	103	hyperimmune	hyperimmune	NN
cord-328352-l1q4uvxl	116	104	immunoglobulin	immunoglobulin	NN
cord-328352-l1q4uvxl	116	105	for	for	IN
cord-328352-l1q4uvxl	116	106	people	people	NNS
cord-328352-l1q4uvxl	116	107	with	with	IN
cord-328352-l1q4uvxl	116	108	COVID-19	COVID-19	NNP
cord-328352-l1q4uvxl	116	109	:	:	:
cord-328352-l1q4uvxl	116	110	a	a	DT
cord-328352-l1q4uvxl	116	111	rapid	rapid	JJ
cord-328352-l1q4uvxl	116	112	review	review	NN
cord-328352-l1q4uvxl	116	113	SARS	SARS	NNP
cord-328352-l1q4uvxl	116	114	-	-	HYPH
cord-328352-l1q4uvxl	116	115	CoV-2	CoV-2	NNP
cord-328352-l1q4uvxl	116	116	inflammatory	inflammatory	JJ
cord-328352-l1q4uvxl	116	117	syndrome	syndrome	NN
cord-328352-l1q4uvxl	116	118	.	.	.
cord-328352-l1q4uvxl	117	1	Clinical	clinical	JJ
cord-328352-l1q4uvxl	117	2	features	feature	NNS
cord-328352-l1q4uvxl	117	3	and	and	CC
cord-328352-l1q4uvxl	117	4	rationale	rationale	NN
cord-328352-l1q4uvxl	117	5	for	for	IN
cord-328352-l1q4uvxl	117	6	immunological	immunological	JJ
cord-328352-l1q4uvxl	117	7	treatment	treatment	NN
cord-328352-l1q4uvxl	117	8	Expanded	expand	VBD
cord-328352-l1q4uvxl	117	9	umbilical	umbilical	JJ
cord-328352-l1q4uvxl	117	10	cord	cord	NN
cord-328352-l1q4uvxl	117	11	mesenchymal	mesenchymal	JJ
cord-328352-l1q4uvxl	117	12	stem	stem	NN
cord-328352-l1q4uvxl	117	13	cells	cell	NNS
cord-328352-l1q4uvxl	117	14	(	(	-LRB-
cord-328352-l1q4uvxl	117	15	uc	uc	NNP
cord-328352-l1q4uvxl	117	16	-	-	HYPH
cord-328352-l1q4uvxl	117	17	mscs	mscs	NNP
cord-328352-l1q4uvxl	117	18	)	)	-RRB-
cord-328352-l1q4uvxl	117	19	as	as	IN
cord-328352-l1q4uvxl	117	20	a	a	DT
cord-328352-l1q4uvxl	117	21	therapeutic	therapeutic	JJ
cord-328352-l1q4uvxl	117	22	strategy	strategy	NN
cord-328352-l1q4uvxl	117	23	in	in	IN
cord-328352-l1q4uvxl	117	24	managing	manage	VBG
cord-328352-l1q4uvxl	117	25	critically	critically	RB
cord-328352-l1q4uvxl	117	26	ill	ill	JJ
cord-328352-l1q4uvxl	117	27	covid-19	covid-19	CD
cord-328352-l1q4uvxl	117	28	patients	patient	NNS
cord-328352-l1q4uvxl	117	29	:	:	:
cord-328352-l1q4uvxl	117	30	the	the	DT
cord-328352-l1q4uvxl	117	31	case	case	NN
cord-328352-l1q4uvxl	117	32	for	for	IN
cord-328352-l1q4uvxl	117	33	compassionate	compassionate	JJ
cord-328352-l1q4uvxl	117	34	use	use	NN
cord-328352-l1q4uvxl	117	35	Transplantation	transplantation	NN
cord-328352-l1q4uvxl	117	36	of	of	IN
cord-328352-l1q4uvxl	117	37	ACE2	ACE2	NNP
cord-328352-l1q4uvxl	117	38	À	À	,
cord-328352-l1q4uvxl	117	39	mesenchymal	mesenchymal	JJ
cord-328352-l1q4uvxl	117	40	stem	stem	NN
cord-328352-l1q4uvxl	117	41	cells	cell	NNS
cord-328352-l1q4uvxl	117	42	improves	improve	VBZ
cord-328352-l1q4uvxl	117	43	the	the	DT
cord-328352-l1q4uvxl	117	44	outcome	outcome	NN
cord-328352-l1q4uvxl	117	45	of	of	IN
cord-328352-l1q4uvxl	117	46	patients	patient	NNS
cord-328352-l1q4uvxl	117	47	with	with	IN
cord-328352-l1q4uvxl	117	48	covid-19	covid-19	NNP
cord-328352-l1q4uvxl	117	49	pneumonia	pneumonia	NN
cord-328352-l1q4uvxl	117	50	Exosomes	Exosomes	NNP
cord-328352-l1q4uvxl	117	51	derived	derive	VBN
cord-328352-l1q4uvxl	117	52	from	from	IN
cord-328352-l1q4uvxl	117	53	bone	bone	NN
cord-328352-l1q4uvxl	117	54	marrow	marrow	NN
cord-328352-l1q4uvxl	117	55	mesenchymal	mesenchymal	JJ
cord-328352-l1q4uvxl	117	56	stem	stem	NN
cord-328352-l1q4uvxl	117	57	cells	cell	NNS
cord-328352-l1q4uvxl	117	58	as	as	IN
cord-328352-l1q4uvxl	117	59	treatment	treatment	NN
cord-328352-l1q4uvxl	117	60	for	for	IN
cord-328352-l1q4uvxl	117	61	severe	severe	JJ
cord-328352-l1q4uvxl	117	62	COVID-19	COVID-19	NNP
cord-328352-l1q4uvxl	117	63	Rationale	Rationale	NNP
cord-328352-l1q4uvxl	117	64	for	for	IN
cord-328352-l1q4uvxl	117	65	the	the	DT
cord-328352-l1q4uvxl	117	66	clinical	clinical	JJ
cord-328352-l1q4uvxl	117	67	use	use	NN
cord-328352-l1q4uvxl	117	68	of	of	IN
cord-328352-l1q4uvxl	117	69	adipose	adipose	NN
cord-328352-l1q4uvxl	117	70	-	-	HYPH
cord-328352-l1q4uvxl	117	71	derived	derive	VBN
cord-328352-l1q4uvxl	117	72	mesenchymal	mesenchymal	JJ
cord-328352-l1q4uvxl	117	73	stem	stem	NN
cord-328352-l1q4uvxl	117	74	cells	cell	NNS
cord-328352-l1q4uvxl	117	75	for	for	IN
cord-328352-l1q4uvxl	117	76	COVID-19	covid-19	JJ
cord-328352-l1q4uvxl	117	77	patients	patient	NNS
cord-328352-l1q4uvxl	117	78	.	.	.
cord-328352-l1q4uvxl	118	1	Version	version	NN
cord-328352-l1q4uvxl	118	2	2	2	CD
cord-328352-l1q4uvxl	118	3	Advancing	advance	VBG
cord-328352-l1q4uvxl	118	4	stem	stem	NN
cord-328352-l1q4uvxl	118	5	cell	cell	NN
cord-328352-l1q4uvxl	118	6	therapy	therapy	NN
cord-328352-l1q4uvxl	118	7	for	for	IN
cord-328352-l1q4uvxl	118	8	repair	repair	NN
cord-328352-l1q4uvxl	118	9	of	of	IN
cord-328352-l1q4uvxl	118	10	damaged	damaged	JJ
cord-328352-l1q4uvxl	118	11	lung	lung	NN
cord-328352-l1q4uvxl	118	12	microvasculature	microvasculature	NN
cord-328352-l1q4uvxl	118	13	in	in	IN
cord-328352-l1q4uvxl	118	14	amyotrophic	amyotrophic	JJ
cord-328352-l1q4uvxl	118	15	lateral	lateral	JJ
cord-328352-l1q4uvxl	118	16	sclerosis	sclerosis	NN
cord-328352-l1q4uvxl	118	17	Human	human	JJ
cord-328352-l1q4uvxl	118	18	umbilical	umbilical	JJ
cord-328352-l1q4uvxl	118	19	cord	cord	NN
cord-328352-l1q4uvxl	118	20	blood	blood	NN
cord-328352-l1q4uvxl	118	21	-	-	HYPH
cord-328352-l1q4uvxl	118	22	derived	derive	VBN
cord-328352-l1q4uvxl	118	23	monocytes	monocyte	NNS
cord-328352-l1q4uvxl	118	24	improve	improve	VBP
cord-328352-l1q4uvxl	118	25	cognitive	cognitive	JJ
cord-328352-l1q4uvxl	118	26	deficits	deficit	NNS
cord-328352-l1q4uvxl	118	27	and	and	CC
cord-328352-l1q4uvxl	118	28	reduce	reduce	VB
cord-328352-l1q4uvxl	118	29	amyloid	amyloid	NN
cord-328352-l1q4uvxl	118	30	-	-	HYPH
cord-328352-l1q4uvxl	118	31	b	b	NN
cord-328352-l1q4uvxl	118	32	pathology	pathology	NN
cord-328352-l1q4uvxl	118	33	in	in	IN
cord-328352-l1q4uvxl	118	34	PSAPP	PSAPP	NNP
cord-328352-l1q4uvxl	118	35	mice	mouse	NNS
cord-328352-l1q4uvxl	119	1	Monocytes	monocyte	NNS
cord-328352-l1q4uvxl	119	2	are	be	VBP
cord-328352-l1q4uvxl	119	3	essential	essential	JJ
cord-328352-l1q4uvxl	119	4	for	for	IN
cord-328352-l1q4uvxl	119	5	the	the	DT
cord-328352-l1q4uvxl	119	6	neuroprotective	neuroprotective	JJ
cord-328352-l1q4uvxl	119	7	effect	effect	NN
cord-328352-l1q4uvxl	119	8	of	of	IN
cord-328352-l1q4uvxl	119	9	human	human	JJ
cord-328352-l1q4uvxl	119	10	cord	cord	NN
cord-328352-l1q4uvxl	119	11	blood	blood	NN
cord-328352-l1q4uvxl	119	12	cells	cell	NNS
cord-328352-l1q4uvxl	119	13	following	follow	VBG
cord-328352-l1q4uvxl	119	14	middle	middle	JJ
cord-328352-l1q4uvxl	119	15	cerebral	cerebral	JJ
cord-328352-l1q4uvxl	119	16	artery	artery	NN
cord-328352-l1q4uvxl	119	17	occlusion	occlusion	NN
cord-328352-l1q4uvxl	119	18	in	in	IN
cord-328352-l1q4uvxl	119	19	rat	rat	NN
cord-328352-l1q4uvxl	119	20	A	a	DT
cord-328352-l1q4uvxl	119	21	gut	gut	NN
cord-328352-l1q4uvxl	119	22	feeling	feeling	NN
cord-328352-l1q4uvxl	119	23	about	about	IN
cord-328352-l1q4uvxl	119	24	stroke	stroke	NN
cord-328352-l1q4uvxl	119	25	reveals	reveal	VBZ
cord-328352-l1q4uvxl	119	26	gut	gut	NN
cord-328352-l1q4uvxl	119	27	-	-	HYPH
cord-328352-l1q4uvxl	119	28	brain	brain	NN
cord-328352-l1q4uvxl	119	29	axis	axis	NN
cord-328352-l1q4uvxl	119	30	'	'	''
cord-328352-l1q4uvxl	119	31	active	active	JJ
cord-328352-l1q4uvxl	119	32	role	role	NN
cord-328352-l1q4uvxl	119	33	in	in	IN
cord-328352-l1q4uvxl	119	34	homeostasis	homeostasis	NN
cord-328352-l1q4uvxl	119	35	and	and	CC
cord-328352-l1q4uvxl	119	36	dysbiosis	dysbiosis	NN
cord-328352-l1q4uvxl	119	37	Gut	gut	NN
cord-328352-l1q4uvxl	119	38	microbiome	microbiome	NN
cord-328352-l1q4uvxl	119	39	:	:	:
cord-328352-l1q4uvxl	119	40	lactation	lactation	NN
cord-328352-l1q4uvxl	119	41	,	,	,
cord-328352-l1q4uvxl	119	42	childbirth	childbirth	NN
cord-328352-l1q4uvxl	119	43	,	,	,
cord-328352-l1q4uvxl	119	44	lung	lung	NN
cord-328352-l1q4uvxl	119	45	dysbiosis	dysbiosis	NN
cord-328352-l1q4uvxl	119	46	,	,	,
cord-328352-l1q4uvxl	119	47	animal	animal	NN
cord-328352-l1q4uvxl	119	48	modeling	modeling	NN
cord-328352-l1q4uvxl	119	49	,	,	,
cord-328352-l1q4uvxl	119	50	stem	stem	NN
cord-328352-l1q4uvxl	119	51	cell	cell	NN
cord-328352-l1q4uvxl	119	52	treatment	treatment	NN
cord-328352-l1q4uvxl	119	53	,	,	,
cord-328352-l1q4uvxl	119	54	and	and	CC
cord-328352-l1q4uvxl	119	55	CNS	CNS	NNP
cord-328352-l1q4uvxl	119	56	disorders	disorder	NNS
cord-328352-l1q4uvxl	120	1	A	a	DT
cord-328352-l1q4uvxl	120	2	gutsy	gutsy	JJ
cord-328352-l1q4uvxl	120	3	move	move	NN
cord-328352-l1q4uvxl	120	4	for	for	IN
cord-328352-l1q4uvxl	120	5	cell	cell	NN
cord-328352-l1q4uvxl	120	6	-	-	HYPH
cord-328352-l1q4uvxl	120	7	based	base	VBN
cord-328352-l1q4uvxl	120	8	regenerative	regenerative	JJ
cord-328352-l1q4uvxl	120	9	medicine	medicine	NN
cord-328352-l1q4uvxl	120	10	in	in	IN
cord-328352-l1q4uvxl	120	11	Parkinson	Parkinson	NNP
cord-328352-l1q4uvxl	120	12	's	's	POS
cord-328352-l1q4uvxl	120	13	disease	disease	NN
cord-328352-l1q4uvxl	120	14	:	:	:
cord-328352-l1q4uvxl	120	15	targeting	target	VBG
cord-328352-l1q4uvxl	120	16	the	the	DT
cord-328352-l1q4uvxl	120	17	gut	gut	NN
cord-328352-l1q4uvxl	120	18	microbiome	microbiome	NN
cord-328352-l1q4uvxl	120	19	to	to	TO
cord-328352-l1q4uvxl	120	20	sequester	sequester	VB
cord-328352-l1q4uvxl	120	21	inflammation	inflammation	NN
cord-328352-l1q4uvxl	120	22	and	and	CC
cord-328352-l1q4uvxl	120	23	neurotoxicity	neurotoxicity	NN
cord-328352-l1q4uvxl	120	24	Gutting	gutte	VBG
cord-328352-l1q4uvxl	120	25	the	the	DT
cord-328352-l1q4uvxl	120	26	brain	brain	NN
cord-328352-l1q4uvxl	120	27	of	of	IN
cord-328352-l1q4uvxl	120	28	inflammation	inflammation	NN
cord-328352-l1q4uvxl	120	29	:	:	:
cord-328352-l1q4uvxl	120	30	a	a	DT
cord-328352-l1q4uvxl	120	31	key	key	JJ
cord-328352-l1q4uvxl	120	32	role	role	NN
cord-328352-l1q4uvxl	120	33	of	of	IN
cord-328352-l1q4uvxl	120	34	gut	gut	NN
cord-328352-l1q4uvxl	120	35	microbiome	microbiome	NN
cord-328352-l1q4uvxl	120	36	in	in	IN
cord-328352-l1q4uvxl	120	37	human	human	JJ
cord-328352-l1q4uvxl	120	38	umbilical	umbilical	JJ
cord-328352-l1q4uvxl	120	39	cord	cord	NN
cord-328352-l1q4uvxl	120	40	blood	blood	NN
cord-328352-l1q4uvxl	120	41	plasma	plasma	NN
cord-328352-l1q4uvxl	120	42	therapy	therapy	NN
cord-328352-l1q4uvxl	120	43	in	in	IN
cord-328352-l1q4uvxl	120	44	Parkinson	Parkinson	NNP
cord-328352-l1q4uvxl	120	45	's	's	POS
cord-328352-l1q4uvxl	120	46	disease	disease	NN
cord-328352-l1q4uvxl	120	47	model	model	NN
cord-328352-l1q4uvxl	120	48	Probiotics	probiotic	NNS
cord-328352-l1q4uvxl	120	49	and	and	CC
cord-328352-l1q4uvxl	120	50	prebiotics	prebiotic	NNS
cord-328352-l1q4uvxl	120	51	as	as	IN
cord-328352-l1q4uvxl	120	52	a	a	DT
cord-328352-l1q4uvxl	120	53	therapeutic	therapeutic	JJ
cord-328352-l1q4uvxl	120	54	strategy	strategy	NN
cord-328352-l1q4uvxl	120	55	to	to	TO
cord-328352-l1q4uvxl	120	56	improve	improve	VB
cord-328352-l1q4uvxl	120	57	memory	memory	NN
cord-328352-l1q4uvxl	120	58	in	in	IN
cord-328352-l1q4uvxl	120	59	a	a	DT
cord-328352-l1q4uvxl	120	60	model	model	NN
cord-328352-l1q4uvxl	120	61	of	of	IN
cord-328352-l1q4uvxl	120	62	middle	middle	NN
cord-328352-l1q4uvxl	120	63	-	-	HYPH
cord-328352-l1q4uvxl	120	64	aged	aged	JJ
cord-328352-l1q4uvxl	120	65	rats	rat	NNS
cord-328352-l1q4uvxl	120	66	Characteristics	characteristic	NNS
cord-328352-l1q4uvxl	120	67	and	and	CC
cord-328352-l1q4uvxl	120	68	outcomes	outcome	NNS
cord-328352-l1q4uvxl	120	69	of	of	IN
cord-328352-l1q4uvxl	120	70	coronavirus	coronavirus	NN
cord-328352-l1q4uvxl	120	71	disease	disease	NN
cord-328352-l1q4uvxl	120	72	patients	patient	NNS
cord-328352-l1q4uvxl	120	73	under	under	IN
cord-328352-l1q4uvxl	120	74	nonsurge	nonsurge	NNP
cord-328352-l1q4uvxl	120	75	conditions	condition	NNS
cord-328352-l1q4uvxl	120	76	Time	Time	NNP
cord-328352-l1q4uvxl	120	77	-	-	HYPH
cord-328352-l1q4uvxl	120	78	to	to	IN
cord-328352-l1q4uvxl	120	79	-	-	HYPH
cord-328352-l1q4uvxl	120	80	death	death	NN
cord-328352-l1q4uvxl	120	81	approach	approach	NN
cord-328352-l1q4uvxl	120	82	in	in	IN
cord-328352-l1q4uvxl	120	83	revealing	reveal	VBG
cord-328352-l1q4uvxl	120	84	chronicity	chronicity	NN
cord-328352-l1q4uvxl	120	85	and	and	CC
cord-328352-l1q4uvxl	120	86	severity	severity	NN
cord-328352-l1q4uvxl	120	87	of	of	IN
cord-328352-l1q4uvxl	120	88	covid-19	covid-19	NN
cord-328352-l1q4uvxl	120	89	across	across	IN
cord-328352-l1q4uvxl	120	90	the	the	DT
cord-328352-l1q4uvxl	120	91	world	world	NN
cord-328352-l1q4uvxl	121	1	A	a	DT
cord-328352-l1q4uvxl	121	2	geroscience	geroscience	NN
cord-328352-l1q4uvxl	121	3	perspective	perspective	NN
cord-328352-l1q4uvxl	121	4	on	on	IN
cord-328352-l1q4uvxl	121	5	COVID-19	COVID-19	NNP
cord-328352-l1q4uvxl	121	6	mortality	mortality	NN
cord-328352-l1q4uvxl	121	7	Neurologic	neurologic	JJ
cord-328352-l1q4uvxl	121	8	complications	complication	NNS
cord-328352-l1q4uvxl	121	9	of	of	IN
cord-328352-l1q4uvxl	121	10	COVID-19	COVID-19	NNP
cord-328352-l1q4uvxl	121	11	COVID-19	COVID-19	NNP
cord-328352-l1q4uvxl	121	12	and	and	CC
cord-328352-l1q4uvxl	121	13	the	the	DT
cord-328352-l1q4uvxl	121	14	cerebro	cerebro	NNP
cord-328352-l1q4uvxl	121	15	-	-	HYPH
cord-328352-l1q4uvxl	121	16	cardiovascular	cardiovascular	JJ
cord-328352-l1q4uvxl	121	17	systems	system	NNS
cord-328352-l1q4uvxl	122	1	:	:	:
cord-328352-l1q4uvxl	122	2	what	what	WP
cord-328352-l1q4uvxl	122	3	do	do	VBP
cord-328352-l1q4uvxl	122	4	we	-PRON-	PRP
cord-328352-l1q4uvxl	122	5	know	know	VB
cord-328352-l1q4uvxl	122	6	so	so	RB
cord-328352-l1q4uvxl	122	7	far	far	RB
cord-328352-l1q4uvxl	122	8	?	?	.
cord-328352-l1q4uvxl	123	1	Potential	potential	JJ
cord-328352-l1q4uvxl	123	2	effects	effect	NNS
cord-328352-l1q4uvxl	123	3	of	of	IN
cord-328352-l1q4uvxl	123	4	coronaviruses	coronaviruse	NNS
cord-328352-l1q4uvxl	123	5	on	on	IN
cord-328352-l1q4uvxl	123	6	the	the	DT
cord-328352-l1q4uvxl	123	7	cardiovascular	cardiovascular	JJ
cord-328352-l1q4uvxl	123	8	system	system	NN
cord-328352-l1q4uvxl	123	9	:	:	:
cord-328352-l1q4uvxl	123	10	a	a	DT
cord-328352-l1q4uvxl	123	11	review	review	NN
cord-328352-l1q4uvxl	123	12	Excess	excess	JJ
cord-328352-l1q4uvxl	123	13	neurological	neurological	JJ
cord-328352-l1q4uvxl	123	14	death	death	NN
cord-328352-l1q4uvxl	123	15	in	in	IN
cord-328352-l1q4uvxl	123	16	New	New	NNP
cord-328352-l1q4uvxl	123	17	York	York	NNP
cord-328352-l1q4uvxl	123	18	City	City	NNP
cord-328352-l1q4uvxl	123	19	after	after	IN
cord-328352-l1q4uvxl	123	20	the	the	DT
cord-328352-l1q4uvxl	123	21	emergence	emergence	NN
cord-328352-l1q4uvxl	123	22	of	of	IN
cord-328352-l1q4uvxl	123	23	COVID-19	COVID-19	NNP
cord-328352-l1q4uvxl	123	24	A	a	DT
cord-328352-l1q4uvxl	123	25	systematic	systematic	JJ
cord-328352-l1q4uvxl	123	26	review	review	NN
cord-328352-l1q4uvxl	123	27	of	of	IN
cord-328352-l1q4uvxl	123	28	neurological	neurological	JJ
cord-328352-l1q4uvxl	123	29	symptoms	symptom	NNS
cord-328352-l1q4uvxl	123	30	and	and	CC
cord-328352-l1q4uvxl	123	31	complications	complication	NNS
cord-328352-l1q4uvxl	123	32	of	of	IN
cord-328352-l1q4uvxl	123	33	COVID-19	COVID-19	NNP